false--12-29Q220190001617669P2Y0.12500.0750.10P1Y0.0010.0011500000015000000977914797791479779147977914700000.0618850.06178130.0618850.0600375000812500337500575000P5Y131735300967000000000001P40YP10YP10YP7YP23YP7YP3YP3YP3Y3.330.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20 0001617669 2018-12-31 2019-06-30 0001617669 2019-08-07 0001617669 2019-06-30 0001617669 2018-12-30 0001617669 2018-04-02 2018-07-01 0001617669 2018-01-01 2018-07-01 0001617669 2019-04-01 2019-06-30 0001617669 2019-03-31 0001617669 2018-12-31 2019-03-31 0001617669 us-gaap:CommonStockMember 2019-06-30 0001617669 us-gaap:RetainedEarningsMember 2019-06-30 0001617669 us-gaap:RetainedEarningsMember 2018-12-30 0001617669 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001617669 us-gaap:CommonStockMember 2019-03-31 0001617669 us-gaap:RetainedEarningsMember 2018-12-31 2019-03-31 0001617669 us-gaap:AdditionalPaidInCapitalMember 2018-12-30 0001617669 us-gaap:RetainedEarningsMember 2019-03-31 0001617669 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001617669 us-gaap:CommonStockMember 2018-12-30 0001617669 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001617669 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001617669 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 2019-03-31 0001617669 2018-07-01 0001617669 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001617669 us-gaap:RetainedEarningsMember 2018-04-02 2018-07-01 0001617669 us-gaap:CommonStockMember 2017-12-31 0001617669 2018-01-01 2018-04-01 0001617669 2017-12-31 0001617669 us-gaap:AdditionalPaidInCapitalMember 2018-04-01 0001617669 us-gaap:RetainedEarningsMember 2018-01-01 2018-04-01 0001617669 2018-04-01 0001617669 us-gaap:CommonStockMember 2018-04-02 2018-07-01 0001617669 us-gaap:RetainedEarningsMember 2018-07-01 0001617669 us-gaap:AdditionalPaidInCapitalMember 2018-04-02 2018-07-01 0001617669 us-gaap:CommonStockMember 2018-01-01 2018-04-01 0001617669 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-04-01 0001617669 us-gaap:RetainedEarningsMember 2018-04-01 0001617669 us-gaap:CommonStockMember 2018-07-01 0001617669 us-gaap:RetainedEarningsMember 2017-12-31 0001617669 us-gaap:AdditionalPaidInCapitalMember 2018-07-01 0001617669 us-gaap:CommonStockMember 2018-04-01 0001617669 ufab:LineOfCreditForCapitalExpendituresMember 2018-01-01 2018-07-01 0001617669 us-gaap:RevolvingCreditFacilityMember 2018-12-31 2019-06-30 0001617669 ufab:LineOfCreditForCapitalExpendituresMember 2018-12-31 2019-06-30 0001617669 us-gaap:RevolvingCreditFacilityMember 2018-01-01 2018-07-01 0001617669 ufab:AutomotiveMember 2018-12-31 2019-06-30 0001617669 ufab:HVACWaterHeaterAndAppliancesMember 2018-12-31 2019-06-30 0001617669 ufab:AutomotiveMember 2019-04-01 2019-06-30 0001617669 ufab:OtherRevenueMember 2018-12-31 2019-06-30 0001617669 ufab:HVACWaterHeaterAndAppliancesMember 2019-04-01 2019-06-30 0001617669 ufab:OtherRevenueMember 2019-04-01 2019-06-30 0001617669 country:CA us-gaap:CostOfGoodsTotalMember us-gaap:GeographicConcentrationRiskMember 2018-04-02 2018-07-01 0001617669 country:CA us-gaap:CostOfGoodsTotalMember us-gaap:GeographicConcentrationRiskMember 2018-12-31 2019-06-30 0001617669 ufab:GeneralMotorsCompanyMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-12-31 2019-06-30 0001617669 country:MX us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2018-04-02 2018-07-01 0001617669 us-gaap:LineOfCreditMember ufab:SeniorCreditFacilityMember us-gaap:RevolvingCreditFacilityMember 2018-12-31 2019-06-30 0001617669 ufab:GeneralMotorsCompanyMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-04-02 2018-07-01 0001617669 ufab:FiatChryslerAutomobileMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-04-01 2019-06-30 0001617669 ufab:FiatChryslerAutomobileMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-04-02 2018-07-01 0001617669 us-gaap:LineOfCreditMember ufab:SeniorCreditFacilityMember us-gaap:RevolvingCreditFacilityMember 2019-06-30 0001617669 ufab:FordMotorCompanyMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-07-01 0001617669 country:MX us-gaap:CostOfGoodsTotalMember us-gaap:GeographicConcentrationRiskMember 2018-12-31 2019-06-30 0001617669 ufab:GeneralMotorsCompanyMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2018-12-31 2019-06-30 0001617669 ufab:CollectiveBargainingArrangementsExpiringAugust2019Member us-gaap:WorkforceSubjectToCollectiveBargainingArrangementsMember us-gaap:LaborForceConcentrationRiskMember 2018-12-31 2019-06-30 0001617669 country:CA us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2019-04-01 2019-06-30 0001617669 country:CA us-gaap:CostOfGoodsTotalMember us-gaap:GeographicConcentrationRiskMember 2019-04-01 2019-06-30 0001617669 ufab:NonUSCountriesExcludingMexicoandCanadaMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2019-04-01 2019-06-30 0001617669 ufab:FordMotorCompanyMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-12-31 2019-06-30 0001617669 country:MX us-gaap:CostOfGoodsTotalMember us-gaap:GeographicConcentrationRiskMember 2018-01-01 2018-07-01 0001617669 us-gaap:AccountsPayableMember 2019-06-30 0001617669 ufab:NonUSCountriesExcludingMexicoandCanadaMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2018-04-02 2018-07-01 0001617669 country:CA us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2018-04-02 2018-07-01 0001617669 ufab:FiatChryslerAutomobileMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-12-31 2019-06-30 0001617669 ufab:CollectiveBargainingArrangementsExpiringFebruary2020Member us-gaap:WorkforceSubjectToCollectiveBargainingArrangementsMember us-gaap:LaborForceConcentrationRiskMember 2018-12-31 2019-06-30 0001617669 country:MX us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2019-04-01 2019-06-30 0001617669 country:MX us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2018-01-01 2018-07-01 0001617669 country:CA us-gaap:CostOfGoodsTotalMember us-gaap:GeographicConcentrationRiskMember 2018-01-01 2018-07-01 0001617669 country:MX us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2018-12-31 2019-06-30 0001617669 ufab:GeneralMotorsCompanyMember ufab:DirectCompanySalesMember us-gaap:CustomerConcentrationRiskMember 2018-12-31 2019-06-30 0001617669 country:MX us-gaap:CostOfGoodsTotalMember us-gaap:GeographicConcentrationRiskMember 2018-04-02 2018-07-01 0001617669 country:CA us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2018-12-31 2019-06-30 0001617669 ufab:FordMotorCompanyMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-04-02 2018-07-01 0001617669 us-gaap:AccountsPayableMember 2018-12-30 0001617669 ufab:FiatChryslerAutomobileMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-07-01 0001617669 ufab:NonUSCountriesExcludingMexicoandCanadaMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2018-12-31 2019-06-30 0001617669 ufab:GeneralMotorsCompanyMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-07-01 0001617669 ufab:NonUSCountriesExcludingMexicoandCanadaMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2018-01-01 2018-07-01 0001617669 ufab:GeneralMotorsCompanyMember ufab:DirectCompanySalesMember us-gaap:CustomerConcentrationRiskMember 2019-04-01 2019-06-30 0001617669 country:MX us-gaap:CostOfGoodsTotalMember us-gaap:GeographicConcentrationRiskMember 2019-04-01 2019-06-30 0001617669 country:CA us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2018-01-01 2018-07-01 0001617669 ufab:GeneralMotorsCompanyMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-04-01 2019-06-30 0001617669 ufab:GeneralMotorsCompanyMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-12-30 0001617669 ufab:FordMotorCompanyMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-04-01 2019-06-30 0001617669 country:CA 2019-06-30 0001617669 country:CA 2018-12-30 0001617669 country:MX 2019-06-30 0001617669 country:MX 2018-12-30 0001617669 us-gaap:VehiclesMember 2018-12-30 0001617669 us-gaap:ConstructionInProgressMember 2018-12-30 0001617669 us-gaap:OfficeEquipmentMember 2018-12-30 0001617669 us-gaap:VehiclesMember 2019-06-30 0001617669 us-gaap:OfficeEquipmentMember 2019-06-30 0001617669 us-gaap:EquipmentMember 2019-06-30 0001617669 us-gaap:EquipmentMember 2018-12-30 0001617669 us-gaap:LandMember 2019-06-30 0001617669 us-gaap:LeaseholdImprovementsMember 2019-06-30 0001617669 us-gaap:BuildingMember 2018-12-30 0001617669 us-gaap:ConstructionInProgressMember 2019-06-30 0001617669 us-gaap:BuildingMember 2019-06-30 0001617669 us-gaap:LeaseholdImprovementsMember 2018-12-30 0001617669 us-gaap:LandMember 2018-12-30 0001617669 srt:MinimumMember us-gaap:BuildingMember 2018-12-31 2019-06-30 0001617669 us-gaap:VehiclesMember 2018-12-31 2019-06-30 0001617669 srt:MaximumMember us-gaap:BuildingMember 2018-12-31 2019-06-30 0001617669 srt:MinimumMember us-gaap:EquipmentMember 2018-12-31 2019-06-30 0001617669 srt:MaximumMember us-gaap:EquipmentMember 2018-12-31 2019-06-30 0001617669 srt:MinimumMember us-gaap:OfficeEquipmentMember 2018-12-31 2019-06-30 0001617669 srt:MaximumMember us-gaap:LeaseholdImprovementsMember 2018-12-31 2019-06-30 0001617669 srt:MaximumMember us-gaap:OfficeEquipmentMember 2018-12-31 2019-06-30 0001617669 srt:MinimumMember us-gaap:LeaseholdImprovementsMember 2018-12-31 2019-06-30 0001617669 srt:WeightedAverageMember us-gaap:NoncompeteAgreementsMember 2018-12-31 2019-06-30 0001617669 us-gaap:UnpatentedTechnologyMember 2019-06-30 0001617669 us-gaap:TradeNamesMember 2019-06-30 0001617669 srt:WeightedAverageMember us-gaap:CustomerContractsMember 2018-12-31 2019-06-30 0001617669 us-gaap:NoncompeteAgreementsMember 2019-06-30 0001617669 us-gaap:CustomerContractsMember 2019-06-30 0001617669 srt:WeightedAverageMember us-gaap:TradeNamesMember 2018-12-31 2019-06-30 0001617669 srt:WeightedAverageMember us-gaap:UnpatentedTechnologyMember 2018-12-31 2019-06-30 0001617669 srt:WeightedAverageMember 2018-12-31 2019-06-30 0001617669 us-gaap:TradeNamesMember 2018-12-30 0001617669 us-gaap:CustomerContractsMember 2018-12-30 0001617669 srt:WeightedAverageMember us-gaap:CustomerContractsMember 2018-01-01 2018-12-30 0001617669 srt:WeightedAverageMember us-gaap:UnpatentedTechnologyMember 2018-01-01 2018-12-30 0001617669 us-gaap:UnpatentedTechnologyMember 2018-12-30 0001617669 srt:WeightedAverageMember us-gaap:NoncompeteAgreementsMember 2018-01-01 2018-12-30 0001617669 us-gaap:NoncompeteAgreementsMember 2018-12-30 0001617669 srt:WeightedAverageMember us-gaap:TradeNamesMember 2018-01-01 2018-12-30 0001617669 us-gaap:LineOfCreditMember ufab:NewRevolverMember us-gaap:RevolvingCreditFacilityMember 2019-06-30 0001617669 ufab:AmendedAndRestatedCreditAgreementMember us-gaap:SubsequentEventMember 2019-07-16 0001617669 us-gaap:LineOfCreditMember ufab:USTermLoanIIMember us-gaap:SecuredDebtMember 2017-08-18 0001617669 us-gaap:LetterOfCreditMember ufab:CreditAgreementMember us-gaap:RevolvingCreditFacilityMember 2016-04-29 0001617669 srt:MaximumMember us-gaap:LineOfCreditMember ufab:CreditAgreementMember us-gaap:SecuredDebtMember us-gaap:BaseRateMember 2018-12-31 2019-06-30 0001617669 us-gaap:LineOfCreditMember ufab:NewRevolverMember us-gaap:RevolvingCreditFacilityMember 2016-04-29 0001617669 us-gaap:LineOfCreditMember ufab:NewRevolverMember us-gaap:RevolvingCreditFacilityMember 2018-11-01 0001617669 ufab:UniqueFabricatingNAInc.AndUniqueIntascoCanadaInc.Member ufab:DebtInstrumentPeriodicPaymentInstallmentsThroughNovemberEighthTwentyTwentyMember ufab:LineOfCreditForCapitalExpendituresMember ufab:AmendedAndRestatedCreditAgreementMember 2018-11-08 0001617669 us-gaap:LineOfCreditMember ufab:SeniorCreditFacilitySecondAmendmentMember us-gaap:RevolvingCreditFacilityMember 2019-06-30 0001617669 us-gaap:LineOfCreditMember ufab:USTermLoanMember us-gaap:SecuredDebtMember 2016-04-29 0001617669 ufab:UniqueFabricatingNAInc.AndUniqueIntascoCanadaInc.Member ufab:DebtInstrumentPeriodicPaymentInstallmentsThroughMaturityMember us-gaap:LineOfCreditMember ufab:NewUSTermLoanMember us-gaap:SecuredDebtMember 2018-11-08 2018-11-08 0001617669 us-gaap:LineOfCreditMember ufab:CreditAgreementMember us-gaap:SecuredDebtMember 2016-04-29 0001617669 ufab:AmendedAndRestatedCreditAgreementMember 2019-03-31 0001617669 srt:MinimumMember us-gaap:LineOfCreditMember ufab:CreditAgreementMember us-gaap:SecuredDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-12-31 2019-06-30 0001617669 ufab:UniqueFabricatingNAInc.AndUniqueIntascoCanadaInc.Member us-gaap:LineOfCreditMember ufab:AmendedAndRestatedCreditAgreementMember us-gaap:RevolvingCreditFacilityMember 2018-11-08 0001617669 ufab:UniqueFabricatingNAInc.AndUniqueIntascoCanadaInc.Member us-gaap:LineOfCreditMember ufab:USTermLoanAndTermLoanIIMember us-gaap:SecuredDebtMember 2018-11-08 0001617669 ufab:NewRevolverMember us-gaap:RevolvingCreditFacilityMember 2019-06-30 0001617669 ufab:UniqueFabricatingNAInc.AndUniqueIntascoCanadaInc.Member us-gaap:LineOfCreditMember ufab:CATermLoanMember us-gaap:SecuredDebtMember 2018-12-30 0001617669 srt:MinimumMember us-gaap:LineOfCreditMember ufab:CreditAgreementMember us-gaap:SecuredDebtMember us-gaap:BaseRateMember 2018-12-31 2019-06-30 0001617669 us-gaap:LineOfCreditMember ufab:CATermLoanMember us-gaap:SecuredDebtMember 2016-04-29 0001617669 us-gaap:LineOfCreditMember ufab:CreditAgreementMember us-gaap:SecuredDebtMember 2016-04-29 2016-04-29 0001617669 ufab:UniqueFabricatingNAInc.AndUniqueIntascoCanadaInc.Member ufab:DebtInstrumentPeriodicPaymentInstallmentsThroughSeptemberThirtyTwoThousandTwentyMember us-gaap:LineOfCreditMember ufab:NewUSTermLoanMember us-gaap:SecuredDebtMember 2018-11-08 2018-11-08 0001617669 us-gaap:LineOfCreditMember ufab:NewRevolverMember us-gaap:RevolvingCreditFacilityMember 2018-09-20 0001617669 ufab:UniqueFabricatingNAInc.AndUniqueIntascoCanadaInc.Member us-gaap:LineOfCreditMember ufab:USTermLoanMember us-gaap:SecuredDebtMember 2018-11-08 2018-11-08 0001617669 ufab:UniqueFabricatingNAInc.AndUniqueIntascoCanadaInc.Member us-gaap:LineOfCreditMember ufab:NewUSTermLoanMember us-gaap:SecuredDebtMember 2018-11-08 0001617669 srt:MaximumMember us-gaap:LineOfCreditMember ufab:CreditAgreementMember us-gaap:SecuredDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-12-31 2019-06-30 0001617669 us-gaap:LineOfCreditMember ufab:NewRevolverMember us-gaap:RevolvingCreditFacilityMember 2017-08-18 0001617669 us-gaap:LineOfCreditMember ufab:NewRevolverMember us-gaap:RevolvingCreditFacilityMember 2016-04-29 2016-04-29 0001617669 ufab:UniqueFabricatingNAInc.AndUniqueIntascoCanadaInc.Member ufab:DebtInstrumentPeriodicPaymentInstallmentsThroughNovemberEighthTwentyNineteenMember ufab:LineOfCreditForCapitalExpendituresMember ufab:AmendedAndRestatedCreditAgreementMember 2018-11-08 0001617669 ufab:UniqueFabricatingNAInc.AndUniqueIntascoCanadaInc.Member ufab:DebtInstrumentPeriodicPaymentInstallmentsThroughSeptemberThirtyTwoThousandTwentyOneMember us-gaap:LineOfCreditMember ufab:NewUSTermLoanMember us-gaap:SecuredDebtMember 2018-11-08 2018-11-08 0001617669 us-gaap:NotesPayableOtherPayablesMember 2018-12-30 0001617669 us-gaap:UnsecuredDebtMember 2019-06-30 0001617669 ufab:LineOfCreditForCapitalExpendituresMember 2018-12-30 0001617669 us-gaap:NotesPayableOtherPayablesMember 2019-06-30 0001617669 us-gaap:UnsecuredDebtMember 2018-12-30 0001617669 ufab:LineOfCreditForCapitalExpendituresMember 2019-06-30 0001617669 us-gaap:LineOfCreditMember ufab:CATermLoanMember us-gaap:SecuredDebtMember 2018-12-30 0001617669 us-gaap:LineOfCreditMember ufab:NewUSTermLoanMember us-gaap:SecuredDebtMember 2018-12-30 0001617669 us-gaap:LineOfCreditMember ufab:NewUSTermLoanMember us-gaap:SecuredDebtMember 2019-06-30 0001617669 us-gaap:LineOfCreditMember ufab:CATermLoanMember us-gaap:SecuredDebtMember 2019-06-30 0001617669 ufab:UniqueFabricatingNAInc.AndUniqueIntascoCanadaInc.Member us-gaap:LineOfCreditMember ufab:AmendedAndRestatedCreditAgreementMember 2018-11-08 2018-11-08 0001617669 ufab:DebtInstrumentPeriodicPaymentInstallmentsThroughNovemberSevenTwentyTwentyThreeMember us-gaap:LineOfCreditMember ufab:NewUSTermLoanMember us-gaap:SecuredDebtMember 2018-12-31 2019-06-30 0001617669 ufab:DebtInstrumentPeriodicPaymentInstallmentsThroughNovemberSevenTwentyTwentyThreeMember us-gaap:LineOfCreditMember ufab:LineOfCreditForCapitalExpendituresMember 2018-12-31 2019-06-30 0001617669 ufab:DebtInstrumentPeriodicPaymentInstallmentsThroughSeptemberThirtyTwentyTwentyMember us-gaap:LineOfCreditMember ufab:LineOfCreditForCapitalExpendituresMember 2018-12-31 2019-06-30 0001617669 ufab:DebtInstrumentPeriodicPaymentInstallmentsThroughNovemberSevenTwentyTwentyThreeMember us-gaap:LineOfCreditMember ufab:CATermLoanMember us-gaap:SecuredDebtMember 2018-12-31 2019-06-30 0001617669 ufab:DebtInstrumentPeriodicPaymentInstallmentsThroughSeptemberThirtyTwentyTwentyOneMember us-gaap:LineOfCreditMember ufab:LineOfCreditForCapitalExpendituresMember 2018-12-31 2019-06-30 0001617669 us-gaap:LineOfCreditMember ufab:LineOfCreditForCapitalExpendituresMember 2019-06-30 0001617669 ufab:DebtInstrumentPeriodicPaymentInstallmentsThroughSeptemberThirtyTwentyTwentyMember us-gaap:LineOfCreditMember ufab:NewUSTermLoanMember us-gaap:SecuredDebtMember 2018-12-31 2019-06-30 0001617669 ufab:DebtInstrumentPeriodicPaymentInstallmentsThroughSeptemberThirtyTwentyTwentyOneMember us-gaap:LineOfCreditMember ufab:NewUSTermLoanMember us-gaap:SecuredDebtMember 2018-12-31 2019-06-30 0001617669 ufab:DerivativeInstrumentPeriodicPaymentInstallmentPeriodsUntilDecemberThirtyFirstTwentyTwentyOneMember us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2018-11-30 0001617669 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2018-11-30 0001617669 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember us-gaap:InterestExpenseMember 2018-04-02 2018-07-01 0001617669 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember us-gaap:InterestExpenseMember 2018-12-31 2019-06-30 0001617669 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember us-gaap:InterestExpenseMember 2018-01-01 2018-07-01 0001617669 ufab:DerivativeInstrumentPeriodicPaymentInstallmentPeriodsThroughJuneTwentyEightTwoThousandNineteenMember us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2018-11-30 0001617669 ufab:DerivativeInstrumentPeriodicPaymentInstallmentPeriodsThroughJuneTwentyNineTwoThousandEighteenMember us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2016-06-30 0001617669 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2018-07-01 0001617669 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2016-06-30 0001617669 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2017-10-02 0001617669 ufab:DerivativeInstrumentPeriodicPaymentInstallmentPeriodsUntilNovemberEighthTwentyTwentyThreeMember us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2018-11-30 0001617669 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember us-gaap:InterestExpenseMember 2019-04-01 2019-06-30 0001617669 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2019-06-30 0001617669 ufab:DerivativeInstrumentPeriodicPaymentInstallmentPeriodsThroughJuneTwentyEightTwoThousandNineteenMember us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2016-06-30 0001617669 ufab:DerivativeInstrumentPeriodicPaymentInstallmentPeriodsUntilSeptemberThirtyTwoThousandTwentyMember us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2018-11-30 0001617669 us-gaap:EmployeeSeveranceMember 2017-12-31 0001617669 us-gaap:OtherRestructuringMember 2018-01-01 2018-07-01 0001617669 us-gaap:OtherRestructuringMember 2017-12-31 0001617669 us-gaap:EmployeeSeveranceMember 2018-01-01 2018-07-01 0001617669 us-gaap:EmployeeSeveranceMember 2018-07-01 0001617669 us-gaap:OtherRestructuringMember 2018-07-01 0001617669 us-gaap:OtherRestructuringMember ufab:PortHuronRestructuringMember 2018-01-01 2018-07-01 0001617669 ufab:FortSmithArkansasMember us-gaap:ManufacturingFacilityMember 2018-10-18 2018-10-18 0001617669 ufab:FortSmithArkansasMember us-gaap:ManufacturingFacilityMember 2018-10-18 0001617669 ufab:SalariedRestructuringMember 2019-04-01 2019-06-30 0001617669 ufab:FortSmithRestructuringMember 2018-07-02 2018-07-31 0001617669 ufab:PortHuronRestructuringMember 2018-02-01 2018-02-01 0001617669 us-gaap:ContractTerminationMember ufab:EvansvilleRestructuringMember 2019-06-30 0001617669 srt:ScenarioForecastMember ufab:EvansvilleRestructuringMember 2019-09-01 2019-09-30 0001617669 us-gaap:OneTimeTerminationBenefitsMember ufab:EvansvilleRestructuringMember 2019-06-30 0001617669 ufab:SalariedRestructuringMember 2019-04-01 2019-06-30 0001617669 us-gaap:OtherRestructuringMember ufab:FortSmithRestructuringMember 2018-04-02 2018-07-01 0001617669 ufab:SalariedRestructuringMember 2018-12-31 2019-06-30 0001617669 ufab:SalariedRestructuringMember 2018-12-31 2019-06-30 0001617669 us-gaap:OtherRestructuringMember ufab:PortHuronRestructuringMember 2018-04-02 2018-07-01 0001617669 us-gaap:OtherRestructuringMember ufab:EvansvilleRestructuringMember 2019-06-30 0001617669 us-gaap:OneTimeTerminationBenefitsMember ufab:PortHuronRestructuringMember 2018-04-02 2018-07-01 0001617669 us-gaap:OneTimeTerminationBenefitsMember ufab:FortSmithRestructuringMember 2018-01-01 2018-07-01 0001617669 us-gaap:OneTimeTerminationBenefitsMember ufab:PortHuronRestructuringMember 2018-01-01 2018-07-01 0001617669 us-gaap:OneTimeTerminationBenefitsMember ufab:FortSmithRestructuringMember 2018-04-02 2018-07-01 0001617669 us-gaap:OtherRestructuringMember ufab:FortSmithRestructuringMember 2018-01-01 2018-07-01 0001617669 us-gaap:EmployeeSeveranceMember 2019-06-30 0001617669 us-gaap:OtherRestructuringMember 2018-12-31 2019-06-30 0001617669 us-gaap:OtherRestructuringMember 2018-12-30 0001617669 us-gaap:OtherRestructuringMember 2019-06-30 0001617669 us-gaap:EmployeeSeveranceMember 2018-12-31 2019-06-30 0001617669 us-gaap:EmployeeSeveranceMember 2018-12-30 0001617669 us-gaap:EmployeeStockOptionMember ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember 2015-08-17 2015-08-17 0001617669 us-gaap:EmployeeStockOptionMember ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember 2017-09-15 2017-09-15 0001617669 us-gaap:EmployeeStockOptionMember ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember 2015-11-20 2015-11-20 0001617669 us-gaap:EmployeeStockOptionMember ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember 2019-06-11 2019-06-11 0001617669 us-gaap:EmployeeStockOptionMember ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember 2016-04-29 2016-04-29 0001617669 ufab:The2013StockIncentivePlanandUniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember 2018-12-31 2019-06-30 0001617669 ufab:The2013StockIncentivePlanandUniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember 2019-06-30 0001617669 ufab:The2013StockIncentivePlanandUniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember 2018-12-30 0001617669 ufab:The2013StockIncentivePlanandUniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember 2018-01-01 2018-12-30 0001617669 us-gaap:EmployeeStockOptionMember ufab:The2013StockIncentivePlanMember 2016-04-29 2016-04-29 0001617669 us-gaap:EmployeeStockOptionMember ufab:The2013StockIncentivePlanMember 2013-07-17 2013-07-17 0001617669 us-gaap:EmployeeStockOptionMember ufab:The2013StockIncentivePlanMember 2017-09-15 2017-09-15 0001617669 us-gaap:EmployeeStockOptionMember ufab:The2013StockIncentivePlanMember 2014-01-01 2014-01-01 0001617669 ufab:The2013StockIncentivePlanMember 2017-09-15 2017-09-15 0001617669 ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember 2019-06-11 2019-06-11 0001617669 ufab:The2013StockIncentivePlanMember 2014-01-01 2014-01-01 0001617669 ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember 2016-04-29 0001617669 ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember 2015-08-17 2015-08-17 0001617669 us-gaap:EmployeeStockOptionMember ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2015-08-17 2015-08-17 0001617669 ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember 2016-04-29 2016-04-29 0001617669 ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember 2016-06-30 0001617669 ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember 2015-01-04 0001617669 ufab:The2013StockIncentivePlanMember 2013-07-17 2013-07-17 0001617669 ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember 2017-09-15 0001617669 us-gaap:EmployeeStockOptionMember 2018-12-31 2019-06-30 0001617669 us-gaap:EmployeeStockOptionMember 2019-06-30 0001617669 ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember 2019-06-11 0001617669 ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember 2015-08-17 0001617669 ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember 2017-09-15 2017-09-15 0001617669 ufab:EmployeeMember ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember 2015-08-17 2015-08-17 0001617669 us-gaap:EmployeeStockOptionMember ufab:The2013StockIncentivePlanMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2014-01-01 2014-01-01 0001617669 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-12-31 2019-06-30 0001617669 ufab:The2013StockIncentivePlanMember 2016-04-29 2016-04-29 0001617669 ufab:The2013StockIncentivePlanMember 2013-12-29 0001617669 ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember 2015-11-20 2015-11-20 0001617669 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-04-01 2019-06-30 0001617669 ufab:The2013StockIncentivePlanMember 2013-07-17 0001617669 us-gaap:EmployeeStockOptionMember ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2015-08-17 2015-08-17 0001617669 ufab:The2013StockIncentivePlanMember 2016-04-29 0001617669 ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember 2015-11-20 0001617669 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-04-02 2018-07-01 0001617669 ufab:The2013StockIncentivePlanMember 2017-09-15 0001617669 us-gaap:EmployeeStockOptionMember ufab:The2013StockIncentivePlanMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2014-01-01 2014-01-01 0001617669 ufab:The2013StockIncentivePlanMember 2014-01-01 0001617669 srt:DirectorMember ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember 2015-08-17 2015-08-17 0001617669 us-gaap:EmployeeStockOptionMember ufab:The2013StockIncentivePlanMember 2013-12-29 0001617669 us-gaap:EmployeeStockOptionMember ufab:The2013StockIncentivePlanMember 2018-12-31 2019-06-30 0001617669 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-01-01 2018-07-01 0001617669 us-gaap:EmployeeStockOptionMember ufab:The2013StockIncentivePlanMember ufab:SharebasedCompensationAwardTrancheFiveMember 2014-01-01 2014-01-01 0001617669 us-gaap:EmployeeStockOptionMember ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember ufab:SharebasedCompensationAwardTrancheFiveMember 2015-11-20 2015-11-20 0001617669 us-gaap:EmployeeStockOptionMember ufab:The2013StockIncentivePlanMember ufab:SharebasedCompensationAwardTrancheFourMember 2014-01-01 2014-01-01 0001617669 us-gaap:EmployeeStockOptionMember ufab:The2013StockIncentivePlanMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2013-07-17 2013-07-17 0001617669 us-gaap:EmployeeStockOptionMember ufab:The2013StockIncentivePlanMember ufab:SharebasedCompensationAwardTrancheFourMember 2013-07-17 2013-07-17 0001617669 us-gaap:EmployeeStockOptionMember ufab:The2013StockIncentivePlanMember ufab:SharebasedCompensationAwardTrancheFourMember 2016-04-29 2016-04-29 0001617669 us-gaap:EmployeeStockOptionMember ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember ufab:SharebasedCompensationAwardTrancheFourMember 2015-11-20 2015-11-20 0001617669 us-gaap:EmployeeStockOptionMember ufab:The2013StockIncentivePlanMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2013-07-17 2013-07-17 0001617669 us-gaap:EmployeeStockOptionMember ufab:The2013StockIncentivePlanMember ufab:SharebasedCompensationAwardTrancheFiveMember 2013-07-17 2013-07-17 0001617669 us-gaap:EmployeeStockOptionMember ufab:The2013StockIncentivePlanMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2017-09-15 2017-09-15 0001617669 us-gaap:EmployeeStockOptionMember ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember ufab:SharebasedCompensationAwardTrancheFiveMember 2015-08-17 2015-08-17 0001617669 us-gaap:EmployeeStockOptionMember ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember ufab:SharebasedCompensationAwardTrancheFourMember 2015-08-17 2015-08-17 0001617669 us-gaap:EmployeeStockOptionMember ufab:The2013StockIncentivePlanMember ufab:SharebasedCompensationAwardTrancheFiveMember 2016-04-29 2016-04-29 0001617669 us-gaap:EmployeeStockOptionMember ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2015-11-20 2015-11-20 0001617669 us-gaap:EmployeeStockOptionMember ufab:The2013StockIncentivePlanMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2014-01-01 2014-01-01 0001617669 us-gaap:EmployeeStockOptionMember ufab:The2013StockIncentivePlanMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2017-09-15 2017-09-15 0001617669 us-gaap:EmployeeStockOptionMember ufab:The2013StockIncentivePlanMember ufab:SharebasedCompensationAwardTrancheFiveMember 2017-09-15 2017-09-15 0001617669 us-gaap:EmployeeStockOptionMember ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2015-08-17 2015-08-17 0001617669 us-gaap:EmployeeStockOptionMember ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2015-11-20 2015-11-20 0001617669 us-gaap:EmployeeStockOptionMember ufab:The2013StockIncentivePlanMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2013-07-17 2013-07-17 0001617669 us-gaap:EmployeeStockOptionMember ufab:The2013StockIncentivePlanMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2016-04-29 2016-04-29 0001617669 us-gaap:EmployeeStockOptionMember ufab:The2013StockIncentivePlanMember ufab:SharebasedCompensationAwardTrancheFourMember 2017-09-15 2017-09-15 0001617669 us-gaap:EmployeeStockOptionMember ufab:The2013StockIncentivePlanMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2016-04-29 2016-04-29 0001617669 us-gaap:EmployeeStockOptionMember ufab:The2013StockIncentivePlanMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2016-04-29 2016-04-29 0001617669 us-gaap:EmployeeStockOptionMember ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2015-11-20 2015-11-20 0001617669 us-gaap:EmployeeStockOptionMember ufab:The2013StockIncentivePlanMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2017-09-15 2017-09-15 0001617669 us-gaap:ForeignPlanMember 2018-12-31 2019-06-30 0001617669 us-gaap:ForeignPlanMember 2019-04-01 2019-06-30 0001617669 us-gaap:ForeignPlanMember 2018-04-02 2018-07-01 0001617669 ufab:DefinedContributionPlanInitialContributionMember 2018-12-31 2019-06-30 0001617669 ufab:DefinedContributionPlanAdditionalContributionMember 2018-12-31 2019-06-30 0001617669 country:US 2018-12-31 2019-06-30 0001617669 country:US 2018-04-02 2018-07-01 0001617669 country:US 2018-01-01 2018-07-01 0001617669 us-gaap:ForeignPlanMember 2018-01-01 2018-07-01 0001617669 ufab:ManagementAgreementMember srt:AffiliatedEntityMember 2013-03-18 2013-03-18 0001617669 ufab:ManagementAgreementMember srt:AffiliatedEntityMember 2018-12-31 2019-06-30 0001617669 ufab:A6thAvenueGroupServicesMember srt:AffiliatedEntityMember 2019-04-01 2019-06-30 0001617669 ufab:ManagementAgreementMember srt:AffiliatedEntityMember 2018-01-01 2018-07-01 0001617669 ufab:ManagementAgreementMember srt:AffiliatedEntityMember 2013-03-18 0001617669 ufab:A6thAvenueGroupServicesMember srt:AffiliatedEntityMember 2018-12-31 2019-06-30 0001617669 ufab:ManagementAgreementMember srt:AffiliatedEntityMember 2018-04-02 2018-07-01 0001617669 ufab:ManagementAgreementMember srt:AffiliatedEntityMember 2019-04-01 2019-06-30 0001617669 ufab:April2016Member ufab:The2013StockIncentivePlanMember 2018-01-01 2018-07-01 0001617669 ufab:September2017Member ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember 2018-01-01 2018-07-01 0001617669 ufab:September2017Member ufab:The2013StockIncentivePlanMember 2018-01-01 2018-07-01 0001617669 ufab:UniqueFabricatingInc.2014OmnibusPerformanceAwardPlanMember 2018-01-01 2018-07-01 0001617669 us-gaap:WarrantMember 2018-01-01 2018-07-01 0001617669 ufab:WarrantsforUnderwritersMember 2018-01-01 2018-07-01 0001617669 ufab:The2013StockIncentivePlanMember 2018-01-01 2018-07-01 0001617669 us-gaap:EmployeeStockOptionMember ufab:The2013StockIncentivePlanMember 2018-01-01 2018-07-01 xbrli:shares ufab:reporting_unit ufab:employee ufab:segment iso4217:USD ufab:lease ufab:member xbrli:pure iso4217:USD xbrli:shares ufab:award_grant ufab:aquisition
 


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 10-Q
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2019
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from              to             .
Commission file number: 001-37480
UNIQUE FABRICATING, INC.
(Exact name of registrant as specified in its Charter)
 
Delaware
 
001-37480
 
46-1846791
(State or other jurisdiction of
incorporation or organization)
 
(Commission File Number)
 
(IRS Employer
Identification No.)

Unique Fabricating, Inc.
800 Standard Parkway
Auburn Hills, MI 48326
(248)-853-2333
(Address including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
Common Stock, par value $.001 per share
UFAB
NYSE American

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company
 
 
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).      Yes No

As of August 7, 2019, the registrant had 9,779,147 shares of common stock outstanding.
 


TABLE OF CONTENTS

TABLE OF CONTENTS

1
1
2
3
4
5
22
39
40
41
43


i

TABLE OF CONTENTS

ITEM 1. FINANCIAL STATEMENTS    
UNIQUE FABRICATING, INC.
Consolidated Balance Sheets (Unaudited)
  
June 30,
2019
 
December 30,
2018
Assets
  

 
 
Current assets
  

 
 
Cash and cash equivalents
$
1,055,038

 
$
1,409,593

Accounts receivable – net
28,132,933

 
30,831,182

Inventory – net
15,221,451

 
16,285,507

Prepaid expenses and other current assets:
  

 
 
Prepaid expenses and other
2,229,757

 
2,511,486

Refundable taxes
1,232,505

 
983,073

Total current assets
47,871,684

 
52,020,841

Property, plant, and equipment – net
25,480,646

 
25,077,745

Goodwill
22,110,782

 
28,871,179

Intangible assets– net
13,594,896

 
15,568,383

Other assets
 
 
 
Investments – at cost
1,054,120

 
1,054,120

Deposits and other assets
225,207

 
198,854

Deferred tax asset
602,071

 
496,181

Total assets
$
110,939,406

 
$
123,287,303

Liabilities and Stockholders’ Equity
  

 
 
Current liabilities
  

 
 
Accounts payable
$
11,915,902

 
$
11,465,222

Current maturities of long-term debt
2,923,123

 
3,350,000

Income taxes payable

 
40,634

Accrued compensation
2,347,998

 
2,848,282

Other accrued liabilities
1,017,115

 
1,432,109

Total current liabilities
18,204,138

 
19,136,247

Long-term debt – net of current portion
33,806,672

 
34,667,768

Line of credit-net
15,613,556

 
17,904,869

Other long-term liabilities
957,125

 
395,154

Deferred tax liability
1,672,762

 
2,295,105

Total liabilities
70,254,253

 
74,399,143

Stockholders’ Equity
 
 
 
Common stock, $0.001 par value – 15,000,000 shares authorized and 9,779,147 and 9,779,147 issued and outstanding at June 30, 2019 and December 30, 2018, respectively
9,780

 
9,780

Additional paid-in-capital
45,980,210

 
45,881,848

Retained earnings
(5,304,837
)
 
2,996,532

Total stockholders’ equity
40,685,153

 
48,888,160

Total liabilities and stockholders’ equity
$
110,939,406

 
$
123,287,303


See Notes to Consolidated Financial Statements.

1

TABLE OF CONTENTS

UNIQUE FABRICATING, INC.
Consolidated Statements of Operations (Unaudited)

  
Thirteen Weeks Ended June 30, 2019
 
Thirteen Weeks Ended July 1, 2018
 
Twenty-Six Weeks Ended June 30, 2019
 
Twenty-Six Weeks Ended July 1, 2018
Net sales
$
38,889,050

 
$
45,742,370

 
$
78,355,987

 
$
93,046,523

Cost of sales
30,676,940

 
34,553,348

 
61,843,875

 
70,777,354

Gross profit
8,212,110

 
11,189,022

 
16,512,112

 
22,269,169

Selling, general, and administrative expenses
7,423,533

 
7,378,506

 
14,696,245

 
15,345,488

Impairment of goodwill
6,760,397

 

 
6,760,397

 

Restructuring expenses
733,995

 
538,117

 
824,539

 
980,384

Operating (loss) income
(6,705,815
)
 
3,272,399

 
(5,769,069
)
 
5,943,297

Non-operating (expense) income
  

 
 
 
  

 
 
Other (expense) income, net
25,249

 
(28,299
)
 
42,799

 
(64,333
)
Interest expense
(1,331,785
)
 
(860,714
)
 
(2,431,734
)
 
(1,596,473
)
Total non-operating expense, net
(1,306,536
)
 
(889,013
)
 
(2,388,935
)
 
(1,660,806
)
(Loss) income – before income taxes
(8,012,351
)
 
2,383,386

 
(8,158,004
)
 
4,282,491

Income tax (benefit) expense
(389,056
)
 
632,377

 
(345,592
)
 
1,019,593

Net (loss) income
$
(7,623,295
)
 
$
1,751,009

 
$
(7,812,412
)
 
$
3,262,898

Net (loss) income per share
  

 
 
 
  

 
 
Basic
$
(0.78
)
 
$
0.18

 
$
(0.80
)
 
$
0.33

Diluted
$
(0.78
)
 
$
0.18

 
$
(0.80
)
 
$
0.33

Cash dividends declared per share
$


$
0.15

 
$
0.05

 
$
0.30

 

See Notes to Consolidated Financial Statements.


2

TABLE OF CONTENTS

UNIQUE FABRICATING, INC.
Consolidated Statements of Stockholders’ Equity  (Unaudited)
 
Number of Shares
 
Common Stock
 
Additional
Paid-In
Capital
 
Retained Earnings
 
Total
Balance - December 31, 2017
9,757,563

 
$
9,758

 
$
45,712,568

 
$
5,159,753

 
$
50,882,079

Net income

 

 

 
1,511,889

 
1,511,889

Stock option expense

 

 
33,260

 

 
33,260

Exercise of warrants and options for common stock
9,000

 
9

 
29,991

 

 
30,000

Cash dividends paid

 

 

 
(1,465,000
)
 
(1,465,000
)
Balance - April 1, 2018
9,766,563

 
$
9,767

 
$
45,775,819

 
$
5,206,642

 
$
50,992,228

Net income
 
 
 
 
 
 
1,751,009

 
1,751,009

Stock option expense
 
 
 
 
32,680

 
 
 
32,680

Exercise of warrants and options for common stock
5,024

 
5

 
3,995

 
 
 
4,000

Cash dividends paid
 
 
 
 
 
 
(1,465,223
)
 
(1,465,223
)
Balance - July 1, 2018
9,771,587

 
$
9,772

 
$
45,812,494

 
$
5,492,428

 
$
51,314,694


 
Number of Shares
 
Common Stock
 
Additional
Paid-In
Capital
 
Retained Earnings
 
Total
Balance - December 30, 2018
9,779,147

 
$
9,780

 
$
45,881,848

 
$
2,996,532

 
$
48,888,160

Net (loss) income

 

 

 
(189,117
)
 
(189,117
)
Stock option expense

 

 
32,681

 

 
32,681

Exercise of warrants and options for common stock

 

 

 

 

Cash dividends paid

 

 

 
(488,957
)
 
(488,957
)
Balance - April 1, 2019
9,779,147

 
$
9,780

 
$
45,914,529

 
$
2,318,458

 
$
48,242,767

Net (loss) income

 

 

 
(7,623,295
)
 
(7,623,295
)
Stock option expense

 

 
65,681

 

 
65,681

Balance - June 30, 2019
9,779,147

 
$
9,780

 
$
45,980,210

 
$
(5,304,837
)
 
$
40,685,153

 

See Notes to Consolidated Financial Statements.


3

TABLE OF CONTENTS

UNIQUE FABRICATING, INC.
 Consolidated Statements of Cash Flows (Unaudited)
  
Twenty-Six Weeks Ended June 30, 2019
 
Twenty-Six Weeks Ended July 1, 2018
Cash flows from operating activities
  

 
  

Net (loss) income
$
(7,812,412
)
 
$
3,262,898

Adjustments to reconcile net income to net cash provided by operating activities:
  

 
  

Impairment of goodwill
6,760,397

 

Depreciation and amortization
3,404,281

 
3,285,818

Amortization of debt issuance costs
88,743

 
71,072

Loss on sale of assets
5,459

 
12,138

Bad debt adjustment
122,279

 
125,698

Loss (gain) on derivative instrument
664,934

 
(25,098
)
Stock option expense
98,362

 
65,940

Deferred income taxes
(728,233
)
 
(55,542
)
Changes in operating assets and liabilities that provided (used) cash:
  

 
  

Accounts receivable
2,575,970

 
(5,042,406
)
Inventory
1,064,056

 
(410,782
)
Prepaid expenses and other assets
(97,022
)
 
921,250

Accounts payable
(106,640
)
 
2,214,196

Accrued and other liabilities
(955,912
)
 
(64,156
)
Net cash provided by operating activities
5,084,262

 
4,361,026

Cash flows from investing activities
  

 
  

Purchases of property and equipment
(1,880,201
)
 
(3,368,448
)
Proceeds from sale of property and equipment
41,048

 
11,850

Net cash used in investing activities
(1,839,153
)
 
(3,356,598
)
Cash flows from financing activities
  

 
  

Net change in bank overdraft
557,320

 
(306,128
)
Payments on term loans and note payable
(2,637,500
)
 
(1,800,000
)
Proceeds from capital expenditure line
1,300,000

 

(Repayment) proceeds from revolving credit facilities, net
(2,330,527
)
 
3,547,519

Proceeds from exercise of stock options and warrants

 
34,000

Distribution of cash dividends
(488,957
)
 
(2,930,223
)
Net cash used in financing activities
(3,599,664
)
 
(1,454,832
)
Net decrease in cash and cash equivalents
(354,555
)
 
(450,404
)
Cash and cash equivalents – beginning of period
1,409,593

 
1,430,937

Cash and cash equivalents – end of period
$
1,055,038

 
$
980,533

Supplemental disclosure of cash flow Information – cash paid for

  

 
  

Interest
$
1,908,549

 
$
1,510,524

Income taxes
$
291,842

 
$
962,500

 
See Notes to Consolidated Financial Statements.

4

TABLE OF CONTENTS
UNIQUE FABRICATING, INC.

Notes to Consolidated Financial Statements (Unaudited)


Note 1 — Nature of Business and Significant Accounting Policies

Nature of Business — UFI Acquisition, Inc. (“UFI”), a Delaware corporation, was formed on January 14, 2013, for the purpose of acquiring Unique Fabricating, Inc. and its subsidiaries (“Unique Fabricating”) (collectively, the “Company” or “Unique”) on March 18, 2013. The Company operates as one operating and reportable segment to fabricate and broker foam and rubber products, which are primarily sold to original equipment manufacturers (“OEMs”) and tiered suppliers in the automotive, appliance, water heater and heating, ventilation and air conditioning (HVAC) industries. In September 2014, UFI changed its name to Unique Fabricating, Inc. which is now the parent company of the consolidated group. As a result of the name change, the subsidiary previously named Unique Fabricating, Inc. became Unique Fabricating NA, Inc.

Basis of Presentation — The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The accompanying consolidated financial statements have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). The information furnished in the consolidated financial statements includes normal recurring adjustments and reflects all adjustments which are, in the opinion of management, necessary for the fair presentation of such financial statements. The interim results for the periods presented may not be indicative of the Company's actual annual results. These consolidated financial statements should be read in conjunction with the notes to the consolidated financial statements as of and for the year ended December 30, 2018 included in Unique’s annual report on Form 10-K for such period.

Principles of Consolidation — The consolidated financial statements include the accounts of the Company and all subsidiaries over which the Company exercises control. All intercompany transactions and balances have been eliminated upon consolidation.

Fiscal Years — The Company’s quarterly periods end on the Sunday closest to the end of the calendar quarterly period. For 2019, the quarterly and year to date period, which were 13 and 26 weeks, ended on June 30, 2019, and for 2018, the quarterly and year to date period, which were 13 and 26 weeks, ended on July 1, 2018. Fiscal year 2018 ended on Sunday, December 30, 2018.

Cash and Cash Equivalents — The Company considers all highly liquid investments with an original maturity of three months or less to be cash and cash equivalents.

Accounts Receivable — Accounts receivable are stated at the invoiced amount and do not bear interest. The allowance for doubtful accounts is management’s best estimate of the amount of probable credit losses in the existing accounts receivable. Management determines the allowance based on historical write-off experience and an understanding of individual customer payment history and financial condition. Management reviews the allowance for doubtful accounts at regular intervals. Account balances are charged off against the allowance when management determines it is probable the receivable will not be recovered. The allowance for doubtful accounts was $791,665 and $684,996 at June 30, 2019 and December 30, 2018, respectively.

Inventory — Inventory is stated at the lower of cost or market, with cost determined on the first in, first out method (FIFO). Inventory acquired as part of a business combination is recorded at its estimated fair value at the time of the business combination. The Company periodically evaluates inventory for obsolescence, excess quantities, slow moving goods and other impairments of value and establishes reserves for any identified impairments.

Valuation of Long-Lived Assets — The carrying value of long-lived assets held for use is periodically evaluated when events or circumstances warrant such a review. The carrying value of a long-lived asset held for use is considered impaired when the anticipated separately identifiable undiscounted cash flows from the asset are less than the carrying value of the asset. In that event, a loss is recognized based on the amount by which the carrying value exceeds the fair value of the long-lived asset. The Company determined that no impairment indicators were present and all originally assigned useful lives remained appropriate during the 13 and 26 weeks ended June 30, 2019 and 13 and 26 weeks ended July 1, 2018, respectively.

Property, Plant, and Equipment — Property, plant, and equipment purchases are recorded at cost. Property, plant, and equipment acquired as part of a business combination are recorded at estimated fair value at the time of the business combination. Depreciation is calculated using the straight line method over the estimated useful life of each asset. Leasehold improvements are depreciated over the shorter of the estimated useful life of the asset or the period of the related leases. Upon

5

TABLE OF CONTENTS
UNIQUE FABRICATING, INC.

Notes to Consolidated Financial Statements (Unaudited)

retirement or disposal, the initial cost or valuation and accumulated depreciation are removed from the accounts, and any gain or loss is included in net income. Repair and maintenance costs are expensed as incurred.

Intangible Assets — The Company does not hold any intangible assets with indefinite lives. Identifiable intangible assets recognized as part of a business combination are recorded at their estimated fair value at the time of the business combination. Acquired intangible assets subject to amortization are amortized on a straight line basis, which approximates the pattern in which the economic benefit of the respective intangible is realized, over their respective estimated useful lives. Amortizable intangible assets are reviewed for impairment whenever events or circumstances indicate that the related carrying amount may be impaired. The remaining useful lives of intangible assets are reviewed to determine whether events and circumstances warrant a revision to the remaining period of amortization. The Company determined that no impairment indicators were present and all originally assigned useful lives remained appropriate during the 13 and 26 weeks ended June 30, 2019 and 13 and 26 weeks ended July 1, 2018, respectively.

Goodwill — Goodwill represents the excess of the acquisition cost of consideration transferred over the fair value of the identifiable assets acquired and liabilities assumed from business combinations at the date of acquisition. Goodwill is not amortized, but rather is assessed at least on an annual basis for impairment. If it is determined that it is more likely than not that the fair value is greater than the carrying value of a reporting unit then a qualitative assessment may be used for the annual impairment test. Otherwise, a one-step process is used which requires estimating the fair value of each reporting unit compared to its carrying value. If the carrying value exceeds the estimated fair value, goodwill impairment will be the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. The Company has one reporting unit and operating segment for goodwill testing purposes.

During the second quarter of 2019, the Company experienced a decline in market capitalization, which is a potential indicator of impairment. As a result, the Company performed an interim quantitative assessment as of June 30, 2019 , utilizing a combination of the income and market approaches, which were weighted evenly. The results of the quantitative analysis performed indicated the carrying value of the reporting unit exceeded the fair value of the reporting unit as of June 30, 2019. A goodwill impairment charge of $6,760,397 and $6,760,397, was recognized during the 13 and 26 weeks ended June 30, 2019, respectively, and no impairment charges recognized during the the 13 and 26 weeks ended July 1, 2018, respectively. Key assumptions used in the analysis were a discount rate of 12.5%, EBITDA margin and a terminal growth rate of 2.0%.

Debt Issuance Costs — Debt issuance costs represent legal, consulting, and other financial costs associated with debt financing and are reported netted against the related debt instrument. Amounts paid to or on behalf of lenders are presented as a debt discount and are also shown as a reduction of the associated debt instrument. Debt issuance costs on term debt are amortized using the straight line basis over the term of the related debt (which is immaterially different from the required effective interest method) while those related to revolving debt are amortized using a straight line basis over the term of the related debt.

At June 30, 2019 and December 30, 2018, debt issuance costs were $342,580 and $381,793, respectively, while amounts paid to or on behalf of lenders presented as debt discounts were $432,702 and $482,232, respectively. On November 8, 2018, the Company amended its current Credit Agreement (the “Amended and Restated Credit Agreement”), which increased the Company's term loan debt and is further described in Note 6. The Company reviewed this amendment for extinguishment accounting and concluded that $59,110 of the remaining $172,600 debt issuance costs not amortized on the revolving debt facility qualified for extinguishment accounting and were recognized as a loss on extinguishment immediately. The remaining unamortized debt issuance costs not extinguished on the old revolving debt facility and all of the of remaining unamortized debt issuance costs on the term loans did not meet extinguishment accounting and therefore were carried forward to the new revolving debt facility and term loans.

Amortization expense of both debt issuance costs and debt discounts has been recognized as a component of interest expense in the amounts of $44,372 and $88,743 for the 13 and 26 weeks ended June 30, 2019, and $35,536 and $71,072 for the 13 and 26 weeks ended July 1, 2018, respectively.

Investments — Investments in entities in which the Company has less than a 20 percent interest or is not able to exercise significant influence are carried at cost, as there is not a readily determined fair value for these investments. Dividends received are included in income, except for those dividends received in excess of the Company’s proportionate share of accumulated earnings, which are applied as a reduction of the cost of the investment. Impairment losses due to a decline in the value of the

6

TABLE OF CONTENTS
UNIQUE FABRICATING, INC.

Notes to Consolidated Financial Statements (Unaudited)

investment that is other than temporary are recognized when incurred. No dividend income or impairment loss was recognized for the 13 and 26 weeks ended June 30, 2019 and 13 and 26 weeks ended July 1, 2018, respectively.

Accounts Payable — Under the Company’s cash management system, checks issued but not yet presented to the Company’s bank frequently result in overdraft balances for accounting purposes and are classified as accounts payable on the consolidated balance sheets. Accounts payable included $2,245,872 and $1,802,712 of checks issued in excess of available cash balances at June 30, 2019 and December 30, 2018, respectively.

Stock Based Compensation — The Company accounts for its stock based compensation using the fair value of the award estimated at the grant date of the award. The Company estimates the fair value of awards, consisting of stock options, using the Black Scholes option pricing model. Compensation expense is recognized in earnings using the straight line method over the vesting period, which represents the requisite service period.

Revenue Recognition — The following table presents the Company's net sales disaggregated by major sales channel for the 13 and 26 weeks ended June 30, 2019:

 
Unique Fabricating, Inc. Consolidated
 
Thirteen Weeks Ended June 30, 2019
Twenty-Six Weeks Ended June 30, 2019
Net Sales


Automotive
$
33,517,050

$
67,531,987

HVAC, water heater, and appliances
3,504,000

7,258,000

Other
1,868,000

3,566,000

Total
$
38,889,050

$
78,355,987



General Recognition Policy

Revenue is recognized by the Company once all performance obligations under the terms of a contract with the Company's customers are satisfied. Generally this occurs with the transfer of control of its automotive, HVAC, and other products. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring its products. The Company’s payment terms vary by the type and location of its customers and the products offered. The term between invoicing and when payment is due is not significant.

In general for sales arrangements, the Company deems control to transfer at a single point in time and recognizes revenue when it ships products from its manufacturing facilities to its customers. Once a product has shipped, the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the asset. The Company considers control to transfer upon shipment because the Company has a present right to payment at that time, the customer has legal title to the asset, and the customer has significant risks and rewards of ownership of the asset. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded.

Contract Balances

The timing of revenue recognition, billings and cash collections and payments results in billed accounts receivable. The Company does not have deferred revenue. Additionally, as noted above in the Accounts Receivable section, management reviews the allowance for doubtful accounts at regular intervals. Account balances are charged off against the allowance when management determines it is probable the receivable will not be recovered. The allowance for doubtful account balances are noted above in the Accounts Receivable section.

Practical Expedients

The Company elects the practical expedient to expense costs incurred for costs to obtain a contract with a customer when the amortization period would have been one year or less. These costs include sales commissions as the Company has determined annual compensation is commensurate with annual sales activities.

7

TABLE OF CONTENTS
UNIQUE FABRICATING, INC.

Notes to Consolidated Financial Statements (Unaudited)


The Company elects the practical expedient that does not require the Company to adjust consideration for the effects of a significant financing component when the period between shipment of its products and customer’s payment is one year or less.

Shipping and Handling — Shipping and handling costs are included in costs of sales as they are incurred.

Income Taxes — A current tax liability or asset is recognized for the estimated taxes payable or refundable on tax returns for the period. Deferred tax liabilities or assets are recognized for the estimated future tax effects of temporary differences between financial reporting and tax accounting measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The Company also evaluates the need for valuation allowances to reduce the deferred tax assets to realizable amounts. Management evaluates all positive and negative evidence and uses judgment regarding past and future events, including operating results, to help determine when it is more likely than not that all or some portion of the deferred tax assets may not be realized. When appropriate, a valuation allowance is recorded against deferred tax assets to reserve for future tax benefits that may not be realized.

The Company recognizes the financial statement effects of a tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. For tax positions meeting the more likely than not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon settlement with the relevant tax authority. The Company assesses all tax positions for which the statute of limitations remain open. The Company had no unrecognized tax benefits as of June 30, 2019 and July 1, 2018. The Company recognizes any penalties and interest when necessary as income tax expense. There were no penalties or interest recorded during the 13 and 26 weeks ended June 30, 2019 or July 1, 2018.

Foreign Currency Adjustments — The Company’s functional currency for all operations worldwide is the United States dollar. Nonmonetary assets and liabilities of foreign operations are remeasured at historical rates and monetary assets and liabilities are remeasured at exchange rates in effect at the end of each reporting period. Income statement accounts are remeasured at average exchange rates for the year. Gains and losses from translation of foreign currency financial statements into United States dollars are classified in other income in the consolidated statements of operations.

Concentration Risks — The Company is exposed to various significant concentration risks as follows:

Customer and Credit — During the 13 and 26 weeks ended June 30, 2019 and 13 and 26 weeks ended July 1, 2018, the Company’s net sales were derived from customers principally engaged in the North American automotive industry. Company sales directly and indirectly to General Motors Company (GM), Fiat Chrysler Automobiles (FCA), and Ford Motor Company (Ford) as a percentage of total net sales were: 17, 16, and 12 percent, respectively, during the thirteen weeks ended June 30, 2019; 18, 15, and 11 percent, respectively, during the 26 weeks ended June 30, 2019; 13, 17, and 10 percent during the thirteen weeks ended July 1, 2018; and 13, 17, and 11 percent, respectively, during the 26 weeks ended July 1, 2018. GM accounted for 10 and 10 percent of direct Company sales for the 13 and 26 weeks ended June 30, 2019, respectively. No customer represented more than 10 percent of direct Company sales for the 13 and 26 weeks ended July 1, 2018. GM accounted for more than 17 percent of direct accounts receivable as of June 30, 2019. GM accounted for 14 percent of direct accounts receivable as of December 30, 2018.

Labor Markets — At June 30, 2019, of the Company’s hourly plant employees working in the United States manufacturing facilities, 41 percent were covered under a collective bargaining agreement which expires in August 2019 while another 7 percent were covered under a separate collective bargaining agreement that expires in February 2020. The Company is currently engaged in negotiations for a new collective bargaining agreement.

Foreign Currency Exchange — The expression of assets and liabilities in a currency other than the Company's functional currency, which is the United States dollar, gives rise to exchange gains and losses when such assets and obligations are paid in another currency. Foreign currency exchange rate adjustments (i.e., differences between amounts recorded and actual amounts owed or paid) are reported in the consolidated statements of operations as the foreign currency fluctuations occur. Foreign currency exchange rate adjustments are reported in the consolidated statements of cash flows using the exchange rates in effect at the time of the cash flows. At June 30, 2019, the Company’s exposure to assets and liabilities denominated in another currency was not significant. To the extent there is a fluctuation in the exchange rates, the amount of local currency to be paid or received to satisfy foreign currency obligations in 2019 may increase or decrease.


8

TABLE OF CONTENTS
UNIQUE FABRICATING, INC.

Notes to Consolidated Financial Statements (Unaudited)

International Operations — The Company manufactures and sells products outside of the United States primarily in Mexico and Canada. Foreign operations are subject to various political, economic and other risks and uncertainties inherent in foreign countries. Among other risks, the Company’s operations may be subject to the risks of: restrictions on transfers of funds; export duties, quotas, and embargoes; domestic and international customs and tariffs; changing taxation policies; foreign exchange restrictions; political conditions; and governmental regulations. During the 13 and 26 weeks ended June 30, 2019 and 13 and 26 weeks ended July 1, 2018, 19, 19 , 17, and 17 percent, respectively, of the Company’s production occurred in Mexico. During the 13 and 26 weeks ended June 30, 2019 and 13 and 26 weeks ended July 1, 2018, 8, 7, 10, and 10 percent, respectively, of the Company's production occurred in Canada. Sales derived from customers located in Mexico, Canada, and other foreign countries were 17, 10, and 1 percent, respectively, during the 13 weeks ended June 30, 2019; 18, 10, and 1 percent, respectively, during the 26 weeks ended June 30, 2019; 16, 10, and 2 percent, respectively, during the 13 weeks ended July 1, 2018; and 16, 10, and 2 percent, respectively, during the 26 weeks ended July 1, 2018.

Derivative Financial Instruments — All derivative instruments are required to be reported on the consolidated balance sheets at fair value unless the transactions qualify and are designated as normal purchases or sales. Changes in fair value are reported currently through earnings unless they meet hedge accounting criteria. See Note 7 for further information regarding the Company's derivative instrument makeup.

Use of Estimates — The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Recently Issued Accounting Pronouncements  —

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers, Topic 606. This ASU superseded most of the existing guidance on revenue recognition in ASC Topic 605, Revenue Recognition, and established a broad principle that would require an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company adopted the new accounting standard ASC 606, Revenue from Contracts with Customers and all the related amendments to all contracts using the modified retrospective method in its first quarter of 2019. The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods. The Company does not expect the adoption of Topic 606 to have a material impact to its net income on an ongoing basis. The Company did not record a cumulative adjustment related to the adoption of ASU 2014-09, and the effects of adoption were not significant.
 
In January 2016, the FASB issued guidance, together with related, subsequently issued guidance, that addresses certain aspects of recognition, measurement, presentation, and disclosure of financial instruments. Among other provisions, the guidance requires certain equity securities to be measured at fair value, with changes in fair value recognized in earnings. For equity securities without readily determinable fair values, entities may elect to measure these securities at cost minus impairment, if any, adjusted for changes in observable prices. The guidance should be applied through a cumulative-effect adjustment to the balance sheet as of the beginning of the year of adoption, except for equity securities without readily determinable fair values, to which the guidance should be applied prospectively. The Company adopted this guidance on January 1, 2018 and concluded this did not have a material effect on its consolidated financial statements. The Company does have a cost method investment in its consolidated financial statements, and there is not a readily determinable value for this investment.

In February 2016, the FASB issued ASU 2016-02, Leases, which will supersede the current lease requirements in Topic 840. The ASU requires lessees to recognize a right of use asset and related lease liability for all leases, with a limited exception for short-term leases. Leases will be classified as either finance or operating, with the classification affecting the pattern of expense recognition in the statement of operations. Currently, leases are classified as either capital or operating, with only capital leases recognized on the balance sheet. The reporting of lease related expenses in the consolidated statements of operations and cash flows will be generally consistent with current guidance. The ASU is effective for the Company for financial statements issued for fiscal years beginning after December 15, 2019. The Company believes the impact that the adoption of this guidance will have on its consolidated financial statements will be to materially increase assets and liabilities on the consolidated balance sheet, but it is not expected to materially impact the consolidated statements of operations.


9

TABLE OF CONTENTS
UNIQUE FABRICATING, INC.

Notes to Consolidated Financial Statements (Unaudited)

Note 2 — Business Combinations

The Company intends to continue to selectively pursue opportunistic acquisitions that provide additional products and processes, as well as entrance into new growth markets. There were no new acquisitions for the 13 and 26 weeks ended June 30, 2019 or for the 13 and 26 weeks ended July 1, 2018.

Note 3 — Inventory

Inventory consists of the following:
  
June 30,
2019
 
December 30,
2018
Raw materials
$
8,793,783

 
$
9,562,962

Work in progress
652,430

 
547,729

Finished goods
5,775,238

 
6,174,816

Total inventory
$
15,221,451

 
$
16,285,507



The allowance for obsolete inventory was $395,744 and $557,066 at June 30, 2019 and December 30, 2018, respectively.

Included in inventory are assets located in Mexico with a carrying amount of $3,609,407 at June 30, 2019 and $3,340,748 at December 30, 2018, and assets located in Canada with a carrying amount of $1,016,819 at June 30, 2019 and $1,177,256 at December 30, 2018.

Note 4 — Property, Plant, and Equipment
Property, plant, and equipment consists of the following:
 
June 30,
2019
 
December 30,
2018
 
Depreciable
Life – Years
Land
$
1,663,153

 
$
1,663,153

 
  
Buildings
6,898,455

 
6,898,455

 
23 – 40
Shop equipment
22,281,606

 
21,165,566

 
7 – 10
Leasehold improvements
1,141,576

 
1,130,507

 
3 – 10
Office equipment
1,671,924

 
1,650,626

 
3 – 7
Mobile equipment
204,575

 
282,805

 
3
Construction in progress
2,180,247

 
1,514,082

 
 
Total cost
36,041,536

 
34,305,194

 
  
Accumulated depreciation
10,560,890

 
9,227,449

 
 
Net property, plant, and equipment
$
25,480,646

 
$
25,077,745

 
 


Depreciation expense was $721,417 and $1,430,794 for the 13 and 26 weeks ended June 30, 2019, respectively, and $621,030 and $1,224,990 for the 13 and 26 weeks ended July 1, 2018, respectively.

Included in property, plant, and equipment are assets located in Mexico with a carrying amount of $3,318,649 and $3,209,973 at June 30, 2019 and December 30, 2018, respectively, and assets located in Canada with a carrying amount of $594,682 and $656,183 at June 30, 2019 and December 30, 2018, respectively.

Note 5 — Intangible Assets

Intangible assets of the Company consist of the following at June 30, 2019:

10

TABLE OF CONTENTS
UNIQUE FABRICATING, INC.

Notes to Consolidated Financial Statements (Unaudited)

 
Gross Carrying
Amount
 
Accumulated
Amortization
 
Weighted Average
Life – Years
Customer contracts
$
26,523,065

 
$
16,609,721

 
8.16
Trade names
4,673,044

 
1,586,746

 
16.43
Non-compete agreements
1,161,790

 
1,129,992

 
2.53
Unpatented technology
$
1,534,787

 
$
971,331

 
5.00
Total
$
33,892,686

 
$
20,297,790

 
 

Intangible assets of the Company consist of the following at December 30, 2018:
 
Gross Carrying
Amount
 
Accumulated
Amortization
 
Weighted Average
Life – Years
Customer contracts
$
26,523,065

 
$
14,936,128

 
8.16
Trade names
4,673,044

 
1,452,276

 
16.43
Non-compete agreements
1,161,790

 
1,117,626

 
2.53
Unpatented technology
1,534,787

 
$
818,273

 
5.00
Total
$
33,892,686

 
$
18,324,303

 
 


The weighted average amortization period for all intangible assets is 8.96 years. Amortization expense for intangible assets totaled $981,052 and $1,973,487 for the 13 and 26 weeks ended June 30, 2019, and $1,030,414 and $2,060,828 for the 13 and 26 weeks ended July 1, 2018.

Estimated amortization expense is as follows for the remainder of the current fiscal year and future fiscal years are as follows:
2019
$
1,971,777

2020
3,913,627

2021
2,455,712

2022
1,305,314

2023
978,787

Thereafter
2,969,679

Total
$
13,594,896



Note 6 — Long-term Debt

Credit Agreement

On April 29, 2016, Unique Fabricating NA, Inc. (the “US Borrower”) and Unique-Intasco Canada, Inc. (the “CA Borrower”) and Citizens Bank, National Association (“Citizens”), acting as lender and Administrative Agent, and other lenders, entered into a credit agreement (the “Credit Agreement”) providing for borrowings of up to the aggregate principal amount of $62.0 million. The Credit Agreement was a senior secured credit facility and consisted of a revolving line of credit of up to $30.0 million (the “Revolver”) to the US Borrower, a $17.0 million principal amount term loan (the “US Term Loan”) to the US Borrower, and a $15.0 million principal amount term loan (the “CA Term Loan”) to the CA Borrower. At Closing, the US Term Loan and the CA Term Loan were fully funded and the US Borrower borrowed approximately $22.9 million under the Revolver.

On August 18, 2017, the US Borrower and the CA Borrower entered into the Second Amendment (the “Amendment”) to the Credit Agreement, with Citizens acting as Administrative Agent, and other lenders. The Amendment converted $4.0 million of outstanding borrowings under the Revolver into an additional $4.0 million term loan to the US Borrower (the “US Term Loan II”). The conversion of a portion of the outstanding borrowings under the Revolver did not reduce the aggregate amount available to be borrowed under it.


11

TABLE OF CONTENTS
UNIQUE FABRICATING, INC.

Notes to Consolidated Financial Statements (Unaudited)

On August 8, 2018, the US Borrower and the CA Borrower entered into the Fourth Amendment (the “Fourth Amendment”) to the Credit Agreement, with Citizens acting as Administrative Agent, and other lenders. The Fourth Amendment required the Company to use the net proceeds from the sale of the Ft. Smith, Arkansas building to reduce the outstanding borrowings under the Revolver. The application of the net proceeds did not permanently reduce the amounts that could be borrowed under the Revolver. The Fourth Amendment also eased, for the fiscal quarter ended September 30, 2018, the financial covenant ratio which determined the Company's ability to pay dividends.

On September 20, 2018, the US Borrower and the CA Borrower entered into the Fifth Amendment (the “Fifth Amendment”) to the Credit Agreement. The Fifth Amendment temporarily increased the maximum amount that could be borrowed under the Revolver to $32.5 million from its then maximum of $30.0 million. This increase implemented by the Fifth Amendment was effective until October 31, 2018, at which point the maximum amount that could be borrowed under the Revolver reverted back to $30.0 million and was replaced by the Amended and Restated Credit Agreement described below.

Amended and Restated Credit Agreement

On November 8, 2018, the US Borrower and the CA Borrower entered into an Amended and Restated Credit Agreement (the “Amended and Restated Credit Agreement”), which amended and restated the existing Credit Agreement, with Citizens, acting as Administrative Agent, and the other lenders. The Amended and Restated Credit Agreement which is a five year agreement, among other things, increased the principal amount of US Term Loan borrowings to $26.0 million, created a two year line to fund capital expenditures of up to $2.5 million through November 8, 2019 and $5.0 million thereafter through November 8, 2020, and extended the maturity dates of all borrowings from April 28, 2021 to November 7, 2023. The Amended and Restated Credit Agreement provides for borrowings of up to $30.0 million under the Revolver, subject to availability, and left the principal amount on the CA Term Loan at approximately $12.0 million, the same as it was under the previous Credit Agreement. The Amended and Restated Credit Agreement combined the previous US Term Loan and US Term Loan II (the “New US Term Loan”), and increased the aggregate principal amount to $26.0 million dollars from $15.9 million, in total, from the previous US Term Loan and Term Loan II. The increase in the principal amount effected by the New U.S. Term Loan replaced and termed-out outstanding borrowings under the Revolver. The Amended and Restated Credit Agreement changes the quarterly principal payments of the New US Term Loan to $337,500 through September 30, 2020, $575,000 thereafter through September 30, 2021, and $812,500 thereafter though maturity. Finally, the agreement made certain changes to the Company's covenants and financial covenant ratios.

The Revolver, New US Term Loan, and CA Term Loan all mature on November 7, 2023 and bear interest at the Company's election of either (i) the greater of the Prime Rate or the Federal Funds Effective Rate (the “Base Rate”) or (ii) the LIBOR rate, plus an applicable margin ranging from 1.75% to 3.25% per annum in the case of the Base Rate and 2.75% to 4.25% per annum in the case of the LIBOR rate, in each case, based on senior leverage ratio thresholds, measured quarterly, as increased by the Waiver and Fourth Amendment to the Amended and Restated Credit Agreement which is further described below. The fair value of debt approximates book value based on the variable terms.

In addition, the Amended and Restated Credit Agreement allows for increases in the principal amount of the Revolver and the New US and CA Term Loans not to exceed a $10.0 million principal amount, in the aggregate, provided that before and after giving effect to the proposed increase (and any transactions to be consummated using proceeds of the increase), the total leverage and debt service coverage ratios do not exceed specified amounts. The Amended and Restated Credit Agreement also provides for the issuance of letters of credit with a face amount of up to a $2.0 million, in the aggregate, provided that any letter of credit that is issued will reduce availability under the Revolver.

As of June 30, 2019, $15,956,136 was outstanding under the Revolver. This amount is gross of debt issuance costs which are further described in Note 1. The Revolver had an effective interest rate of 6.1885% percent per annum at June 30, 2019, and is secured by substantially all of the Company’s assets. At June 30, 2019, the maximum additional available borrowings under the Revolver were $13,943,864, which includes a reduction for a $100,000 letter of credit issued for the benefit of the landlord of one of the Company’s leased facilities. The maximum amount available to be borrowed under the Revolver is further subject to borrowing base restrictions.


12

TABLE OF CONTENTS
UNIQUE FABRICATING, INC.

Notes to Consolidated Financial Statements (Unaudited)

Long term debt consists of the following:
  
June 30,
2019
 
December 30,
2018
New US Term Loan, payable to lenders in quarterly installments of $337,500 through September 30, 2020, $575,000 through September 30, 2021, and $812,500 through November 7, 2023 with a lump sum due at maturity. The effective interest rate was 6.1885% per annum at June 30, 2019. At June 30, 2019, the balance of the New US Term Loan is presented net of a debt discount of $300,967 from costs paid to or on behalf of the lenders.
$
24,686,531

 
$
25,664,582

CA Term Loan, payable to lenders in quarterly installments of $375,000 through November 7, 2023, with a lump sum due at maturity. The effective interest rate was 6.1885% per annum at June 30, 2019. At June 30, 2019, the balance of the CA Term Loan is presented net of a debt discount of $131,735 from costs paid to or on behalf of the lenders.
10,743,264

 
$
11,853,186

Note payable to the seller of former owner of business Unique acquired in 2014 which is unsecured and subordinated to the Credit Agreement. Interest accrued monthly at an annual rate of 6.00%. The note payable was paid in full on February 6, 2019.

 
500,000

Capital expenditure line payable to lenders in quarterly installments of 7.5% per annum of the outstanding principal balance commencing December 31, 2019 through September 30, 2020, 10% per annum through September 30, 2021, and 12.5% per annum through November 7, 2023 with a lump sum due at maturity. The effective interest rate was 6.17813% per annum at June 30, 2019.
1,300,000

 

Other debt

 

Total debt excluding Revolver
36,729,795

 
38,017,768

Less current maturities
2,923,123

 
3,350,000

Long-term debt – Less current maturities
$
33,806,672

 
$
34,667,768



Covenant Compliance

The Amended and Restated Credit Agreement contains customary negative covenants and requires that the Company comply with various financial covenants, including a total leverage ratio and debt service coverage ratio, as defined in the Amended and Restated Credit Agreement. As of December 30, 2018, the Company was in compliance with these financial covenants. Additionally, the New US Term Loan and CA Term Loan each contains a clause, effective December 30, 2018, that requires an excess cash flow payment to be made to the lenders to reduce the New US Term Loan and CA Term Loan if the Company’s cash flow exceeds certain thresholds as defined by the Amended and Restated Credit Agreement. No payments were required to be made in the periods presented above.

As of March 31, 2019, the Company was not in compliance with the total leverage ratio financial covenant. As a result of this non-compliance, on May 7, 2019, the US Borrower and the CA Borrower entered into the Waiver and First Amendment (the “First Amendment”) to the Amended and Restated Credit Agreement, with Citizens, acting as Administrative Agent, and the other lenders. The First Amendment temporarily waived the default on the March 31, 2019 covenant violation until the earlier of June 15, 2019 and the execution and delivery of a further amendment revising the calculation of the total leverage ratio and such other financial covenants as necessary taking into account the Borrowers current and future financial condition. As a result of this waiver, the lenders did not accelerate the maturity of the debt.

On June 14, 2019, the Company entered into the Waiver and Second Amendment (the “Second Amendment”) to the Amended and Restated Credit Agreement, with Citizens, acting as Administrative Agent, and the other lenders.  The Second Amendment revised the waiver period as defined with respect to the March 31, 2019 covenant violation and resulting default until the earlier of June 30, 2019 (which was June 15, 2019 under the First Amendment to the Amended and Restated Credit Agreement) and the execution and delivery of a further amendment revising the calculation of the total leverage ratio and such other financial covenants as necessary taking into account the Borrowers current and future financial condition.


13

TABLE OF CONTENTS
UNIQUE FABRICATING, INC.

Notes to Consolidated Financial Statements (Unaudited)

On June 28, 2019, the Company entered into the Waiver and Third Amendment (the “Third Amendment”) to the Amended and Restated Credit Agreement, with Citizens, acting as Administrative Agent, and the other lenders.  The Third Amendment revised the waiver period as defined with respect to the March 31, 2019 covenant violation and resulting default until the earlier of July 22, 2019 (which was June 30, 2019 under the Second Amendment to the Amended and Restated Credit Agreement) and the execution and delivery of a further amendment revising the calculation of the total leverage ratio and such other financial covenants as necessary taking into account the Borrowers current and future financial condition.

On July 16, 2019, the Company entered into the Waiver and Fourth Amendment (the “Fourth Amendment”) to the Amended and Restated Credit Agreement, with Citizens, acting as Administrative Agent, and the other lenders.  The Fourth Amendment provided a permanent waiver by the Lenders and Agent with respect to the Borrower's non-compliance with the total leverage ratio financial covenant, as defined, not in excess of 3.50 to 1.00 as of March 31, 2019. The Fourth Amendment also revised the definition of consolidated EBITDA and certain financial covenants, including the maximum total leverage ratio and the minimum debt service coverage ratio, as well as adding the requirement that the Company maintain minimum liquidity and minimum unadjusted consolidated EBITDA, each as defined. The Fourth Amendment permits distributions as long as the Borrower is in compliance with specified conditions including that the Borrower's liquidity, as defined, is not less than $5 million after giving effect to the distribution, total leverage ratio is not more than 2.00 to 1.00, post distribution debt service coverage ratio ("DSCR"), as defined, is not greater than 1.10 to 1.00, and Borrower is in compliance with financial convenants, before and after giving effect to the distributions. The Company is compliant with the covenants set forth in the Waiver and Fourth Amendment as of June 30, 2019. The Company does not anticipate the payment of dividends in 2019.

Maturities on the Company’s Amended and Restated Credit Agreement and other long term debt obligations for the remainder of the current fiscal year and future fiscal years are as follows:
2019
$
712,500

2020
3,193,125

2021
4,175,625

2022
4,912,500

2023
40,124,883

Thereafter

Total
53,118,633

Discounts
(432,702
)
Debt issuance costs
(342,580
)
Total debt – Net
$
52,343,351



Note 7 — Derivative Financial Instruments

Interest Rate Swap

The Company holds derivative financial instruments, in the form of an interest rate swap, as required by its Credit Agreement and Amended and Restated Credit Agreement, for the purpose of hedging certain identifiable transactions in order to mitigate risks relating to the variability of future earnings and cash flows caused by interest rate fluctuations. The Company has elected not to apply hedge accounting for financial reporting purposes. The interest rate swap is recognized in the accompanying consolidated balance sheets at its fair value. Monthly settlement payments due on the interest rate swap and changes in its fair value are recognized currently in net income as interest expense in the accompanying consolidated statements of operations.

Effective June 30, 2016, as required under the Credit Agreement entered into during April 2016, the Company entered into an interest rate swap which requires the Company to pay a fixed rate of 1.055 percent per annum while receiving a variable rate per annum based on the one month LIBOR for a net monthly settlement based on the notional amount. The notional amount at the effective date was $16,681,250 which decreased by $318,750 each quarter until June 30, 2017, and thereafter decreased by $425,000 each quarter until June 29, 2018, when it began decreasing by $531,250 per quarter until it expired on June 28, 2019.

Effective October 2, 2017, as required under the Second Amendment to the Credit Agreement, the Company entered into another interest rate swap with requires the Company to pay a fixed rate of 1.093 percent per annum while receiving a variable interest rate per annum based on the one month LIBOR, for a net monthly settlement based on the notional amount in effect.

14

TABLE OF CONTENTS

The notional amount at the effective date was $1,900,000 which decreases by $100,000 each quarter until it expires on September 30, 2020.

Effective November 30, 2018, as required under the Amended and Restated Credit Agreement, the Company entered into another interest rate swap that requires the Company to pay a fixed rate of 3.075 percent per annum while receiving a variable interest rate per annum based on the one month LIBOR for a net monthly settlement based on the notional amount in effect. The notional amount at the effective date was $5,037,500 which increases by $378,125 each quarter until June 28, 2019 when the notional amount increases to $17,540,625 due to the interest rate swap from 2016 described above expiring. The notional amount then decreases each quarter by $153,125 until September 30, 2020 when the notional amount increases to $17,475,000 due to the interest rate swap from 2017 above expiring. The notional amount then decreases each quarter by $431,250 until December 31, 2021, then decreases each subsequent quarter by $609,375 until it expires on November 8, 2023

At June 30, 2019, the fair value of all swaps was in a net liability position of $957,125 and is included in other long term liabilities in the consolidated balance sheet. The Company received $35,783 and $86,039 in the aggregate, in net monthly settlements with respect to the interest rate swaps for the 13 and 26 weeks ended June 30, 2019, respectively. At July 1, 2018, the fair value of the swaps was $184,418, and was included in other long-term assets in the consolidated balance sheets. The Company received $30,589 and  $48,894 with respect to the interest rate swaps for the 13 and 26 weeks ended July 1, 2018, respectively. Both the change in fair value and the monthly settlements were included in interest expense in the consolidated statements of operations.

Note 8 — Restructuring

Unique's restructuring activities are undertaken as necessary to implement management's strategy, streamline operations, take advantage of available capacity and resources, and achieve net cost reductions. The restructuring activities generally relate to realignment of existing manufacturing capacity and closure of facilities and other exit or disposal activities, either in the normal course of business or pursuant to specific restructuring programs.

2019 Restructuring

Evansville Restructuring

On July 16, 2019, subsequent to our second quarter-end, the Company made the decision to close its manufacturing facility in Evansville, Indiana. The Company currently expects to cease operations at the Evansville facility by the end of September 2019, and that approximately 53 positions will be eliminated as a result of the closure. The Company's decision resulted from its desire to streamline operations and to utilize some of the available excess capacity in other of our facilities.

The Company will move existing Evansville production to its manufacturing facilities in LaFayette, GA, Auburn Hills, MI, and Louisville, KY. The Company will provide the affected employees severance pay, health benefits continuation, and job search assistance. The Company evaluated whether or not this closing met the criteria for discontinued operations and concluded that the closing did not meet the definition as it did not represent a strategic shift in the Company's operations and the Company will have continuing cash flows from the production being moved to other facilities within the Company.

The Company expects to incur one-time severance costs as a result of this plant closure of approximately $309,000 during the remainder of 2019. The amount of other costs incurred associated with this plant closure, which will primarily consist of preparing and moving existing production equipment and inventory at Evansville to other facilities will be approximately $1,325,000 and early lease termination fees, will be approximately $1,200,000, during the remainder of 2019. The Company is actively pursing a sublease of the facility.

Salaried Restructuring

On July 30, 2019, subsequent to our quarter-end, our former President and Chief Executive Officer of the Company (CEO), resigned as President of the board of directors. The Company did not incur any additional restructuring costs in connection with his resignation.

On May 6, 2019, the former President and CEO of the Company resigned by mutual agreement of both parties. The Company incurred one-time restructuring costs of $579,972 and $579,972 during the 13 and 26 weeks ended June 30, 2019,

15

TABLE OF CONTENTS
UNIQUE FABRICATING, INC.

Notes to Consolidated Financial Statements (Unaudited)

respectively, in connection with his resignation. Further charges expected to be incurred in 2019 subsequent to June 30, 2019 are expected to be immaterial.

On May 15, 2019 and February 1, 2019, the Company announced that in order to reduce fixed costs it would be eliminating a number of salaried positions throughout the Company. The Company provided the affected employees severance pay, health benefits continuation and job search assistance. This reduction took place and was paid in the 13 and 26 weeks ended June 30, 2019, and in connection with this workforce reduction the Company incurred one-time severance costs of $154,022 and $244,567, respectively.

The table below summarizes the activity in the restructuring liability for the 26 weeks ended June 30, 2019.

 
 
Employee Termination Benefits Liability
 
Other Exit Costs Liability
 
Total
Accrual balance at December 31, 2018
 
$

 
$

 
$

Provision for estimated expenses incurred during the year
 
824,539

 

 
824,539

Payments made during the period
 
490,675

 

 
490,675

Accrual balance at June 30, 2019
 
333,864

 

 
333,864



2018 Restructuring

Fort Smith Restructuring

On February 13, 2018, the Company made the decision to close its manufacturing facility in Fort Smith, Arkansas. The Company ceased operations at the Fort Smith facility in July of 2018, and approximately 20 positions were eliminated as a result of the closure. The Company's decision resulted from its desire to streamline operations and to utilize some of the available excess capacity in other of our facilities. The Company moved existing Fort Smith production to its manufacturing facilities in Evansville, Indiana and Monterrey, Mexico. The Company provided the affected employees severance pay, health benefits continuation and job search assistance. The Company evaluated whether or not this closing met the criteria for discontinued operations and concluded that the closing did not meet the definition as it did not represent a strategic shift in the Company's operations and the Company has continuing cash flows from the production being moved to other of its facilities.

In October, 2018, the Company sold the building it owned in Fort Smith, which had a net book value of $733,059, for cash proceeds of $876,032 resulting in a gain on the sale of $142,973. The Company did not incur any restructuring costs associated with this closure in the 13 and 26 weeks ended June 30, 2019.

The Company incurred one-time severance costs as a result of this plant closure of $(58,933) and $173,359 in the 13 and 26 weeks ended July 1, 2018, respectively. The amount of other costs incurred associated with this plant closure, which primarily consisted of preparing and moving existing production equipment and inventory at Fort Smith to other facilities was $423,705 and $444,358 in the 13 and 26 weeks ended July 1, 2018. All of these costs were recorded to the restructuring expense line in continuing operations in the Company's consolidated statement of operations.

Port Huron Restructuring

On February 1, 2018, the Company made the decision to close its manufacturing facility in Port Huron, Michigan. The Company ceased operations at the Port Huron facility in June of 2018 and 7 positions were eliminated as a result of the closure. The Company's decision resulted from its desire to streamline operations and to utilize some of the available excess capacity in other of its facilities. As such, the Company moved existing Port Huron production to our manufacturing facilities in London, Ontario, Auburn Hills, Michigan, and Louisville, Kentucky. The Company provided the affected employees severance pay, health benefits continuation and job search assistance. The Company evaluated whether or not this closing met the criteria for discontinued operations and concluded that the closing did not meet the definition as it did not represent a strategic shift in the Company's operations, and the Company has continuing cash flows from the production being moved to other of its facilities.  The Company did not incur any restructuring costs associated with this closure in the 13 and 26 weeks ended June 30, 2019.

The Company incurred one-time severance costs as a result of this plant closure of $(17,125) and $64,768 in the 13 and 26 weeks ended July 1, 2018. The amount of other costs incurred associated with this plant closure, which primarily consisted of preparing and moving existing production equipment and inventory at Port Huron to other facilities was $190,470 and

16

TABLE OF CONTENTS
UNIQUE FABRICATING, INC.

Notes to Consolidated Financial Statements (Unaudited)

$297,899 in the 13 and 26 weeks ended July 1, 2018. All of these costs were recorded to the restructuring expense line in continuing operations in the Company's consolidated statement of operations.

The table below summarizes the activity in the restructuring liability for the 26 weeks ended July 1, 2018.
 
 
Employee Termination Benefits Liability
 
Other Exit Costs Liability
 
Total
Accrual balance at January 1, 2018
 
$

 
$

 
$

Provision for estimated expenses incurred during the year
 
238,128

 
742,256

 
980,384

Payments made during the period
 
163,439

 
705,873

 
869,312

Accrual balance at July 1, 2018
 
$
74,689

 
$
36,383

 
$
111,072



Note 9 — Stock Incentive Plans

2013 Stock Incentive Plan

The Company’s board of directors approved a stock incentive plan (the “Plan”) in 2013. The Plan permits the Company to grant 495,000 non statutory or incentive stock options to the employees, directors and consultants of the Company. 495,000 shares of unissued common stock are reserved for the Plan. The board of directors has the authority to determine the participants to whom stock options shall be awarded as well as any restrictions to be placed upon the awards. The exercise price cannot be less than the fair value of the underlying shares at the time the stock options are issued and the maximum length of an award is ten years.

On July 17, 2013 and January 1, 2014, the board of directors approved the issuance of 375,000 and 120,000 non statutory stock option awards, respectively, to employees of the Company with an exercise price of $3.33 per share with a weighted average grant date fair value of $0.23 and $0.35 per share, respectively. On April 29, 2016, the Company issued 7,200 non statutory stock option awards to employees of the Company with an exercise price of $12.58 and with a weighted average grant date fair value of $2.80 per share. On September 15, 2017, the Company issued 5,000 non statutory stock option awards to employees of the Company with an exercise price of $7.65 per share and with a weighted average grant date fair value of $1.41 per share. All 4 grants of the awards vest 20 percent on the grant date and an additional 20 percent on each of the first, second, third and fourth anniversaries thereafter. Vested awards can only be exercised while the participants are employed by the Company.

The fair value of each option award is estimated on the grant date using a Black Scholes option pricing model that uses the weighted average assumptions noted in the following table. The expected volatility is based on the historical volatility of the stock of comparable companies. The expected term of the awards was estimated based on findings from academic studies investigating the average holding period for options adjusted for the Company’s size and risk factors. The risk free rate for periods within the contractual life of the option is based on the United States Treasury yield curve in effect at the time of grant.
 
September 15, 2017
 
April 29, 2016
 
January 1, 2014
 
July 17, 2013
Expected volatility
40.00
%
 
40.00
%
 
34.00
%
 
34.00
%
Dividend yield
7.00
%
 
5.00
%
 
%
 
%
Expected term (in years)
5

 
5

 
4

 
4

Risk-free rate
1.81
%
 
1.28
%
 
1.27
%
 
0.96
%


2014 Omnibus Performance Award Plan

In 2014, the board of directors and stockholders adopted the Unique Fabricating, Inc. 2014 Omnibus Performance Award Plan, or the 2014 Plan. The 2014 Plan provides for the grant of cash awards, stock options, stock appreciation rights, or SARs, shares of restricted stock and restricted stock units, or RSUs, performance shares and performance units. The 2014 Plan originally authorized the grant of awards relating to 250,000 shares of our common stock. In the event of any transaction that causes a change in capitalization, the Compensation Committee, such other committee administering the 2014 Plan or the board of directors will make such adjustments to the number of shares of common stock delivered, and the number and/or price of shares of common stock subject to outstanding awards granted under the 2014 Plan, as it deems appropriate and equitable to prevent dilution or enlargement of participants’ rights. An amendment approved in March of 2016 by our board of directors

17

TABLE OF CONTENTS
UNIQUE FABRICATING, INC.

Notes to Consolidated Financial Statements (Unaudited)

which was approved by our stockholders at our annual meeting of stockholders in June 2016, increased the number of shares authorized for grant of awards under the 2014 Plan to a total of 450,000 shares of our common stock.

On August 17, 2015, the board of directors approved the issuance of stock option awards for 230,000 shares of which 45,000 shares subject to non statutory awards were granted to the board of directors and 185,000 incentive stock options were granted to employees of the Company. All of the awards had an exercise price of $12.50 per share with a weighted average grant date fair value of $2.72 per share. These awards vest 20 percent on the grant date and an additional 20 percent on each of the first, second, third and fourth anniversaries of the grant date thereafter. Vested awards can only be exercised while the participants are employed by the Company.

On November 20, 2015, the board of directors approved the issuance of incentive stock option awards for 15,000 shares to employees of the Company. All of the awards had an exercise price of $11.50 per share with a weighted average grant date fair value of $2.23 per share. The vesting schedule, vesting percentage, and capability of the employees to exercise these options are the same as these for the August 17, 2015 grants discussed above.

On April 29, 2016, the board of directors approved the issuance of stock option awards for 5,000 shares to employees of the Company. All of the awards had an exercise price of $12.58 per share with a weighted average grant date fair value of $2.80 per share. The vesting schedule, vesting percentage, and ability of the employees to exercise these options are the same as these for the November 20 and August 17, 2015 grants described above.

On September 15, 2017, the board of directors approved the issuance of stock option awards for 15,000 shares to employees of the Company. All of the awards had an exercise price of $7.65 per share with a weighted average grant date fair value of $1.41 per share. The vesting schedule, vesting percentage, and ability of the employees to exercise these options are the same as these for the November 20, August 17, 2015, and April 29, 2016 grants discussed above.

On June 11, 2019, the compensation committee of the board of directors approved the issuance of stock option awards for 30,000 shares to one member of the board. The award had an exercise price of $2.93 per share with a weighted average grant date fair value of $1.10 per share. These options vested immediately on the date of grant as the service conditions required for this award had already been met on the day of the award.

The fair value of each option award is estimated on the grant date using a Black Scholes option pricing model that uses the weighted average assumptions noted in the following table. The expected volatility is based on the historical volatility of the stock of comparable companies. The expected term of the awards was estimated based on findings from academic studies investigating the average holding period for options for adjusted for the Company’s size and risk factors. The risk free rate for periods within the contractual life of the option is based on the United States Treasury yield curve in effect at the time of grant.
 
June 11, 2019
 
September 15, 2017
 
April 29, 2016
 
November 20, 2015
 
August 17, 2015
Expected volatility
40.00
%
 
40.00
%
 
40.00
%
 
35.00
%
 
38.00
%
Dividend yield
%
 
7.00
%
 
5.00
%
 
5.00
%
 
4.80
%
Expected term (in years)
5

 
5

 
5

 
5

 
5

Risk-free rate
1.85
%
 
1.81
%
 
1.28
%
 
1.70
%
 
1.58
%


A summary of option activity under both plans is presented below:

18

TABLE OF CONTENTS
UNIQUE FABRICATING, INC.

Notes to Consolidated Financial Statements (Unaudited)

  
Number of
Shares
 
Weighted
Average
Exercise Price
 
Weighted Average Remaining
Contractual Term
(in years)
 
Aggregate
Intrinsic Value(1)
Outstanding at December 30, 2018
563,680

 
$
7.25

 
5.61
 
  

Granted
30,000

 
$
2.93

 
10.00
 
  

Exercised

 
$

 
0
 
  

Forfeited or expired

 
$

 
0
 
 
Outstanding at June 30, 2019
593,680

 
$
7.03

 
5.35
 
$

Vested and exercisable at June 30, 2019
535,240

 
$
5.23

 
6.64
 
$




(1)
The aggregate intrinsic value above is obtained by subtracting the weighted average exercise price from the estimated fair value of the underlying shares as of June 30, 2019 and multiplying this result by the related number of options outstanding and exercisable at June 30, 2019. The estimated fair value of the shares is based on the closing price of the stock of $2.71 as of June 30, 2019. As of June 30, 2019 there is no intrinsic value as the exercise prices are greater than the estimated fair value.

The Company recorded compensation expense of $65,681 and $98,362 for the 13 and 26 weeks ended June 30, 2019, respectively, and $32,681 and $65,940 for the 13 and 26 weeks ended July 1, 2018, respectively, in its consolidated statements of operations, as a component of sales, general and administrative expenses. The income tax benefit related to share based compensation expense was $14,573 and $24,325 for the 13 and 26 weeks ended June 30, 2019 and $8,919 and $15,700 for the 13 and 26 weeks ended July 1, 2018.

As of June 30, 2019, there was $67,958 of total unrecognized compensation cost related to non-vested stock option awards under the plans. That cost is expected to be recognized over a weighted average period of 0.67 years.

Note 10 — Income Taxes

For interim tax reporting we estimate our annual effective tax rate and apply it to our year to date income before income taxes. The tax effects of unusual or infrequently occurring items, including changes in judgment about valuation allowances and the effect of changes in tax laws or rates, are reported in the interim period in which they occur, if applicable.  

Income tax (benefit) expense for the 13 and 26 weeks ended June 30, 2019 was $(389,056) and $(345,592), respectively, compared to $632,377 and $1,019,593 for the 13 and 26 weeks ended July 1, 2018, respectively. During the 13 and 26 weeks ended June 30, 2019, the differences between the actual effective tax rate of 4.9% and 4.2%, respectively, and the statutory rate of 21.0% was primarily due to the impairment of non-deductible goodwill as well as earnings generated in Mexico and Canada, which both have higher statutory income tax rates than the U.S., and U.S. taxation of foreign earnings under the Global Intangible Low-Taxed Income (GILTI) provisions of the Tax Cut and Jobs Act, partially offset by tax credits in the U.S. During the 13 and 26 weeks ended July 1, 2018, the actual effective tax rate of 26.5% and 23.8%, respectively, and the statutory rate of 21.0% was mainly a result of earnings generated in Mexico and Canada, which both have higher income tax rates than the U.S.

Note 11 — Operating Leases

The Company leases office space, production facilities and equipment under operating leases with various expiration dates through the year 2024. The leases for office space and production facilities require the Company to pay taxes, insurance, utilities and maintenance costs. Five of the leases for office space and production facilities provide for escalating rents over the life of the respective leases and rent expense for these leases is recognized over the term of the lease on a straight line basis, with the difference between lease payments and rent expense recorded as deferred rent in other accrued liabilities in the consolidated balance sheets. Total rent expense charged to operations was approximately $500,920 and $986,417 for the 13 and 26 weeks ended June 30, 2019 and $665,269 and $1,334,451 for the 13 and 26 weeks ended July 1, 2018.

Future minimum lease payments required under operating leases that have initial or remaining non-cancelable lease terms in excess of one year are as follows at June 30, 2019:

19

TABLE OF CONTENTS
UNIQUE FABRICATING, INC.

Notes to Consolidated Financial Statements (Unaudited)

2019
$
986,417

2020
1,419,556

2021
577,375

2022
452,657

2023
65,973

Thereafter
698

Total
$
3,502,676



Note 12 — Retirement Plans

The Company maintains a defined contribution plan covering certain full time salaried employees. Employees can make elective contributions to the plan. The Company contributes 100 percent of an employee’s contribution up to the first 3 percent of each employee’s total compensation and 50 percent for the next 2 percent of each employee’s total compensation. In addition, the Company, at the discretion of the board of directors, may make additional contributions to the plan on behalf of the plan participants. The Company contributed $122,921 and $252,408, respectively, for the 13 and 26 weeks ended June 30, 2019 and $132,363 and $259,882, respectively, for the 13 and 26 weeks ended July 1, 2018.

The Intasco operations acquired in April 2016 had separate retirement plans. The United States facility in Port Huron, Michigan sponsored a SIMPLE IRA account for qualifying employees. The plan makes a contribution equal to 3 percent of a participant's gross wages to the participating employees' SIMPLE IRA accounts. Contributions by Intasco in the United States totaled $0 for the 13 and 26 weeks ended June 30, 2019, because the plant closed in June of 2018 as noted in Note 8, and $194 and $1,502, respectively, for the 13 and 26 weeks ended July 1, 2018.

The Canadian facility sponsors a retirement plan whereby Intasco makes a matching contribution of participant contributions up to a maximum amount based on the participants' number of years of service. Contributions by Intasco in Canada totaled $13,184 and $29,702, respectively, for the 13 and 26 weeks ended June 30, 2019 and $12,707 and $28,365, respectively, for the 13 and 26 weeks ended July 1, 2018.

Note 13 — Related Party Transactions

Effective March 18, 2013, the Company is under a management agreement with a firm related to several stockholders. The agreement initially provided for annual management fees of $300,000 and additional fees for assistance provided with acquisitions. Effective upon completion of the Company's initial public offering, the agreement was amended to reduce the annual management fee by an amount equal to the amount, if any, of annual cash retainers and equity awards received as compensation for service on the board of directors to any person who is a related person of Taglich Private Equity, LLC or Taglich Brothers, Inc. The Company incurred management fees of $56,250 and $112,500, respectively, for the 13 and 26 weeks ended June 30, 2019 and $56,250 and $112,500, respectively, for the 13 and 26 weeks ended July 1, 2018. The management agreement had an initial term of five years, expiring on March 18, 2018, and renews automatically annually for additional one year terms. The current term expires on March 18, 2020. The agreement also will terminate on the date that the Taglich Founding Investors or Taglich Equity Investors, each as defined, no longer also collectively own 50% of the equity securities owned by either of them on March 18, 2013.

In 2019, the Company has entered into a services agreement with 6th Avenue Group, which is a company owned by a Board member of the Company. The services performed have been related to providing assistance for long term strategic planning for the Company as well as aiding in helping the Company with CEO transition services. As previously mentioned in Note 8, the Company's CEO resigned on May 6, 2019. The Company incurred fees to the 6th Avenue Group of $75,819 and $75,819, respectively, for the 13 and 26 weeks ended June 30, 2019. The services provided by 6th Avenue Group are expected to end in 2019. This Board member, as discussed in Note 9, was also awarded stock options for 30,000 shares for her services on June 11, 2019.




Note 14 — Fair Value Measurements

20

TABLE OF CONTENTS
UNIQUE FABRICATING, INC.

Notes to Consolidated Financial Statements (Unaudited)


Financial instruments consist of cash equivalents, accounts receivable, accounts payable and debt. The carrying amount of all significant financial instruments approximates fair value due to either the short maturity or the existence of variable interest rates that approximate prevailing market rates.

Accounting standards require certain other items be reported at fair value in the financial statements and provides a framework for establishing that fair value. The framework for determining fair value is based on a hierarchy that prioritizes the valuation techniques and inputs used to measure fair value.

Fair values determined by Level 1 inputs use quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

Fair values determined by Level 2 inputs use other inputs that are observable, either directly or indirectly. Level 2 inputs may include quoted prices for similar items in active markets, and other inputs such as interest rates and yield curves that are observable at commonly quoted intervals.

Level 3 inputs are unobservable inputs, including inputs that are available in situations where there is little, if any, market activity for the related item. Level 3 fair value measurements are based primarily on management’s own estimates using inputs such as pricing models, discounted cash flow methodologies or similar techniques taking into account the characteristics of the item.

In instances whereby inputs used to measure fair value fall into different levels of the fair value hierarchy, fair value measurements in their entirety are categorized based on the lowest level input that is significant to the valuation. The Company’s assessment of the significance of particular inputs to these fair value measurements requires judgment and considers factors specific to each item.

The Company measures its interest rate swaps at fair value on a recurring basis based primarily on Level 2 inputs using an income model based on disparity between variance and fixed interest rates, the scheduled balance of principal outstanding, yield curves and other information readily available in the market.

Note 15 — Contingencies

The Company is engaged from time to time in legal matters and proceedings arising out of its normal course of business. The Company establishes a liability related to its legal proceedings and claims when it has determined that it is probable that the Company has incurred a liability and the related amount can be reasonably estimated. If the Company determines that an obligation is reasonably possible, the Company will, if material, disclose the nature of the loss contingency and the estimated range of possible loss, or include a statement that no estimate of loss can be made. While uncertainties are inherent in the final outcome of such matters, the Company believes that there are no pending proceedings in which the Company is currently involved that will have a material effect on its financial position, results of operations or cash flow.

Note 16 — Earnings Per Share

Basic earnings per share is computed by dividing the net income by the weighted-average number of shares outstanding during the period. Diluted earnings per share is computed giving effect to all potentially weighted average dilutive shares including stock options and warrants. The dilutive effect of outstanding awards, if any, is reflected in diluted earnings per share by application of the treasury stock method.

The following table sets forth the computation of basic and diluted earnings per share.

21

TABLE OF CONTENTS
UNIQUE FABRICATING, INC.

Notes to Consolidated Financial Statements (Unaudited)

 
Thirteen Weeks Ended June 30, 2019
 
Thirteen Weeks Ended July 1, 2018
 
Twenty-Six Weeks Ended June 30, 2019
 
Twenty-Six Weeks Ended July 1, 2018
Basic earnings per share calculation:
 
 
 
 
 
 
 
Net (loss) income
$
(7,623,295
)
 
$
1,751,009

 
$
(7,812,412
)
 
$
3,262,898

Net (loss) income attributable to common stockholders
$
(7,623,295
)
 
$
1,751,009

 
$
(7,812,412
)
 
$
3,262,898

Weighted average shares outstanding
9,779,147

 
9,768,159

 
9,779,147

 
9,767,180

Net (loss) income per share-basic
$
(0.78
)
 
$
0.18

 
$
(0.80
)
 
$
0.33

Diluted earnings per share calculation:
 
 
 
 
 
 
 
Net (loss) income
$
(7,623,295
)
 
$
1,751,009

 
$
(7,812,412
)
 
$
3,262,898

Weighted average shares outstanding
9,779,147

 
9,768,159

 
9,779,147

 
9,767,180

Effect of dilutive securities:
  

 
 
 
 
 
 
Stock options(1)(2)

 
148,115

 

 
146,802

Warrants(1)

 
725

 

 
706

Diluted weighted average shares outstanding
9,779,147

 
9,916,999

 
9,779,147

 
9,914,688

Net (loss) income per share-diluted
$
(0.78
)
 
$
0.18

 
$
(0.80
)
 
$
0.33

 

(1)Due to a net loss for the 13 and 26 weeks ended June 30, 2019, the effect of certain dilutive securities were excluded from the computation of weighted average diluted shares outstanding, as inclusion would have resulted in anti-dilution.

(2)Options to purchase 329,080 shares of common stock remaining to be exercised under the 2013 plan were considered in the computation of diluted earnings per share using the treasury stock method in the 2018 calculation. Warrants to purchase 1,185 shares of common stock remaining to be exercised, warrants to purchase 141,000 shares of common stock issued to the underwriters of the Company's IPO in July 2015, options to purchase 220,000 shares of common stock that were granted in August 2015 and November 2015 remaining to be exercised, as discussed in Note 9, under the 2014 plan, options to purchase 7,200 shares of common stock and 5,000 shares of common stock that were granted under the 2013 and 2014 plan, respectively, in April 2016, and options to purchase 5,000 and 15,000 shares of common stock that were granted under the 2013 and 2014 plan, were not included in the computation of diluted earnings per share in the 2018 period because the effect would have been anti-dilutive.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

This Management's Discussion and Analysis of Financial Condition and Results of Operation is intended to provide a reader of our financial statements with a narrative from the perspective of our management on our financial condition, results of operations, liquidity, and certain other factors that may affect our future results. You should read the following discussion and analysis of our financial condition and results of operations in conjunction with the accompanying unaudited consolidated financial statements and the related notes to unaudited consolidated financial statements included elsewhere in this document as well as the consolidated financial statements and the related notes to consolidated financial statements for the year ended December 30, 2018 included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission (the "SEC"). Our actual results and the timing of events could differ materially from those discussed in forward-looking statements contained herein. Factors that could cause or contribute to these differences include those discussed below as well as in our Annual Report on Form 10-K, particularly in “Risk Factors” and “Special Note Regarding Forward-Looking Statements.” We make no guarantees regarding outcomes, and assume no obligation to update the forward-looking statements herein, except as may be required by law.

Forward-Looking Statements


22

TABLE OF CONTENTS

The following discussion contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties. These statements are based on management's beliefs and assumptions and on information currently available to us. These statements relate to future events or to our future financial performance and involve known and unknown risks, uncertainties, and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these statements. When used in this document the words “anticipate,” “believe,” “continue,” “could,” “seek,” “might,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “approximately,” “project,” “should,” “will,” “would,” or the negative or plural of these words or similar expressions, as they relate to our company, business and management, are intended to identify forward-looking statements. In light of these risks and uncertainties, the future events and circumstances discussed may not occur, and actual results could differ materially from those anticipated or implied in the forward-looking statements, including those discussed in our Annual Report on Form 10-K and in particular the section entitled “Risk Factors” of the Annual Report on Form 10-K.

Forward-looking statements speak only as of the date of this Form 10-Q filing. Except as required by law, we assume no obligation to publicly update or revise any forward-looking statement to reflect actual results, changes in assumptions based on new information, future events or otherwise. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.

Basis of Presentation

The Company’s policy is that quarterly periods end on the Sunday closest to the end of the calendar quarterly period. The second quarter of 2019 ended on June 30, 2019 and the second quarter of 2018 ended on July 1, 2018. The Company’s policy is that fiscal years end annually on the Sunday closest to the end of the calendar year end. Our 2018 fiscal year ended on December 30, 2018 and the current fiscal year will end on December 29, 2019. The Company’s operations are aggregated in one reportable business segment. Although we expanded the products that we manufacture and sell to include components used in the appliance, HVAC and water heater industries, products for these industries are manufactured at facilities that also manufacture or are capable of manufacturing products for the automotive industries. All of our manufacturing locations have similar capabilities, and most plants serve multiple markets. The manufacturing operations for our automotive, appliance, HVAC and water heater products share management and labor forces and use common personnel and strategies for new product development, marketing and the sourcing of raw materials.

We qualify as an “emerging growth company” under the JOBS Act. As a result, we are permitted to, and intend to, rely on exemptions from certain disclosure requirements. For so long as we are an emerging growth company, we will not be required to:
have an auditor report on our internal controls over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act;
comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding a supplement to the auditor’s report providing additional information about the audit and the financial statements (i.e., an auditor discussion and analysis);
submit certain executive compensation matters to shareholder advisory votes, such as “say-on-pay” and “say-on-frequency”; and
disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation.

In addition, Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to take advantage of the benefits of this extended transition period. Our financial statements may therefore not be comparable to those of companies that comply with such new or revised accounting standards.

We will remain an “emerging growth company” for up to five years from our initial public offering, or until the earliest to occur of (1) the last day of the first fiscal year in which our total annual gross revenues exceed $1.1 billion, (2) the date that we become a “large accelerated filer” as defined in Rule 12b-2 under the Securities Exchange Act of 1934, which would occur if the market value of our common stock that is held by non-affiliates exceeds $700 million as of the last business day of our most recently completed second fiscal quarter or (3) the date on which we have issued more than $1.0 billion in non-convertible debt during the preceding three year period.

23

TABLE OF CONTENTS


Our emerging growth status will expire on the first day of the fiscal year 2020, and as such at the time we will no longer be able to take advantage of the exemptions noted above.

Overview

Unique is engaged in the engineering and manufacture of multi-material foam, rubber, and plastic components utilized in noise, vibration and harshness, acoustical management, water and air sealing, decorative and other functional applications. The Company combines a long history of organic growth with some more recent strategic acquisitions to diversify both product capabilities and markets served.

Unique’s markets served are the North America automotive and heavy duty truck, as well as the appliance, water heater and HVAC markets. Sales are conducted directly with major automotive and heavy duty truck, appliance, water heater and HVAC OEMs, or indirectly through the Tier 1 suppliers of these OEMs. The Company has its principal executive offices in Auburn Hills, Michigan and has sales, engineering and production facilities in Auburn Hills, Michigan, Concord, Michigan, LaFayette, Georgia, Louisville, Kentucky, Evansville, Indiana, Bryan, Ohio, Monterrey, Mexico, Queretaro, Mexico and London, Ontario. The Company also has an independent client sales representative who maintains offices in Baldham, Germany.

Unique derives the majority of its net sales from the sales of foam, rubber plastic, and tape adhesive related automotive products. These products are produced from a variety of manufacturing processes including die cutting, compression molding, thermoforming, reaction injection molding, and fusion molding. We believe Unique has a broader array of processes and materials utilized than any of its direct competitors, based on our product offerings. By sealing out air noise and water intrusion, and by providing sound absorption and blocking, Unique’s products improve the interior comfort of a vehicle, increasing perceived vehicle quality and the overall experience of its passengers. Unique’s products perform similar functions for appliances, water heaters and HVAC systems, improving thermal characteristics, reducing noise and prolonging equipment life.

We primarily operate within the highly competitive and cyclical automotive parts industry. Through 2016, the industry experienced consistent growth as it recovered from the recession of 2009. However, the industry has been declining somewhat in the years since then. Over the same period we were able to grow our core automotive parts business at a faster rate than the industry as a whole, indicating we were taking market share from competitors and increasing our content per vehicle on the programs we supply.

Recent Developments

Impairment of Goodwill

During the second quarter of 2019, the Company experienced a decline in market capitalization, which under applicable accounting standards, is a potential indicator of impairment. As a result, the Company performed an interim quantitative assessment as of June 30, 2019, utilizing a combination of the income and market approaches, which were weighted evenly. The results of the quantitative analysis performed indicated the carrying value of the Company exceeded the fair value of the Company by $6.76 million and, accordingly, an impairment was recorded. Key assumptions used in the analysis were a discount rate of 12.5%, EBITDA margin and a terminal growth rate of 2.0%. Future events and changing market conditions may, however, lead us to reevaluate the assumptions we have used to test for goodwill impairment, including key assumptions used in our expected EBITDA margins and cash flows, as well as other key assumptions with respect to matters out of our control, such as discount rates and market multiple comparables. Based on the results of the quantitative test, we performed sensitivity analysis around the key assumptions used in the analysis, the results of which were a 50 basis point decline in EBITDA margin used to determine expected future cash flows would have resulted in an additional impairment of approximately $12.3 million.
 
Second Quarter Results

Second quarter results were adversely affected by a number of factors including an overall decrease in North American vehicle production, the loss of business due to end of life of certain vehicle platforms and the discontinuation of certain passenger car platforms at a certain OEM. We expect that these factors may continue to adversely affect results through the remainder of this year. In addition, our results were adversely affected by the impairment charge of $6.76 million.

Salaried Restructuring

24

TABLE OF CONTENTS


On July 30, 2019, subsequent to our quarter-end, our former President and Chief Executive Officer of the Company (CEO), resigned as a member of the board of directors. The Company did not incur any additional restructuring costs in connection with his resignation as a director.
    
On May 6, 2019, our former President and CEO resigned by mutual agreement of both parties. The Company incurred one-time restructuring costs of $579,972 and $579,972 during the 13 and 26 weeks ended June 30, 2019, respectively in connection with his resignation. Further charges with respect to his resignation as President and CEO are expected to be incurred in 2019 subsequent to quarter end and are expected to be immaterial.

On May 15, 2019 and on February 1, 2019, the Company announced that in order to reduce fixed costs it would be eliminating a number of salaried positions throughout the Company. The Company provided the affected employees severance pay, health benefits continuation and job search assistance. This reduction took place and was paid in the 13 and 26 weeks ended June 30, 2019 , and in connection with this workforce reduction the Company incurred one-time severance costs of $154,022 and $244,567, respectively.

Evansville Facility Closure

On July 16, 2019, subsequent to our second quarter-end, the Company made the decision to close its manufacturing facility in Evansville, Indiana. The Company currently expects to cease operations at the Evansville facility by the end of September 2019, and that approximately 53 positions will be eliminated as a result of the closure. The Company's decision resulted from its desire to streamline operations and to utilize some of the available excess capacity in other of our facilities.

As such, the Company will move existing Evansville production to its manufacturing facilities in LaFayette, GA, Auburn Hills, MI, and Louisville, KY. The Company will provide the affected employees severance pay, health benefits continuation, and job search assistance. The Company evaluated whether or not this closing met the criteria for discontinued operations and concluded that the closing did not meet the definition as it did not represent a strategic shift in the Company's operations and the Company will have continuing cash flows from the production being moved to other facilities within the Company.

The Company expects to incur one-time severance costs as a result of this plant closure of approximately $309,000 during the remainder of 2019. The amount of other costs incurred associated with this plant closure, which will primarily consist of preparing and moving existing production equipment and inventory at Evansville to other facilities, will be approximately $1.325 million, and early lease termination fees will be approximately $1.2 million during the remainder of 2019. The Company is actively pursing a sublease of the facility.

Fort Smith Facility Closure

On February 13, 2018, the Company made the decision to close its manufacturing facility in Fort Smith, Arkansas. The Company ceased operations at the Fort Smith facility in July of 2018, and approximately 20 positions were eliminated as a result of the closure. The Company's decision resulted from its desire to streamline operations and to utilize some of the available excess capacity in other of its facilities. The Company moved existing Fort Smith production to our manufacturing facilities in Evansville, Indiana and Monterrey, Mexico. The Company provided the affected employees severance pay, health benefits continuation and job search assistance. The Company evaluated whether or not this closing met the criteria for discontinued operations and concluded that the closing did not meet the definition as it did not represent a strategic shift in the Company's operations, and the Company has continuing cash flows from the production being moved to other of its facilities.

In October, 2018, the Company sold the building it owned in Fort Smith, which had a net book value of $733,059, for cash proceeds of $876,032 resulting in a gain on the sale of $142,973.  The Company did not incur any restructuring costs associated with this closure in the 13 and 26 weeks ended June 30, 2019.

The Company incurred one-time severance costs as a result of this plant closure of $(58,933) and $173,359, respectively, in the 13 and 26 weeks ended July 1, 2018. The amount of other costs incurred associated with this plant closure, which primarily consisted of preparing and moving existing production equipment and inventory at Fort Smith to other facilities was $423,705 and $444,358, respectively, in the 13 and 26 weeks ended July 1, 2018. All of these costs were recorded to the restructuring expense line in continuing operations in the Company's consolidated statements of operations.

Port Huron Facility Closure


25

TABLE OF CONTENTS

On February 1, 2018, the Company made the decision to close its manufacturing facility in Port Huron, Michigan. The Company ceased operations at the Port Huron facility in June of 2018, and 7 positions were eliminated as a result of the closure. The Company's decision resulted from its desire to streamline operations and to utilize some of the available excess capacity in other of its facilities.

The Company moved existing Port Huron production to our manufacturing facilities in London, Ontario, Auburn Hills, Michigan, and Louisville, Kentucky. The Company provided the affected employees severance pay, health benefits continuation and job search assistance. The Company evaluated whether or not this closing met the criteria for discontinued operations and concluded that the closing did not meet the definition as it did not represent a strategic shift in the Company's operations and the Company has continuing cash flows from the production being moved to other of its facilities. The Company did not incur any restructuring costs associated with this closure in the 13 and 26 weeks ended June 30, 2019.

The Company incurred one-time severance costs as a result of this plant closure of $(17,125) and $64,768, respectively, in the 13 and 26 weeks ended July 1, 2018. The amount of other costs incurred associated with this plant closure, which primarily consisted of preparing and moving existing production equipment and inventory at Port Huron to other facilities was $190,470 and $297,899, respectively, in the 13 and 26 weeks ended July 1, 2018. All of these costs were recorded to the restructuring expense line in continuing operations in the Company's consolidated statements of operations.

Tax Cut and JOBS Act

The Tax Cuts and Jobs Act (the “Act”), enacted in December 2017, changed many aspects of U.S. corporate income taxation and included the reduction of the corporate income tax rate from 35% to 21%. The Act also included implementation of a territorial system and imposition of a one-time tax on deemed repatriated earnings of foreign subsidiaries. During 2018, we completed our accounting for the income tax effects of the Act and recorded a benefit of $(80,453) as an adjustment to the provisional estimate of the one-time transition tax expense recorded in 2017. Also during 2018, the Act required a calculation of tax under the Global Intangible Low-Taxed Income (“GILTI”) provisions of the Act, which resulted in a $320,000 expense. The Company calculates the tax impact of GILTI quarterly.

Amended and Restated Credit Agreement

On November 8, 2018, the US Borrower and the CA Borrower, entered into an Amended and Restated Credit Agreement (the “Amended and Restated Credit Agreement”), which amended and restated the existing Credit Agreement, with Citizens, acting as Administrative Agent, and the other lenders. The Amended and Restated Credit Agreement, among other things increases the principal amount of US Term Loan borrowings to $26.0 million, creates a two year line to fund capital expenditures of up to $2.5 million through November 8, 2019 and $5.0 million thereafter through November 8, 2020, and extends the maturity dates of all borrowings from April 28, 2021 to November 7, 2023. The Amended and Restated Credit Agreement provides for borrowings of up to $30.0 million under the Revolver, subject to availability, and left the principal amount on the CA Term Loan the same as at September 30, 2018, approximately $12.0 million, and the same as it was under the previous Credit Agreement. The Amended and Restated Credit Agreement combined the previous US Term Loan and US Term Loan II (the “New US Term Loan”) into one term loan, and increases the aggregate principal amount to $26.0 million dollars from $15.9 million. The increase in the principal amount effected by the New U.S. Term Loan replaced and termed-out outstanding borrowings under the Revolver. The Amended and Restated Credit Agreement changes the quarterly principal payments of the New US Term Loan to $337,500 through September 30, 2020, $575,000 thereafter through September 30, 2021, and $812,500 thereafter though maturity. Finally, the agreement made certain changes to the Company's covenants and financial covenant ratios.

Covenant Compliance

As of March 31, 2019, the Company was not in compliance with the total leverage ratio financial covenant. As a result of this non-compliance, on May 7, 2019, the US Borrower and the CA Borrower entered into the waiver and First Amendment (the “First Amendment”) to the Amended and Restated Credit Agreement, with Citizens, acting as Administrative Agent, and the other lenders. The First Amendment temporarily waived the default on the March 31, 2019 covenant violation until the earlier of June 15, 2019 and the execution and delivery of a further amendment revising the calculation of the total leverage ratio and such other financial covenants as are necessary taking into account the Borrowers current and future financial condition.

On June 14, 2019, the Company entered into the Second Amendment (the “Second Amendment”) to the Amended and Restated Credit Agreement, with Citizens, acting as Administrative Agent, and the other lenders.  The Second Amendment revised the waiver period as defined with respect to the March 31, 2019 covenant violation and resulting default until the earlier

26

TABLE OF CONTENTS

of June 30, 2019 (which was June 15, 2019 under the First Amendment to the Amended and Restated Credit Agreement) and the execution and delivery of a further amendment revising the calculation of the total leverage ratio and such other financial covenants as are necessary taking into account the Borrowers current and future financial condition.

On June 28, 2019, the Company entered into the Third Amendment (the “Third Amendment”) to the Amended and Restated Credit Agreement, with Citizens, acting as Administrative Agent, and the other lenders.  The Third Amendment revised the waiver period as defined with respect to the March 31, 2019 covenant violation and resulting default until the earlier of July 22, 2019 (which was June 30, 2019 under the Second Amendment to the Amended and Restated Credit Agreement) and the execution and delivery of a further amendment revising the calculation of the total leverage ratio and such other financial covenants as are necessary taking into account the Borrowers current and future financial condition.

On July 16, 2019, the Company entered into the Waiver and Fourth Amendment (the “Fourth Amendment”) to the Amended and Restated Credit Agreement, with Citizens, acting as Administrative Agent, and the other lenders.  The Fourth Amendment provided a permanent waiver by the Lenders and Agent with respect to the Borrower's non-compliance with the total leverage ratio financial covenant, as defined, not in excess of 3.50 to 1.00 as of March 31, 2019. The Fourth Amendment also revised the definition of consolidated EBITDA and certain financial covenants, including the maximum total leverage ratio and the minimum debt service coverage ratio, as well as adding the requirement that the Company maintain minimum liquidity and minimum unadjusted consolidated EBITDA, each as defined. The Fourth Amendment permits distributions as long as the Borrower is in compliance with specified conditions including that the Borrower's liquidity, as defined, is not less than $5 million after giving effect to the distributions,, total leverage ratio is not more than 2.00 to 1.00, post distribution debt service coverage ratio ("DSCR"), as defined, is not greater than 1.10 to 1.00, and Borrower is in compliance with financial covenants, before and after giving effect to the distributions. The Company is compliant with the covenants set forth in the Waiver and Fourth Amendment as of June 30, 2019. The Company does not anticipate the payment of dividends in 2019.

Comparison of Results of Operations for the Thirteen Weeks Ended June 30, 2019 and the Thirteen Weeks Ended July 1, 2018

Thirteen Weeks Ended June 30, 2019 and Thirteen Weeks Ended July 1, 2018

Net Sales
 
Thirteen Weeks Ended June 30, 2019
 
Thirteen Weeks Ended July 1, 2018
 
(in thousands)
Net sales
$
38,889

 
$
45,742


Net sales for the 13 weeks ended June 30, 2019 were approximately $38.89 million compared to $45.74 million for the 13 weeks ended July 1, 2018. The decrease in sales for the 13 weeks ended June 30, 2019, was primarily attributable to a 1% overall industry decrease in North American vehicle production in such period as compared to production in the 13 weeks ended July 1, 2018, the loss of business due to end of life of certain vehicle platforms, the loss of business at two major non-automotive customers as a result of our closing our Ft. Smith, Arkansas facility in June of 2018, as well as the discontinuation of certain passenger car platforms at an automotive OEM.

Cost of Sales
 
Thirteen Weeks Ended June 30, 2019
 
Thirteen Weeks Ended July 1, 2018
 
(in thousands)
Materials
$
19,758

 
$
22,944

Direct labor and benefits
6,150

 
6,787

Manufacturing overhead
4,112

 
4,282

Sub-total
30,020

 
34,013

Depreciation
657

 
540

Cost of Sales
30,677

 
34,553

Gross Profit
$
8,212

 
$
11,189



27

TABLE OF CONTENTS

The major components of cost of sales are raw materials purchased from third parties, direct labor and benefits, and manufacturing overhead, including facility costs, utilities, supplies, repairs and maintenance, insurance, freight costs of products shipped to customers and depreciation.






Cost of Sales as a percent of Net Sales
 
Thirteen Weeks Ended June 30, 2019
 
Thirteen Weeks Ended July 1, 2018
Materials
50.8
%
 
50.2
%
Direct labor and benefits
15.8
%
 
14.8
%
Manufacturing overhead
10.6
%
 
9.4
%
Sub-total
77.2
%
 
74.4
%
Depreciation
1.7
%
 
1.2
%
Cost of Sales
78.9
%
 
75.6
%
Gross Profit
21.1
%
 
24.4
%

Cost of sales as a percentage of net sales for the 13 weeks ended June 30, 2019 increased to 78.9% from 75.6% for the 13 weeks ended July 1, 2018. The increase in cost of sales as a percentage of net sales was primarily attributable to higher material, labor and manufacturing overhead costs as a percentage of net sales. Material costs increased to 50.8% of net sales for the 13 weeks ended June 30, 2019 from 50.2% for the 13 weeks ended July 1, 2018 primarily due to unfavorable product mix. Direct labor and benefit costs as a percentage of net sales was 15.8% for the 13 weeks ended June 30, 2019 compared to 14.8% for the 13 weeks ended July 1, 2018 primarily due to higher health insurance claims incurred under our self-insured health and welfare benefit plans. Manufacturing overhead costs as a percentage of net sales was 10.6% for the 13 weeks ended June 30, 2019 versus 9.4% for the 13 weeks ended July 1, 2018. The increase in manufacturing overhead costs as a percentage of net sales was primarily due to the decline in sales from the second quarter of 2018. Depreciation costs increased to 1.7% of net sales for the 13 weeks ended June 30, 2019 compared to 1.2% for the 13 weeks ended July 1, 2018, again largely due to the decline in revenues from the second quarter of 2018, as well as the investment in new equipment we made during 2018 to increase our capacity to meet expected future demand and to add production capabilities at our manufacturing facilities.

Gross Profit
         
As a result of the increase in cost of sales as a percentage of sales described above, gross profit as a percentage of net sales for the 13 weeks ended June 30, 2019 decreased to 21.1% from 24.4% for the 13 weeks ended July 1, 2018.


Selling, General and Administrative Expenses
 
Thirteen Weeks Ended June 30, 2019
 
Thirteen Weeks Ended July 1, 2018
 
(in thousands, except SG&A as a
% of net sales)
SG&A, exclusive of depreciation and amortization
$
6,379

 
$
6,268

Depreciation and amortization
1,045

 
1,111

SG&A
$
7,424

 
$
7,379

SG&A as a % of net sales
19.1
%
 
16.1
%

SG&A as a percentage of net sales for the 13 weeks ended June 30, 2019, increased to 19.1% from 16.1% for the 13 weeks ended July 1, 2018. The increase is primarily related to the decline of overall net sales in the 13 weeks ended June 30, 2019 compared to the 13 weeks ended July 1, 2018.

Operating (Loss) Income

28

TABLE OF CONTENTS


Impairment of goodwill was $6.76 million and restructuring expenses were $0.73 million for the 13 weeks ended June 30, 2019, compared to impairment of goodwill of $0 and restructuring expenses of $0.54 million for the 13 weeks ended July 1, 2018. As a result of the impairment and restructuring expense, as well as the other factors that were discussed above, operating (loss) income for the 13 weeks ended June 30, 2019 was $(6.71) million compared to operating income of $3.27 million for the 13 weeks ended July 1, 2018.



Non-Operating Expense

Non-operating expense for the 13 weeks ended June 30, 2019 was $1.31 million compared to $0.89 million for the 13 weeks ended July 1, 2018. The change in non-operating expense was primarily driven by an increase in interest expense due to an unfavorable mark-to-market on the interest rate swaps of $0.27 million entered into during the fourth quarter of 2018, as required under the Amended and Restated Credit Agreement.

(Loss) Income Before Income Taxes

As a result of the foregoing factors, (loss) income before income taxes for the 13 weeks ended June 30, 2019 was $(8.01) million compared to income before income taxes of $2.38 million for the 13 weeks ended July 1, 2018.

Income Tax Provision

During the 13 weeks ended June 30, 2019, income tax benefit was $(0.39) million, and the effective income tax rate was 4.9%. The differences between the effective tax rate and the statutory rate of 21.0% are primarily due to permanent differences between book and tax accounting on the impairment of goodwill as well as earnings generated in Mexico and Canada, which both have higher statutory income tax rates than the U.S., and U.S, taxation of foreign earnings under the GILTI provisions of the Act, partially offset by tax credits in the U.S. These adjustments are explained further in Note 10.

During the 13 weeks ended July 1, 2018, income tax expense was $0.63 million, and the effective income tax rate was 26.5%. The effective tax rate was higher than the new Federal statutory rate of 21.0% that was enacted with the Tax Cuts on Jobs Act on December 22, 2017 primarily due to earnings generated in Mexico and Canada, which both have higher income tax rates than the U.S.

Net (loss) income

As a result of the impairment of goodwill, restructuring expenses, lower net sales, and changes in other expenses and benefits discussed above, net loss for the 13 weeks ended June 30, 2019 was $(7.62) million compared to net income of $1.75 million during the 13 weeks ended July 1, 2018.

Twenty-Six Weeks Ended June 30, 2019 and Twenty-Six Weeks Ended June 30, 2018

Net Sales
 
Twenty-Six Weeks Ended June 30, 2019
 
Twenty-Six Weeks Ended July 1, 2018
 
(in thousands)
Net sales
$
78,356

 
$
93,047


Net sales for the 26 weeks ended June 30, 2019 were approximately $78.36 million compared to $93.05 million for the 26 weeks ended July 1, 2018. The decrease in net sales for the 26 weeks ended June 30, 2019 , was primarily attributable to a 2.4% overall industry decrease in North American vehicle production in such period as compared to production in the 26 weeks ended July 1, 2018, the loss of business due to end of life of certain vehicle platforms, the loss of business at two major non-automotive customers as a result of our closing our Ft. Smith, Arkansas facility in June of 2018, as well as the discontinuation of certain passenger car platforms at a certain automotive OEM.


29

TABLE OF CONTENTS

Cost of Sales
 
Twenty-Six Weeks Ended June 30, 2019
 
Twenty-Six Weeks Ended July 1, 2018
 
(in thousands)
Materials
$
39,840

 
$
46,682

Direct labor and benefits
12,273

 
14,158

Manufacturing overhead
8,432

 
8,870

Sub-total
60,545

 
69,710

Depreciation
1,299

 
1,067

Cost of Sales
61,844

 
70,777

Gross Profit
$
16,512

 
$
22,269


The major components of cost of sales are raw materials purchased from third parties, direct labor and benefits, and manufacturing overhead, including facility costs, utilities, supplies, repairs and maintenance, insurance, freight costs of products shipped to customers and depreciation.

Cost of Sales as a percent of Net Sales
 
Twenty-Six Weeks Ended June 30, 2019
 
Twenty-Six Weeks Ended July 1, 2018
Materials
50.8
%
 
50.2
%
Direct labor and benefits
15.7
%
 
15.2
%
Manufacturing overhead
10.8
%
 
9.5
%
Sub-total
77.3
%
 
74.9
%
Depreciation
1.7
%
 
1.2
%
Cost of Sales
79.0
%
 
76.1
%
Gross Profit
21.1
%
 
23.9
%

Cost of sales as a percentage of net sales for the 26 weeks ended June 30, 2019 increased to 79.0% from 76.1% for the 26 weeks ended July 1, 2018. The increase in cost of sales as a percentage of net sales was primarily attributable to higher material, labor and manufacturing overhead costs as a percentage of net sales. Material costs increased to 50.8% of net sales for the 26 weeks ended June 30, 2019 from 50.2% for the 26 weeks ended July 1, 2018 primarily due to unfavorable product mix. Direct labor and benefit costs as a percentage of net sales was 15.7% for the 26 weeks ended June 30, 2019 compared to 15.2% for the 26 weeks ended July 1, 2018 primarily due to higher health insurance claims incurred under our self-insured health and welfare benefit plans. Manufacturing overhead costs as a percentage of net sales was 10.8% for the 26 weeks ended June 30, 2019 versus 9.5% for the 26 weeks ended July 1, 2018. The increase in manufacturing overhead costs as a percentage of net sales was primarily due to the decline in sales from the twenty-six weeks ended June 30, 2018. Depreciation costs increased to 1.7% of net sales for the 26 weeks ended June 30, 2019 compared to 1.2% for the 26 weeks ended July 1, 2018, again largely due to the decline in net sales during the first six months of 2019, as well as the investment in new equipment we made during 2018 to increase our capacity to meet expected future demand and to add production capabilities at our manufacturing facilities.

Gross Profit
         
As a result of the increase in cost of sales as a percentage of sales described above, gross profit as a percentage of net sales for the 26 weeks ended June 30, 2019 decreased to 21.1% from 23.9% for the 26 weeks ended July 1, 2018.










30

TABLE OF CONTENTS

Selling, General and Administrative Expenses
 
Twenty-Six Weeks Ended June 30, 2019
 
Twenty-Six Weeks Ended July 1, 2018
 
(in thousands, except SG&A as a
% of net sales)
SG&A, exclusive of depreciation and amortization
$
12,590

 
$
13,126

Depreciation and amortization
2,106

 
2,219

SG&A
$
14,696

 
$
15,345

SG&A as a % of net sales
18.8
%
 
16.5
%

SG&A as a percentage of net sales for the 26 weeks ended June 30, 2019, despite a decline in the amount expensed, increased to 18.8% from 16.5% for the 26 weeks ended July 1, 2018. The increase is primarily related to the decline of overall net sales in the 26 weeks ended June 30, 2019 compared to the 26 weeks ended July 1, 2018.

Operating (Loss) Income

Impairment of goodwill was $6.76 million and restructuring expenses were $.82 million for the 26 weeks ended June 30, 2019 compared to impairment of goodwill of $0 and restructuring expenses of $0.98 million for the 26 weeks ended July 1, 2018. As a result of the impairment and restructuring expenses, as well as the other factors discussed above, operating (loss) income for the 26 weeks ended June 30, 2019 was $(5.77) million compared to $5.94 million for the 26 weeks ended July 1, 2018.

Non-Operating Expense

Non-operating expense for the 26 weeks ended June 30, 2019 was $2.39 million compared to $1.66 million for the 26 weeks ended July 1, 2018. The change in non-operating expense was primarily driven by an increase in interest expense due to an unfavorable mark-to-market on the interest rate swaps of $0.66 million entered into during the fourth quarter of 2018, as required under the Amended and Restated Credit Agreement.

(Loss) Income Before Income Taxes

As a result of the foregoing factors, the (loss) income before income taxes for the 26 weeks ended June 30, 2019 was $(8.16) million compared to $4.28 million for the 26 weeks ended July 1, 2018.

Income Tax Provision

During the 26 weeks ended June 30, 2019 , income tax benefit was $0.35 million, and the effective income tax rate was 4.2%. The differences between the effective tax rate and the statutory rate of 21.0% are primarily due to to permanent differences between book and tax accounting on the impairment of goodwill as well as earnings generated in Mexico and Canada, which both have higher statutory income tax rates than the U.S., and U.S, taxation of foreign earnings under the GILTI provisions of the Act, partially offset by tax credits in the U.S. These adjustments are explained further in Note 10.

During the 26 weeks ended July 1, 2018, income tax expense was $1.02 million and the effective income tax rate was 23.8%. The effective tax rate was higher than the new Federal statutory rate of 21.0% that was enacted with the Tax Cuts and Jobs Act on December 22, 2017 primarily due to earnings generated in Mexico and Canada, which both have higher income tax rates than the U.S.

Net (loss) income

As a result of the impairment of goodwill, restructuring expenses, lower net sales, and changes in other expenses and benefits discussed above, net loss for the 26 weeks ended June 30, 2019 was $(7.81) million compared to net income of $3.26 million during the 26 weeks ended July 1, 2018.






31

TABLE OF CONTENTS

Non-GAAP Financial Measures

Adjusted EBITDA

We present Adjusted EBITDA (defined below), a measure that is not in accordance with generally accepted accounting principles in the United States of America (non-GAAP), in this document to provide investors with a supplemental measure of our operating performance. We believe that Adjusted EBITDA is a useful performance measure and it is used by us to facilitate a comparison of our operating performance on a consistent basis from period-to-period and to provide for a more complete understanding of factors and trends affecting our business and measures under GAAP can provide alone. Our board and management also use Adjusted EBITDA as one of the primary methods for planning and forecasting overall expected performance and for evaluating on a quarterly and annual basis actual results against such expectations, and as a performance evaluation metric in determining achievement of certain compensation programs and plans for Company management. In addition, the financial covenants in our new credit facility are based on Adjusted EBITDA subject to dollar limitations on certain adjustments.

We define “Adjusted EBITDA” as earnings before interest expense, income taxes, depreciation and amortization expense, non-cash stock awards, non-recurring integration expense, goodwill impairment, restructuring expenses, and one-time consulting and licensing ERP system implementation costs as we implement a new ERP system at all locations. We believe omitting these items provides a financial measure that facilitates comparisons of our results of operations with those of companies having different capital structures. Since the levels of indebtedness and tax structures that other companies have are different from ours, we omit these amounts to facilitate investors’ ability to make these comparisons. Similarly, we omit depreciation and amortization because other companies may employ a greater or lesser amount of property and intangible assets. We believe that investors, analysts and other interested parties view our ability to generate Adjusted EBITDA as an important measure of our operating performance and that of other companies in our industry. Adjusted EBITDA should not be considered as an alternative to net income for the periods indicated as a measure of our performance. Other companies in our industry may calculate Adjusted EBITDA differently than we do, limiting its usefulness as a comparative measure.

The use of Adjusted EBITDA has limitations as an analytical tool, and you should not consider this performance measure in isolation from, or as an alternative to, GAAP measures such as net income. Adjusted EBITDA is not a measure of liquidity under GAAP or otherwise, and is not an alternative to cash flow from continuing operating activities. Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by the expenses that are excluded from that term or by unusual or non-recurring items. The limitations of Adjusted EBITDA include that: (1) it does not reflect our cash expenditures or future requirements for capital expenditures or contractual commitments; (2) it does not reflect changes in, or cash requirements for, our working capital needs; (3) it does not reflect income tax payments we may be required to make; and (4) it does not reflect the cash requirements necessary to service interest or principal payments associated with indebtedness.

To properly and prudently evaluate our business, we encourage you to review our unaudited consolidated financial statements included elsewhere in this document, our audited consolidated financial statements included in our Annual Report on Form 10-K, and the reconciliation to Adjusted EBITDA from net income, the most directly comparable financial measure presented in accordance with GAAP, set forth in the following table. All of the items included in the reconciliation from net income to Adjusted EBITDA are either (1) non-cash items or (2) items that management does not consider in assessing our on-going operating performance. In the case of the non-cash items, management believes that investors may find it useful to assess our comparative operating performance because the measures without such items are less susceptible to variances in actual performance resulting from depreciation, amortization and other non-cash charges and more reflective of other factors that affect operating performance. In the case of the other items that management does not consider in assessing our on-going operating performance, management believes that investors may find it useful to assess our operating performance if the measures are presented without these items because their financial impact may not reflect on-going operating performance.












32

TABLE OF CONTENTS

Thirteen and Twenty-Six Weeks Ended June 30, 2019 and Thirteen and Twenty-Six Weeks Ended July 1, 2018
 
Thirteen Weeks Ended June 30, 2019
 
Thirteen Weeks Ended July 1, 2018
 
Twenty-Six Weeks Ended June 30, 2019
 
Twenty-Six Weeks Ended July 1, 2018
 
(in thousands)
Net income
$
(7,623
)
 
$
1,751

 
$
(7,812
)
 
$
3,263

Plus: Interest expense, net
1,332

 
861

 
2,432

 
1,596

Plus: Income tax (benefit) expense
(389
)
 
632

 
(346
)
 
1,020

Plus: Depreciation and amortization
1,702

 
1,651

 
3,404

 
3,286

Plus: Non-cash stock award
66

 
33

 
98

 
66

Plus: Non-recurring integration expenses
68

 

 
68

 

Plus: Goodwill impairment
6,760

 

 
6,760

 

Plus: Restructuring expenses
734

 
538

 
825

 
980

Plus: One-time consulting and licensing ERP system implementation costs
221

 
139

 
395

 
320

Adjusted EBITDA
$
2,871

 
$
5,605

 
$
5,824

 
$
10,531


Liquidity and Capital Resources

Our principal sources of liquidity are cash flow from operations and borrowings under our Credit Agreement from our senior lenders.

Our primary uses of cash are payment of vendors, payroll, operating costs, capital expenditures and debt service. As of June 30, 2019 and December 30, 2018, we had a cash balance of $1.01 million and $1.41 million, respectively. Our excess cash balance is swept daily and applied to reduce borrowings under our revolving line of credit, which remains available for re-borrowing, as needed, subject to compliance with the terms of the facility. As of June 30, 2019 and December 30, 2018, we had $14.14 million and $11.61 million, respectively, available to be borrowed under our revolving credit facility, subject to borrowing base restrictions and outstanding letters of credit. At each such date, we were in compliance with all debt covenants, as outlined in the Waiver and Fourth Amendment to the Amended and Restated Credit Agreement. We believe that our sources of liquidity, including cash flow from operations, existing cash and our revolving line of credit are sufficient to meet our projected cash requirements for at least the next fifty two weeks.

In 2019, we plan to spend approximately $3.43 million in capital expenditures, of which $1.88 million was spent through June 30, 2019, primarily to add new production equipment as we expand our production capabilities, upgrade existing equipment, and improve our information technology software and hardware throughout our facilities.

While we believe we have sufficient liquidity and capital resources to meet our current operating requirements and planned capital expenditures, we may elect to pursue additional growth opportunities that could require additional debt or equity financing. If we are unable to secure additional financing at favorable terms in order to pursue such additional growth opportunities, our ability to pursue such opportunities could be materially adversely affected.

Covenant Compliance

As of March 31, 2019, the Company was not in compliance with the total leverage ratio financial covenant. As a result of this non-compliance, on May 7, 2019, the US Borrower and the CA Borrower entered into the waiver and First Amendment (the “First Amendment”) to the Amended and Restated Credit Agreement with Citizens, acting as Administrative Agent, and the other lenders. The First Amendment temporarily waived the default on the March 31, 2019 covenant violation until the earlier of June 15, 2019 and the execution and delivery of a further amendment revising the calculation of the total leverage ratio and such other financial covenants as are necessary taking into account the Borrowers current and future financial condition. The temporary waiver was extended by a Waiver and Second Amendment and a Waiver and Third Amendment to the Amended and Restated Credit Agreement.

On June 14, 2019, the Company entered into the Second Amendment (the “Second Amendment”) to the Amended and Restated Credit Agreement, with Citizens acting as Administrative Agent, and the other lenders.  The Second Amendment

33

TABLE OF CONTENTS

revised the waiver period as defined with respect to the March 31, 2019 covenant violation and resulting default until the earlier of June 30, 2019 (which was June 15, 2019 under the First Amendment to the Amended and Restated Credit Agreement) and the execution and delivery of a further amendment revising the calculation of the total leverage ratio and such other financial covenants as are necessary taking into account the Borrowers current and future financial condition.

On June 28, 2019, the Company entered into the Third Amendment (the “Third Amendment”) to the Amended and Restated Credit Agreement, with Citizens acting as Administrative Agent, and the other lenders.  The Third Amendment revised the waiver period as defined with respect to the March 31, 2019 covenant violation and resulting default until the earlier of July 22, 2019 (which was June 30, 2019 under the Second Amendment to the Amended and Restated Credit Agreement) and the execution and delivery of a further amendment revising the calculation of the total leverage ratio and such other financial covenants as are necessary taking into account the Borrowers current and future financial condition.

On July 16, 2019, the Company entered into the Waiver and Fourth Amendment (the “Fourth Amendment”) to the Amended and Restated Credit Agreement, with Citizens acting as Administrative Agent, and the other lenders.  The Fourth Amendment provided a permanent waiver by the Lenders and Agent with respect to the Borrower's non-compliance with the total leverage ratio financial covenant, as defined, not in excess of 3.50 to 1.00 as of March 31, 2019. The Fourth Amendment also revised the definition of consolidated EBITDA and certain financial covenants, including the maximum total leverage ratio and the minimum debt service coverage ratio, as well as adding the requirement that the Company maintain minimum liquidity and minimum unadjusted consolidated EBITDA, each as defined. The Company is compliant with the covenants set forth in the Waiver and Fourth Amendment as of June 30, 2019.

Dividends

The Fourth Amendment permits distributions as long as the Borrower is in compliance with specified conditions including that the Borrower's liquidity, as defined, is not less than $5 million after giving effect to the distributions, total leverage ratio is not more than 2.00 to 1.00, post distribution DSCR, as defined, is not greater than 1.10 to 1.00, and Borrower is in compliance with financial covenantss, before and after giving effect to the distributions. The Company does not anticipate the payment of dividends in 2019.

Cash Flow Data

The following table presents cash flow data for the periods indicated.
 
Twenty-Six Weeks Ended June 30, 2019
 
Twenty-Six Weeks Ended July 1, 2018
Cash flow data
(in thousands)
Cash flow provided by (used in):
 
 
 
Operating activities
$
5,084

 
$
4,361

Investing activities
(1,839
)
 
(3,357
)
Financing activities
(3,600
)
 
(1,455
)

Operating Activities

Cash provided by operating activities consists of: net income adjusted for non-cash items; including depreciation and amortization; gain or loss on sale of assets; gain or loss on derivative instruments; bad debt adjustments; stock option expense; changes in deferred income taxes; accrued and other liabilities; prepaid expenses and other assets; and the effect of working capital changes. The primary factors affecting cash inflows and outflows are accounts receivable, inventory, prepaid expenses and other assets, and accounts payable and accrued interest.

During the 26 weeks ended June 30, 2019, net cash provided by operating activities was $5.08 million, compared to net cash provided by operating activities of $4.36 million for the 26 weeks ended July 1, 2018.

Net cash provided by operations for the 26 weeks ended June 30, 2019 was positively impacted by decreases in working capital, primarily in accounts receivable and inventory.


34


Net cash provided by operations for the 26 weeks ended July 1, 2018 was positively impacted by decreases in working capital, primarily in accounts payable and prepaid expenses.

Investing Activities

Cash used in investing activities consists principally of purchases of property, plant and equipment.

In the 26 weeks ended June 30, 2019 and 26 weeks ended July 1, 2018, we made capital expenditures of $1.88 million and $3.37 million, respectively.

We plan to spend a total of approximately $3.43 million in capital expenditures during 2019, including the $1.88 million spent through June 30, 2019.

Financing Activities

Cash flows used in financing activities consists primarily of borrowings and payments under our new and old senior credit facilities, debt issuance costs, proceeds from any exercise of stock options and warrants, and distribution of cash dividends.

In the 26 weeks ended June 30, 2019, we had outflows of $3.60 million primarily due to $2.64 million payment of the principal amount of our term loans and note payable under our new amended and restated senior credit facility. These outflows were partially offset by $1.30 million net proceeds from borrowings under our capital expenditure line.

As of June 30, 2019, $15.96 million was outstanding under the revolving credit facility, gross of debt issuance costs. Borrowings under the new revolving credit facility are subject to borrowing base restrictions and reduced to the extent of letters of credit issued under the new senior credit facility. As of June 30, 2019, the maximum additional available borrowings under the revolver was $14.14 million, subject to borrowing base restrictions and a reduction for a $0.1 million letter of credit issued for the benefit of the landlord of one of the Company’s leased facilities. Amounts repaid under the revolving credit facility will be available to be re-borrowed, subject to compliance with the terms of the facility.

In the 26 weeks ended July 1, 2018, we had outflows of $1.45 million primarily due to $1.80 million of pay-off of the principal amount of our term loan under our old senior credit facility, and $2.93 million for payments of cash dividends. These outflows were partially offset by $3.55 million net proceeds from borrowings under our old revolving credit facility.

Credit Agreement

On April 29, 2016, the US Borrower and the CA Borrower and Citizens, acting as lender and Administrative Agent and the other lenders, entered into the Credit Agreement providing for borrowings of up to the aggregate principal amount of $62.00 million. The Credit Agreement was a senior secured credit facility and consisted of a revolving line of credit (the “Revolver”) of up to $30.00 million to the US Borrower, a $17.00 million principal amount term loan to the US Borrower, (the “US Term Loan” and a $15.00 million term loan to the CA Borrower.

On August 18, 2017, the US Borrower and the CA Borrower entered into the Second Amendment (the “Amendment”) to the Credit Agreement, with Citizens, acting as Administrative agent, and other lenders. The Amendment converted $4.00 million of outstanding borrowings under the revolving line of credit under the Credit Agreement into an additional $4,000,000.00 million term loan to the US Borrower (the “US Term Loan II”). The conversion of a portion of the outstanding borrowings under the revolving line of credit did not reduce the aggregate amount available to be borrowed under it.

On August 8, 2018 the US Borrower and the CA Borrower entered into the Fourth Amendment (the “Fourth Amendment”) to the Credit Agreement, with Citizens acting as Administrative Agent, and the other lenders. The Fourth Amendment required the Company to use the net proceeds from the sale of the Ft. Smith, Arkansas building to reduce the outstanding borrowings under the Revolver. The application of the net proceeds did not permanently reduce the aggregate amount that could be borrowed under the Revolver. The Fourth Amendment also eased, for the fiscal quarter ended September 30, 2018, the financial covenant ratio which determined the Company's ability to pay dividends.

On September 20, 2018, the US Borrower and the CA Borrower entered into the Fifth Amendment (the “Fifth Amendment”) to the Credit Agreement, with Citizens acting as Administrative Agent, and the other lenders. The Fifth Amendment temporarily increased the maximum amount that could be borrowed under the Revolver to $32.5 million from its previous maximum of $30.0 million. This increase implemented by the Fifth Amendment was effective until October 31, 2018, at which point the maximum amount that could be borrowed under the Revolver reverted back to $30,000,000.0 million.

35



Amended and Restated Credit Agreement

On November 8, 2018, the US Borrower and the CA Borrower, entered into an Amended and Restated Credit Agreement (the “Amended and Restated Credit Agreement”), which amended and restated the existing Credit Agreement, with Citizens, acting as Administrative Agent, and the other lenders. The Amended and Restated Credit Agreement, among other things increased the principal amount of US Term Loan borrowings to $26.0 million, created a two year line to fund capital expenditures of up to $2.5 million through November 8, 2019 and $5.0 million thereafter through November 8, 2020, and extends the maturity dates of all borrowings from April 28, 2021 to November 7, 2023. The Amended and Restated Credit Agreement provides for borrowings of up to $30.0 million under the Revolver, subject to availability, and left the principal amount on the CA Term Loan at approximately $12.0 million on September 30, 2018, and the same as it was under the previous Credit Agreement as of the end of the third quarter. The Amended and Restated Credit Agreement combined the previous US Term Loan and US Term Loan II (the “New US Term Loan”), and increases the aggregate principal amount to $26.0 million dollars from $15.9 million. The increase in the principal amount effected by the New U.S. Term Loan replaced and termed-out outstanding borrowings under the Revolver. The Amended and Restated Credit Agreement changes the quarterly principal payments of the New US Term Loan to $337,500 through September 30, 2020, $575,000 thereafter through September 30, 2021, and $812,500 thereafter though maturity. Finally, the agreement made certain changes to the Company's covenants and financial covenant ratios.

The Revolver, New US Term Loan, and CA Term Loan all mature on November 7, 2023 and bear interest at the Company's election of either (i) the greater of the Prime Rate or the Federal Funds Effective Rate (the “Base Rate”) or (ii) the LIBOR rate, plus an applicable margin ranging from 1.75% to 2.75% in the case of the Base Rate and 2.75% to 3.75% in the case of the LIBOR rate, in each case, based on senior leverage ratio thresholds measured quarterly, as amended by the Waiver and Fourth Amendment to the Amended and Restated Credit Agreement. The effective interest rate as of June 30, 2019 was 6.1885%.

In addition, the Amended and Restated Credit Agreement allows for increases in the principal amount of the Revolver and New US and CA Term Loans not to exceed $10.00 million, in the aggregate, provided that before and after giving effect to any proposed increase (and any transactions to be consummated using proceeds of the increase), the total leverage and debt service coverage ratios do not exceed specified amounts. The Amended and Restated Credit Agreement also provides for the issuance of letters of credit with a face amount of up to $2.00 million, in the aggregate, provided that any letter of credit issued will reduce availability under the Revolver.

We are permitted to prepay in part or in full the amounts due under the Amended and Restated Credit Agreement without penalty, provided that with respect to prepayment of the Revolver at least $0.10 million remains outstanding. Our obligations under the Amended and Restated Credit Agreement may be accelerated upon the occurrence of an event of default, which include customary events for a financing arrangement of this type, including, without limitation, payment defaults, defaults in the performance of affirmative or negative covenants (including financial ratio maintenance requirements), bankruptcy or related defaults, defaults on certain other indebtedness, the material inaccuracy of representations or warranties, material adverse changes, and changes related to ownership of the U.S. Borrower or Unique Fabricating, Inc. In the event of an event of default, the interest rate on the Revolver and New US Term Loan and CA Term Loan will increase by 3.0% per annum plus the hen applicable rate. The Amended and Restated Credit Agreement requires that, in addition to scheduled principal payments, we repay both the New US Term Loan and CA Term Loan principal annually in an amount equal to (a) 50% of excess cash flow, as defined, if the total leverage ratio, as defined, as calculated as of the end of such year is greater than or equal to 2.75 to 1.00, or (b) 25% of excess cash flow calculated as of the end of such fiscal year if the total leverage ratio is greater than or equal to 2.00 to 1.00 but less than 2.75 to 1.00.

The US Borrower's obligations under the Amended and Restated Credit Agreement are guaranteed by each of its United States subsidiaries and by Unique Fabricating, Inc. and secured by a first priority security interest in all tangible and intangible assets, including a pledge of capital stock of the United States subsidiaries of the US Borrower and of 65% of the capital stock of the CA Borrower, and by mortgages on our facilities in LaFayette, Georgia, Louisville, Kentucky, and Evansville, Indiana. The US borrower guarantees all of the obligations and liabilities of the CA Borrower. Unique Fabricating, Inc. also pledged all of the capital stock of the US Borrower. The Fourth Amendment provided for the discharge and release of the mortgage on the Ft. Smith, Arkansas facility subject to the application of the net proceeds of its sale to reduce borrowings under the Revolver. The application of the net proceeds did not permanently reduce the amounts that could be borrowed under the Revolver.

Effective June 30, 2016, as required under the Credit Agreement, the Company purchased a derivative financial instrument, in the form of an interest rate swap, for the purpose of hedging certain identifiable transactions in order to mitigate risks related to cash flow variability caused by interest rate fluctuations. The interest rate swap requires the Company to pay a

36


fixed rate of 1.055% per annum while receiving a variable rate of one-month LIBOR. The notional amount at the effective date began at $16.68 million and decreased by $0.32 million each quarter until June 30, 2017, decreased thereafter by $0.43 million per quarter until June 29, 2018, when it began decreasing by $0.53 million until it expires on June 28, 2019. The interest rate swap was recognized at its fair value. Monthly settlement payments due on the interest rate swap and changes in its fair value are recognized as interest expense in the period incurred. Please see Note 7 of our consolidated financial statements for further information.

Effective October 2, 2017, as required under the Second Amendment to the Credit Agreement, as discussed in Note 7 of our consolidated financial statements, the Company entered into an interest rate swap which requires the Company to pay a fixed rate of 1.093% per annum while receiving a variable interest rate per annum based on one month LIBOR for a net monthly settlement based on half of the notional amount beginning immediately. The notional amount at the effective date was $1.90 million and decreases by $0.10 million each quarter until it expires on September 30, 2020. The interest rate swap is recognized at its fair value, and monthly settlement payments due on the interest rate swap and changes in its fair value are recognized as interest expense in the period incurred.

Effective November 30, 2018, as required under the Amended and Restated Credit Agreement, the Company entered into another interest rate swap the requires the Company to pay a fixed rate of 3.075% per annum while receiving a variable interest rate per annum based on the one month LIBOR for a net monthly settlement based on the notional amount in effect. The notional amount at the effective date was $5.04 million which increases by $0.38 million each quarter until June 28, 2019 when the notional amount increases to $17.54 million due to the interest rate swap from 2016 above expiring. The notional amount then decreases each quarter by $0.15 million until September 30, 2020 when the notional amount increases to $17.48 million due to the interest rate swap from 2017 above expiring. The notional amount then decreases each quarter by $0.43 million until December 31, 2021, then decreases each subsequent quarter by $0.61 million until it expires on November 8, 2023.The Company has elected not to apply hedge accounting for financial reporting purposes on all of its swaps.

We must comply with a minimum debt service financial covenant and a senior funded indebtedness to EBITDA covenant, as revised under the Waiver and Fourth Amendment (the “Fourth Amendment”) to the Amended and Restated Credit Agreement, with Citizens, acting as Administrative Agent, and the other lenders.  The Fourth Amendment provided a permanent waiver by the Lenders and Agent with respect to the Borrower's failure to maintain a total leverage ratio, as defined, not in excess of 3.50 to 1.00 as of March 31, 2019. The Fourth Amendment also revised the definition of consolidated EBITDA and certain financial covenants, including the maximum total leverage ratio and the minimum debt service coverage ratio, as well as added the requirement that the Company maintain minimum liquidity and minimum unadjusted consolidated EBITDA, each as defined.

The Amended and Restated Credit Agreement also contains customary affirmative covenants, including: (1) maintenance of legal existence and compliance with laws and regulations; (2) delivery of consolidated financial statements and other information; (3) maintenance of properties in good working order; (4) payment of taxes; (5) delivery of notices of defaults, litigation, ERISA events and material adverse changes; (6) maintenance of adequate insurance; and (7) inspection of books and records.

The Amended and Restated Credit Agreement contains customary negative covenants, including restrictions on: (1) the incurrence of additional debt; (2) liens and sale-leaseback transactions; (3) loans and investments; (4) guarantees and hedging agreements; (5) the sale, transfer or disposition of assets and businesses; (6) dividends on, and redemptions of, equity interests and other restricted payments, including dividends and distributions to the issuer by its subsidiaries; (7) transactions with affiliates; (8) changes in the business conducted by us; (9) payment or amendment of subordinated debt and organizational documents; and (10) maximum capital expenditures. The Fourth Amendment prohibits the payment of any dividend, redemption or other payment or distribution by the Borrowers other than distributions to the US Borrower by its subsidiaries, unless after giving effect to the dividend or other distribution, the post distribution DSCR, as defined, is greater than 1.2 to 1.0, and the US Borrower's liquidity, as defined is no less than $5.0 million, plus Borrowers remain in compliance with the other financial covenants.

Off Balance Sheet Arrangements

We do not have any off balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, sales or expenses, results of operations, liquidity or capital expenditures, or capital resources that are material to an investment in our securities.




37


Indemnification Agreements

In the normal course of business, we provide customers with indemnification provisions of varying scope against claims of intellectual property infringement by third parties arising from the use of our products. Historically, costs related to these indemnification provisions have not been significant and we are unable to estimate the maximum potential impact of these indemnification provisions on our future results of operations. In addition, we have entered into indemnification agreements with directors and certain officers and employees that will require us, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers or employees. No demands have been made upon us to provide indemnification under such agreements and there are no claims that we are aware of that could have a material effect on our consolidated balance sheets, consolidated statements of operations, consolidated statements of stockholders’ equity or consolidated cash flows.

Contractual Obligations and Commitments

The Company's contractual obligations and commitments outstanding as of June 30, 2019 have not changed materially since the amounts as of December 30, 2018 as set forth in our Annual Report on Form 10-K. These obligations and commitments relate to operating leases, future debt payments, and a management services agreement.

Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations is based upon our consolidated financial statements which have been prepared in accordance with GAAP. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect amounts reported in those statements. We have made our best estimates of certain amounts contained in our consolidated financial statements. We base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities. However, application of our accounting policies involves the exercise of judgment and use of assumptions as to future uncertainties and, as a result, actual results could differ materially from these estimates. Management believes that the estimates, assumptions, and judgments involved in the accounting policies that have the most significant impact on our consolidated financial statements are discussed in the Critical Accounting Policies section of Management's Discussion and Analysis of Financial Condition and Results of Operations in the Annual Report on Form 10-K. There have been no material changes to our critical accounting policies or uses of estimates since the date of our Annual Report on Form 10-K.


Recently Issued Accounting Pronouncements

Refer to Note 1 to the consolidated financial statements in Part I Item 1 of this Quarterly Report on Form 10-Q.

38


ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We have operations both within the United States and internationally, and we are exposed to market risks in the ordinary course of our business. These risks primarily include interest rate and foreign exchange risks.

Interest Rate Fluctuation Risk

Our borrowings under our Credit Agreement bear interest at fluctuating rates. In order to mitigate, in part, the potential effects of the fluctuating rates, effective June 30, 2016, we entered into a interest rate swap with a notional amount initially of $16.68 million, which decreased by $0.32 million each quarter until June 30, 2017, and began decreasing by $0.43 million each quarter until June 29, 2018, when it began decreasing by $0.53 million per quarter until the swap terminated on June 28, 2019. The interest rate swap required the Company to pay a fixed rate of 1.055 percent per annum while receiving a variable rate per annum based upon the one month LIBOR rate for a net monthly settlement based on the notional amount in effect. This swap terminated an old swap that we entered into on January 17, 2014 under our old senior credit facility. See Note 7 of our consolidated financial statements for further information.

Effective October 2, 2017, as required under the Second Amendment to the Credit Agreement, as discussed in Note 7 of our consolidated financial statements, the Company entered into another interest rate swap that requires the Company to pay a fixed rate of 1.093% percent per annum while receiving a variable interest rate per annum based on one month LIBOR for a net monthly settlement based on the notional amount in effect. The notional amount at the effective date was $1.90 million which decreases by $0.10 million each quarter until it expires on September 30, 2020.

Effective November 30, 2018, as required under the Amended and Restated Credit Agreement, the Company entered into another interest rate swap that requires the Company to pay a fixed rate of 3.075 per annum while receiving a variable interest rate per annum based on one month LIBOR for a net monthly settlement based on the notional amount in effect. The notional amount at the effective date was $5,037,500 which increases by $378,125 each quarter until June 29, 2018 when the notional amount increases to $17,540,625 due to the interest rate swap from 2016 above expiring. The notional amount then decreases each quarter by $153,125 until September 30, 2020 when the notional amount increases to $17,475,000 due to the interest rate swap from 2017 above expiring. The notional amount then decreases each quarter by $431,250 until December 31, 2021, then decreases each subsequent quarter by $609,375 until it expires on November 8, 2023.

We do not believe that an increase or decrease in interest rates of 100 basis points would have a material effect on our operating results or financial condition.



39

TABLE OF CONTENTS

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management establishes and maintains disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) to ensure that the information we disclose under the Exchange Act is properly and timely reported. We provide this information to our Chief Executive Officer and Chief Financial Officers as appropriate to allow for timely decisions.

Our controls and procedures are based on assumptions. Additionally, even effective controls and procedures only provide reasonable assurance of achieving their objectives. Accordingly, we cannot guarantee that our controls and procedures will succeed or be adhered to in all circumstances.

We have evaluated our disclosure controls and procedures, with the participation, and under the supervision, of our management, including our Chief Executive Officer and Chief Financial Officer. Based on this evaluation, our Chief Executive and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report.

Changes in Internal Control over Financial Reporting

There were no material changes in the Company's internal controls over financial reporting during the twenty-six weeks ended June 30, 2019 that have materially affected, or are reasonably likely to materially affect, the Company's internal controls over financial reporting.
 

40

TABLE OF CONTENTS

PART II

OTHER INFORMATION


ITEM 1. LEGAL PROCEEDINGS

Not applicable

ITEM 1A. RISK FACTORS

Impairment of goodwill

Under current accounting standards, if the Company's market capitalization were to decline, this would be considered a potential indicator of goodwill impairment. Any write-down of goodwill would have a negative effect on the consolidated financial statements of the Company. If the stock price remains below the net book value per share, or other negative business factors exist, the Company may be required to perform another goodwill impairment analysis, which could result in an impairment of up to the entire balance of the Company’s goodwill.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
             
None

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

Not applicable.


41

TABLE OF CONTENTS

ITEM 6. EXHIBITS

Exhibit
No.
 
Description
10.1*
 
10.2*
 
10.3*
 
31.1
 
Certification of the Chief Executive Officer of the Company, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2
 
Certification of the Chief Financial Officer of the Company, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**
 
Certification of the Chief Executive Officer and Chief Financial Officer of the Company, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS+
 
XBRL Instance Document
101.SCH+
 
XBRL Taxonomy Extension Schema Document
101.CAL+
 
XBRL Taxonomy Calculation Linkbase Document
101.DEF+
 
XBRL Taxonomy Definition Linkbase Document
101.LAB+
 
XBRL Taxonomy Label Linkbase Document
101.PRE+
 
XBRL Taxonomy Presentation Linkbase Document
 
* Filed herewith.
** Pursuant to Item 601(b)(32)(ii) of Regulation S-K(17 C.F.R 229.601(b)(32)(ii)), this certification is deemed furnished, not filed, for purposes of section 18 of the Exchange Act, nor is it otherwise subject to liability under that section. It will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except if the registrant specifically incorporates it by reference.
*** Previously filed.
+ Filed electronically with the report.




42

TABLE OF CONTENTS

SIGNATURES

Pursuant to the requirements of the Securities Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
UNIQUE FABRICATING, INC.
 
 
 
Date: August 7, 2019
By:
/s/ Thomas Tekiele
 
 
Name: Thomas Tekiele
 
 
Title:  Interim Chief Executive Officer and Chief Financial Officer (Principal Financial and Accounting Officer)
 
 
 



43


SEPARATION AGREEMENT AND GENERAL RELEASE
    This Separation Agreement and General Release (the “Separation Agreement”) is made and entered into by and between John Weinhardt (“Executive”), on the one hand, and Unique Fabricating Incorporated, subsequently renamed Unique Fabricating, NA, Inc. (the “Company”), on the other hand. Executive and the Company shall be referred to collectively herein as the “Parties” and each as a “Party.”
PRELIMINARY STATEMENTS:
Executive has been employed by the Company as President/Chief Executive Officer pursuant to an Employment Agreement dated as of March 15, 2013 (the “Employment Agreement”);
The Company and the Executive mutually agree to terminate the Executive’s employment as of the close of business on May 6, 2019 (the “Termination Date”); and
The Company agrees to provide Executive with such payments and benefits under the “Termination By Company Without Cause” provisions set forth in Section 6(b) of the Employment Agreement, which are conditioned upon the Executive’s executing and delivering a general release of claims as set forth in Section 6(e) of the Employment Agreement.

AGREEMENT:
NOW, THEREFORE, the Parties, intending to be legally bound hereby, agree as follows:
1.Termination of Employment. Executive’s employment is hereby terminated effective at the Termination Date. Executive hereby: (a) resigns effective as at the Termination Date from any and all positions he holds or held with any Company Group Entity (as defined below) as at the Termination Date, except that Executive shall continue to serve as a Director of Unique Fabricating, Inc., the Company’s parent, under the applicable terms and conditions; and (b) agrees to execute any documentation the Company reasonably requests to give effect to or otherwise reflect such resignations. For the purposes of this Separation Agreement, “Company Group Entity” means the (i) Company or (ii) any entity of any kind or nature that is (x) a direct or indirect parent, subsidiary or affiliate of the Company, (y) a division of any entity described in the immediately preceding clause (x) or (z) any benefit plan or other plan of any entity or division described in the immediately preceding clauses (x) and (y).

2.Consideration.
(a).Executive shall be eligible for continuation of his Base Salary in substantially equal installments and subject to applicable deductions, plus the continued use of the Company paid lease vehicle, over the Non-Compete Period of twelve (12) months as defined in Section 8(a) of the Employment Agreement or until such time that Executive accepts employment with another Company, whichever period is shorter, payable in accordance with the usual payroll practices in effect at the Company as if Executive was employed at the time (the “Separation Payment”).

(b).If Executive elects COBRA coverage under the Company’s medical and/or dental plan, the Company shall also during the Non-Compete Period (unless Executive shall be employed elsewhere and has been offered medical benefits by such employer) pay the same proportion of the costs of medical, dental and vision coverage as it pays for active employees participating in such plans (“COBRA Benefit”).

(c).Should Executive accept employment with another company during the Non-Compete Period, Executive is required to notify the Company in writing at the address set forth in Section 12(j) prior to his start date in which case the Separation Payment will cease upon such alternate employment and he





will not be entitled to any further payments. In addition, if Executive is employed elsewhere and has been offered medical benefits by such employer, he is required to notify the Company in writing as set forth above and such Company-paid benefits will cease.

(d).As a condition of receiving the Separation Payment and COBRA Benefit, Executive must timely sign and deliver the Separation Agreement to the Company at the address set forth in Section 12(j) within thirty (30) days of the Termination Date and shall not exercise his right to revoke the Separation Agreement; if Executive so timely signs, delivers and does not revoke the Separation Agreement, then the Separation Payment and COBRA Benefit shall not be discretionary and such payments and benefits will commence the first payroll period after the expiration of the revocation period. As a further condition of receipt of the Separation Payment and COBRA Benefit, Executive must comply with his obligations pursuant to this Separation Agreement and under any other agreement(s) to which Executive and the Company are a party.

3.No Further Payments or Benefits. After giving effect to the employment termination and resignations referenced in Section 1 (the “Employment Termination and Resignations”), Executive acknowledges and agrees that he shall not be entitled to (and waives and forfeits any right to) any payments or benefits of any kind or nature from any one or more Company Group Entities, except as set forth in Section 4(b).

4.General Release of Claims.

(a).In exchange for and in consideration of the promises, covenants and agreements set forth herein, effective as of the date of his execution of this Separation Agreement, Executive hereby forever releases and discharges each Company Group Entity and their respective past and present officers, directors, agents, employees, shareholders, investors, successors and assigns (collectively, the “Company Group Releasees”), from any and all manner of Claims that Executive has or may have for any period prior to the date of the execution of this Separation Agreement against or in relation to any one or more Company Group Entities (the “CG Released Claims”). Executive acknowledges and agrees that the CG Released Claims include, but are not limited to, any and all Claims arising out of or related to the following: (i) any Claim under any contract or binding arrangement between any one or more Company Group Entities, on the one hand, and Executive on the other hand, including the Employment Agreement, (ii) Executive’s employment by or other association with the Company Group Entities, (iii) any Claim related to the Employment Termination and Resignations, (iv) any Claim for additional compensation, unpaid wages, severance pay, bonuses, deferred compensation, stock options, restricted stock, restricted stock units, medical, dental, life or disability insurance coverage, or any other fringe benefit, (v) any Claim of emotional distress, defamation, fraud, misrepresentation, (vi) any Claim of discrimination under Title VII of the Civil Rights Act of 1964, as amended, the Age Discrimination in Employment Act of 1967 (ADEA), as amended by the Older Workers Benefit Protection Act (OWBPA), the Americans With Disabilities Act of 1990, the Family and Medical Leave Act, and all other federal, state and local laws, including but not limited to claims arising, inter alia, under the Civil Rights Act of 1991, the Occupational Safety and Health Act (OSHA), the Employee Retirement Income Security Act of 1974, as amended, the Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act, the Elliott-Larsen Civil Rights Act, the Michigan Persons with Disabilities Act; and (vii) any Claim for attorneys’ fees or costs incurred in pursuing any legal claim.

(b).This section does not waive any Claims (i) to vested benefits, (ii) any claims that lawfully cannot be waived, (iii) indemnification or other rights that Executive may have by virtue of his serving as a Director or executive officer; or (iv) to enforce the terms of this Separation Agreement.





(c).For the purposes of this section, “Claims” means collectively all claims, demands, causes of action, obligations, damages, or liabilities whatsoever of every kind and nature, at law or in equity, known or unknown, and whether or not discoverable.

5.Confidentiality. Executive agrees that the terms of this Separation Agreement and any disputes or disagreements between Executive and the Company are and shall remain confidential. Executive agrees that he will not disclose any terms or provisions of this Separation Agreement or to talk or write about the payments under this Separation Agreement, the negotiation or implementation of this Separation Agreement or any disputes between Executive and the Company without the prior written consent of the Company, except as required by law or legal process. Notwithstanding the foregoing, Executive may disclose the terms of this Separation Agreement to Executive’s immediate family, accountant, attorney, or investment advisor, provided they are made aware of and agree to the confidentiality provisions set forth in this section.

6.Non-Disparagement. Executive agrees that he shall not make or publish any statement (orally, electronically, or in writing), or instigate, assist or participate in the making or publication of any statement, which would or could libel, slander, expose to hatred, contempt or ridicule, or intentionally disparage (whether or not such disparagement legally constitutes libel or slander) any one or more Company Group Entities or any of their respective services, affairs or operations, or the reputations of any of its or their respective past or present directors, officers, employees, agents, shareholders, or investors. Nothing contained in this Section 6 is intended to prohibit Executive from providing information or truthful testimony in order to comply with any order of a court of competent jurisdiction, applicable laws, regulations of any governmental or regulatory body, or request of any governmental entity.

7.Acknowledgements.

(a).Executive represents that he has no employment discrimination, wrongful dismissal or any other complaints, claims or charges as described in Section 4 against any of the Company Group Releasees pending before any local, state or federal court, tribunal or administrative agency. Executive agrees that he will not file any judicial complaints against the any of the Company Group Releasees at any time hereinafter, nor lend support to any individual contemplating or taking such action other than if compelled by a subpoena.

(b).Executive acknowledges that nothing in this Separation Agreement is intended to preclude Executive from (i) enforcing the terms of this Separation Agreement; (ii) challenging the validity of this Separation Agreement; or (iii) providing information to, filing a charge or participating in any investigation or proceeding conducted by the Equal Employment Opportunity Commission, the National Labor Relations Board, the Securities and Exchange Commission or comparable state or local agency. By signing this Agreement, Executive waives his right to recovery based on any such claim, however, this Agreement does not limit Executive’s right to receive an award for information provided to any government agencies. Executive further understands that this Agreement does not limit Executive’s ability to communicate with any government agencies or otherwise participate in any investigation or proceeding that may be conducted by any government agency, including providing documents or other information, without notice to the Company.

8.No Admission of Liability. In executing this Separation Agreement, neither of the Parties or any of their respective officers, directors, representatives, agents, employees admit any liability or wrongdoing, and the considerations exchanged herein do not constitute an admission of any liability, error, contract violation, or violation of any federal, state, local, or foreign law or regulation.






9.OWBPA Waiver. Executive acknowledges that he has been, and hereby is, advised to consult with the attorneys of his choice prior to executing this Separation Agreement and that he has had an adequate opportunity to review this Separation Agreement before its execution and that he knows that he is giving up his rights under the Age Discrimination in Employment Act, as amended by the Older Workers Benefit Protection Act.

10.Time Period for Consideration and Effective Date. Executive acknowledges that he has a period of up to twenty-one (21) days to consider this Separation Agreement and return it to the Company in accordance with the notice provisions of Section 12(j) below. Executive may voluntarily execute and deliver this Separation Agreement prior the expiration of the twenty-one (21) day period. Executive will have seven (7) days from the date he signs this Separation Agreement to revoke this Separation Agreement. Any revocation of this Separation Agreement must be in writing and transmitted in accordance with the notice provisions of Section 12(j) below such that it is received by the Company before the expiration of the seven (7) day revocation period. This Separation Agreement will not become effective or enforceable until receipt of Executive’s executed Separation Agreement and the expiration of the seven (7) day revocation period. Executive’s signature below indicates that he is entering into this Separation Agreement freely, knowingly and voluntarily, with a full understanding of its terms.

11.Non-Disclosure of Confidential Information and Trade Secrets, Non-Solicitation and Non-Competition.

(a)Non-Disclosure of Confidential Information and Trade Secrets. Executive hereby reaffirms the provisions set forth in Section 9 of the Employment Agreement as if set forth fully herein and which remain in full force and effect in accordance with their terms.

(b)Non-Solicitation and Non-Competition. Executive hereby reaffirms the provisions set forth in Section 8 of the Employment Agreement as if set forth fully herein and which remain in full force and effect in accordance with their terms.

(c)Acknowledgments.
(1)Executive acknowledges and agrees that the covenants set forth in Sections 8 and 9 of the Employment Agreement (and as reaffirmed in Sections 11(a) and (b) above) are necessary and reasonably limited in scope and duration, and that these restrictions protect the Company’s legitimate commercial interests, including, but not limited to, protection from unfair competition, disparagement, misappropriation, disclosure or use of its Confidential Information and/or trade secrets, and misuse or unauthorized use of the work product/inventions.

(2)If the period of time, scope or the area specified in the covenants set forth in Section 8 and/or Section 9 of the Employment Agreement (and as reaffirmed in Sections 11(a) and (b) above) should be adjudged unreasonable in any proceeding, then the period of time shall be reduced by such number of months, the scope shall be modified or the area shall be reduced by the elimination of such portion thereof or both, so that such restrictions may be enforced in such area and for such time as is adjudged to be reasonable.

(3)If Executive violates any of the restrictions contained in the covenants set forth in Section 8 and/or Section 9 of the Employment Agreement (and as reaffirmed in Sections 11(a) and (b) above), the applicable restricted period shall not run in favor of the Executive from the time of the commencement of any such violation until such time as such violation shall be cured by Executive to the satisfaction of the Company, and a Court shall extend the applicable restricted period for the period of time of the breach.






(4)In the event any covenant contained in Sections 8 or 9 of the Employment Agreement (and as reaffirmed in Sections 11(a) and (b) above) is not enforceable in accordance with its terms, Executive and the Company agree that such provision shall be reformed to make such covenant enforceable in a manner that provides the Company with the maximum rights permitted at law.

(5)Executive acknowledges that he has returned to the Company all equipment, notebooks, documents, memoranda, reports, files, samples, books, correspondence, mailing lists, calendars, software, card files, rolodexes, and all other written, graphic or electronic records affecting or relating to the business of the Company which Executive prepared, used, constructed, observed, possessed, or controlled or otherwise obtained during his employment and that he has not taken, procured, photocopied or copied any property of the Company after notification of his termination.

(d)Disputes.

(1)Injunctive Relief. Notwithstanding the agreement to arbitrate between Executive and the Company set forth in Section 19 of the Employment Agreement, Executive acknowledges and agrees that a breach or threatened breach by the Employee of the obligations pursuant to Section 11 of this Separation Agreement will cause the Company irreparable harm, the amount of which will be impossible to estimate or determine and that cannot be adequately compensated. Accordingly, if any dispute arises between the parties relating to the obligations pursuant to this Separation Agreement, the Company will have the right to institute immediately judicial proceedings in any court of competent jurisdiction with respect to such dispute or claim and shall be entitled to relief enjoining such acts without the need to post a bond.

(2)Jurisdiction; Venue. The Parties agree that any claims for injunctive relief shall be brought in the United States District Court for the Eastern District of Michigan or in a Michigan state court having jurisdiction and not in or before any other court, agency or other tribunal. Each Party hereby irrevocably consents to the exercise of personal jurisdiction over such Party by the respective courts, agrees that venue shall be proper in such courts, and irrevocably waives and releases any and all defenses based on lack of personal jurisdiction, improper venue, and forum non conveniens.

(e)Defend Trade Secrets Act of 2016 Notice. In accordance with 18 U.S.C. § 1833(b), nothing in this Agreement is intended to interfere with or discourage Executive’s good faith disclosure of a trade secret or other confidential information to any governmental entity related to a suspected violation of law. Notwithstanding anything to the contrary in this Agreement, the federal Defend Trade Secrets Act of 2016 (“DTSA”) provides that Executive cannot be held criminally or civilly liable under any federal or state trade secret law if Executive discloses a trade secret or other confidential information (a) in confidence to (i) any federal, state, or local government official, either directly or indirectly, or (ii) an attorney, and solely for the purpose of reporting or investigating a suspected violation of the law; or (b) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. DTSA further provides that an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual (a) files any document containing the trade secret under seal; and (b) does not disclose the trade secret, except pursuant to court order.

12.Other Matters.

(a).Entire Agreement. This Separation Agreement constitutes the entire agreement among the Parties with respect to the subject matter of this Separation Agreement and supersedes all prior





understandings of the Parties with respect thereto, except for Section 8 (“Non-Competition; Non-Solicitation”), Section 9 (“Non-Disclosure of Confidential Information and Trade Secrets”), Section 19 (“Binding Arbitration”) and Section 21 (“Statute of Limitations”) of the Employment Agreement, which shall remain in full force and effect.

(b).Arbitration. Except for a breach or threatened breach of Paragraph 11 hereof (“Non-Disclosure of Confidential Information, Non-Solicitation and Non-Competition”), any dispute, controversy or claim between Executive and the Company based on, arising out of or relating to this Separation Agreement or Executive’s employment by the Company or the termination thereof, including without limitation any and all claims under the Age Discrimination in Employment Act of 1967, Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act of 1990, the Family and Medical Leave Act, the Fair Labor Standards Act, the Employee Retirement Income Security Act of 1974, the Elliott-Larsen Civil Rights Act, the Michigan Persons with Disabilities Act, and any other federal, state or local law, statute or ordinance, shall be settled by final and binding arbitration, administered by the American Arbitration Association (“AAA”) pursuant to the Employment Arbitration Rules and Mediation Procedures of the AAA then in effect, provided that no depositions shall be permitted except to preserve the testimony of witnesses who would otherwise be unavailable at the hearing or for other extraordinary circumstances. Any such arbitration shall proceed in the State of Michigan before a single arbitrator. Except as otherwise required by law, each Party shall be responsible for the fees and expenses of its own attorneys and witnesses, and the fees and expenses of the arbitrator shall be divided equally between the Company and Executive. Judgment upon any resulting arbitration award shall be entered in any federal or state court of competent jurisdiction.

(c).Governing Law. This Agreement shall be governed by and interpreted in accordance with the laws of the State of Michigan without giving effect to principles of conflicts of law and as though made and to be fully performed in that state. Venue for any action arising from this Separation Agreement shall be exclusively in Auburn Hills, Michigan or the United States District Court for the Eastern District of Michigan.

(d).Waiver of Jury Trial. EXECUTIVE AND THE COMPANY EACH HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY OF ANY CLAIM OR CAUSE OF ACTION IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT OR EXECUTIVE’S EMPLOYMENT BY THE COMPANY. EXECUTIVE AND THE COMPANY EACH AGREE THAT ANY AND ALL SUCH CLAIMS AND CAUSES OF ACTION WILL BE TRIED BY THE COURT WITHOUT A JURY.

(e).Expenses. Each Party shall bear their respective expenses incurred or to be incurred in connection with the execution and delivery of this Separation Agreement.

(f).Successors and Assigns. This Separation Agreement may be assigned, without Executive’s consent, by the Company to any person, partnership, corporation or other entity which succeeds to all or substantially all of the business of the Company. This Separation Agreement may not be assigned by Executive without the prior written consent of the Company. This Separation Agreement shall be binding upon, and shall inure to the benefit of, the Parties and their respective legal representatives, estates, heirs, successors, and permitted assigns.

(g).Amendments; Waivers. No supplement, modification or amendment of this Separation Agreement will be binding unless executed in writing by each Party. No waiver of any provision of this Separation Agreement will be deemed to be or will constitute a continuing waiver. No waiver will be binding unless executed in writing by the Party making the waiver.






(h).Construction. The headings contained in this Separation Agreement are included for purposes of convenience only, and do not affect the meaning or interpretation of this Separation Agreement. Any reference to the singular in this Separation Agreement also includes the plural and vice versa.

(i).Severability. If any provision of this Separation Agreement or the application of any provision of this Separation Agreement to any Party or circumstance is, to any extent, invalid or unenforceable, the application of the remainder of such provision to such Party or circumstance, the application of such provision to other persons or circumstances, and the application of the remainder of this Separation Agreement will not be affected thereby. To the extent any provision of this Separation Agreement is enforceable in part but not in whole, such provision shall be enforced to the maximum extent permitted by applicable law.

(j).Notices. All notices and other communications required or permitted under this Separation Agreement (“Notices”) must be in writing. A Notice will be deemed to have been duly given (a) when delivered in person, (b) when sent by a reliable overnight courier service, such as Federal Express and signed for by or on behalf of a Party or (c) five Business Days after being sent by certified mail, return receipt requested, postage prepaid, as follows:

To the Company:
Unique Fabricating Incorporated
Standard Parkway
Auburn Hills, MI 48326
Attention: Corporate Secretary

With a copy (which shall not constitute notice) to:
Sills Cummis & Gross P.C.
One Riverfront Plaza
Newark, New Jersey 07102
Attn: Ira Rosenberg, Esq.

To Executive:
John Weinhardt    
    
    Any Party may change their address for the purposes of this paragraph by giving written notice as provided in this Separation Agreement.
(k).Third Party Beneficiaries. Except as expressly provided herein including Section 4 hereof as relating to Releasees, the provisions of this Separation Agreement are for the sole benefit of the Parties, and do not create any third party beneficiary rights in any other person.

(l).Rights and Remedies. Except to the extent provided in this Separation Agreement, all rights and remedies of any Party shall be independent and cumulative and may be exercised concurrently or separately. The exercise of any one right or remedy shall not constitute an election of such right or remedy or preclude or waive the exercise of any other right or remedy.
(m).Representations. Each Party represents and warrants to the other Party that its or his execution, delivery and performance of this Separation Agreement will not breach or otherwise conflict with any contract to which they are a party, subject or bound.






(n).Attorney. Executive acknowledges and agrees that Executive has had the opportunity to consult with an attorney of Executive’s choosing and has consulted with such attorney in connection with this Separation Agreement or knowingly and voluntarily declined to do so.

(o).Counterparts. This Agreement may be executed in counterparts. Counterpart signature pages may be delivered by fax and/or PDF format. Each counterpart will be deemed an original. All counterparts will constitute one and the same instrument.

(p).Section 409A.
(1)It is the intention of the Parties that this Separation Agreement comply with the requirements of Section 409A of the Internal Revenue Code of 1986, as amended, and applicable guidance issued thereunder (“Section 409A”), and this Separation Agreement will be interpreted in a manner intended to comply with Section 409A. All payments under this Separation Agreement are intended to be excluded from the requirements of Section 409A or be payable on a fixed date or schedule in accordance with Section 409A(a)(2)(iv). Executive shall be solely responsible and liable for the satisfaction of all taxes and penalties that may be imposed upon Executive in connection with this Separation Agreement (including any taxes and penalties under Section 409A), and shall indemnify and hold the Company harmless from any or all of such taxes or penalties.

(2)Notwithstanding anything in this Separation Agreement to the contrary, in the event that Executive is deemed to be a “specified employee” within the meaning of Section 409A(a)(2)(B)(i) and is not “disabled” within the meaning of Section 409A(a)(2)(C), no payments hereunder that are “deferred compensation” subject to Section 409A shall be made to Executive prior to the date that is six months after the date of Executive’s “separation from service” (as defined in Section 409A and any Treasury Regulations promulgated thereunder) or, if earlier, Executive’s date of death. Following any applicable six (6) month delay, all such delayed payments will be paid in a single lump sum on the earliest permissible payment date. For purposes of this Separation Agreement, with respect to payments of any amounts that are considered to be “deferred compensation” subject to Section 409A, references to “termination of employment” (and substantially similar phrases) shall be interpreted and applied in a manner that is consistent with the requirements of Section 409A for a “separation of service.” For purposes of Section 409A, Executive’s right to receive any installment payment pursuant to this Separation Agreement will be treated as a right to receive a series of separate and distinct payments.

(3)All reimbursements and in-kind benefits provided under this Agreement shall be made or provided in accordance with Section 409A, including, where applicable, the requirement that (a) any reimbursement is for expenses incurred during the period of time specified in this Agreement, (b) the amount of expenses available for reimbursement, or the in-kind benefits provided, during a calendar year may not affect the expenses eligible for reimbursement, or in-kind benefits provided, in any other calendar year, (c) the reimbursement of an eligible expense will be made no later than the last day of the calendar year following the year in which the expense is incurred, and (d) the right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit.

IN WITNESS WHEREOF, the Parties have executed this Separation Agreement on the dates indicated below.





EXECUTIVE:
COMPANY:




     /s/ John Weinhardt
John Weinhardt


Date: May 10, 2019
UNIQUE FABRICATING, NA, INC.

By: _____________________________

Name: ___________________________

Title: Authorized Signatory

Date: May 10, 2019








5
 

CONSULTING AGREEMENT

THIS CONSULTING AGREEMENT (this “Agreement”) is made as of the 15th day of May, 2019 (the “Effective Date”), by and between Unique Fabricating NA, Inc., a Delaware corporation (the “Company”), and Kim Korth (“Consultant”).

In consideration of the mutual promises and agreements set forth herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, agree as follows:

1.Consulting Services. The Company hereby engages Consultant to perform the services specified on the attached Schedule 1 (the “Services”). The parties agree that Consultant shall (a) provide the Services in person, by correspondence or by telephone and devote that number of days required to successfully perform such Services as determined by the Company in its discretion; (b) perform all Services in a professional and workmanlike manner; and (c) not knowingly infringe upon any third party’s intellectual property rights in performing the Services or otherwise complying with the terms of this Agreement. To the extent the Company requires that Consultant perform any additional services not specified on Schedule 1, the parties shall mutually agree on the actual number of additional days that Consultant shall devote, as well as the appropriate rate of compensation. Consultant shall perform the Services at the Company’s principal offices or such other location as may be mutually agreed upon by the parties.

2.Term; Termination. The term of this Agreement (the “Term”) shall commence on the Effective Date and shall end upon the earlier of September 15, 2019 or completion of the Services to the satisfaction of the Company (the “Expiration Date”), subject to earlier termination as provided in this paragraph. The Term may be extended upon the mutual written consent of the Company and Consultant. The Company may terminate this Agreement at any time prior to the Expiration Date upon written notice to Consultant and this Agreement shall terminate without notice to Consultant upon the death or disability of Kim Korth. For purposes hereof, disability shall have the same meaning as the term “permanent and total disability” under Section 22(e)(3) of the Internal Revenue Code of 1986, as amended, and the rules and regulations thereunder. Consultant may terminate this Agreement prior to the Expiration Date upon thirty (30) days’ prior written notice to the Company.

3.Compensation and Expenses. For performance of the Services, the Company shall pay Consultant at the rate of $25,000 per month. Consultant shall be reimbursed for all reasonable and necessary expenses incurred by it while performing the Services, subject to first obtaining the prior approval by the Company of any such expense. All fees and expenses set forth herein shall accrue from the Effective Date of this Agreement and shall be paid promptly by the Company after Consultant’s submission of the required supporting documentation. Other than as specifically set forth in this Section 3, Consultant acknowledges and agrees that it: (a) shall not be entitled to any other compensation or incentives from the Company; (b) is responsible for any and all other expenses, costs, charges and taxes of any kind incurred in connection with this Agreement, including, without limitation, all federal, state and local withholding taxes, and any other taxes that in any way relate to compensation paid by the Company to Consultant under this Agreement; and (c) shall indemnify and hold the Company and its directors, officers and employees harmless from and against any claims, debts, obligations or liabilities arising from any compensation or expenses paid pursuant to this Agreement.





4.Work Product. “Work Product” means all inventions, discoveries, software, works, products, processes, methods, materials, data, documentation, specifications, designs, reports, other works of authorship, or other deliverables, whether or not protectable by patent, trade secret or copyright, that are developed, conceived or reduced to practice by Consultant, either alone or with others, in the performance of Services hereunder, including, without limitation, any and all intellectual property rights therein. Consultant agrees that any copyrightable work created by Consultant under this Agreement constitutes a “work-for-hire” to the extent allowed by applicable law, with all right, title and interest in such copyrightable work belonging to the Company. Consultant shall, at the Company’s expense, execute documents and provide other reasonable assistance as requested by the Company to assist the Company to evidence and perfect its ownership of the Work Product and any available patent, copyright or other legal protection for the Work Product. The Company shall pay Consultant for any such assistance, other than for the execution of documents, on a time and materials basis at a mutually agreed upon rate.

5.Confidentiality. Consultant agrees to maintain in confidence all information that it has received or developed or may receive or develop, or to which it has been exposed or may be exposed as a result of the activities with the Company under this Agreement (“Confidential Information”). Consultant further agrees that it shall not disclose such Confidential Information to any third party, nor permit use of the same for the benefit of itself or others, without the express written consent of the Company. At the request of the Company, Consultant shall promptly return or give to the Company all Confidential Information (including all samples, documentation, information, and derivative information, including Consultant’s notes and prototypes which have been generated as a result of the Services).

6.     Restrictive Covenants.
         (a)     Non-Competition. Consultant acknowledges that the Company is engaged in the business of engineering and manufacturing multi-material foam, rubber and plastic components used in noise, vibration and harshness acoustical management, water sealing, for the North American automotive and heavy duty truck and the appliance, water heater and HVAC industries and markets (the “Field of Interest”) and that any engagement by Consultant, directly or indirectly, in the Field of Interest may be detrimental to the Company. Consultant agrees that, during the term of this Agreement and for a period of 12 months thereafter, it shall not, without the prior written consent of the Company, for it or on behalf of any other person or entity, directly or indirectly, either as principal, agent, employee, consultant, representative or in any other capacity, own, manage, operate or control, or be connected or employed by, or otherwise associate in any manner with, or engage in any business which is in all or any part of the Field of Interest anywhere in the world; provided that ownership, directly or indirectly, of less than one percent (1%) of the outstanding equity of a publicly-traded entity or fund shall not be deemed a breach of the foregoing restriction.
         (b)     Non-Solicitation/Diversion. Consultant hereby agrees that, during the term of this Agreement and for a period of 12 months thereafter, that it shall not, without the prior written consent of the Company, directly or indirectly, either individually or on behalf of or through any other person, business, enterprise or entity (other than the Company) (a) solicit or induce, or in any manner attempt to solicit or induce, any person employed by, an agent of, or a service provider to, the Company to terminate such person’s employment, agency or service, as the case may be, with the Company; or (b) divert, or attempt to divert, any person, concern, or entity from doing business with the Company, or attempt to induce any such person, concern or entity to cease being a licensor, customer or supplier of the Company or from doing business with the Company.

7.     Reasonableness of Restrictions; Independence. Consultant recognizes and acknowledge that the restrictions and limitations set forth in this Agreement, including such provisions set forth in Sections 5





and 6 above, are legitimate and fair in light of its access to confidential and proprietary information of the Company and its relationship with the Company. Each of the rights of the Company enumerated in this Agreement shall be independent of the others and shall be in addition to and not in lieu of any other rights and remedies available to the Company at law or in equity.

8.    Cooperation with the Company after Termination. Following expiration or earlier termination of this Agreement for any reason, Consultant shall fully cooperate with the Company in all matters relating to the winding up of Consultant’s Services and the orderly transfer of such matters to any person designated by the Company and shall promptly return to the Company all of the property of the Company and any other materials or information related to the Company, including all work product, whether finished or unfinished, prepared or produced by Consultant for the benefit of the Company under this Agreement. Consultant shall be reasonably available, at the Company’s expense, to the Company in connection with any threatened, actual or future litigation or dispute involving the Company (collectively, “Future Litigation”) in which, and to the extent that, Consultant’s availability is deemed necessary or desirable by the Company.
9.    No Conflict. Consultant hereby represents and warrants to the Company that: (a) this Agreement constitutes Consultant’s legal and binding obligation, enforceable against it in accordance with its terms; (b) its execution and performance of this Agreement does not and shall not breach any other agreement, arrangements, understanding, obligation of confidentiality or employment relationship to which it is a party or by which it is bound; and (c) during the Term, it shall not enter into any agreement, either written or oral, in conflict with this Agreement or its obligations hereunder.
10.    Independent Contractor. It is understood and agreed that this Agreement does not create any relationship of association, partnership or joint venture between the parties, nor create any implied licenses, nor constitute either party as the agent or legal representative of the other for any purpose whatsoever; and the relationship of Consultant to the Company for all purposes, including, but not limited to, federal and state tax purposes, shall be one of independent contractor. Neither party shall have any right or authority to create any obligation or responsibility, express or implied, on behalf or in the name of the other, or to bind the other in any manner whatsoever.
11.    Remedies. 12.     Miscellaneous
(a)Successors and Assigns; Entire Agreement; No Assignment; Severability. This Agreement shall bind and inure to the benefit of the parties hereto and their respective successors or heirs, distributees and personal representatives. This Agreement contains the entire agreement between the parties with respect to the subject matter hereof and supersedes other prior and contemporaneous arrangements or understandings with respect thereto. Consultant may not assign this Agreement without the prior written consent of the Company. If any portion of this Agreement is deemed unenforceable, such provision shall be enforced to the fullest extent permitted by law and the remainder of this Agreement shall remain in full force and effect.
(b)Notices. All notices, consents and other communications under this Agreement shall be in writing and shall be deemed to have been duly given (a) when delivered by hand, (b) seven (7) business days after the business day of transmission, if sent by telecopier (with receipt confirmed), provided that a copy is mailed by registered mail, return receipt requested, or (c) seven (7) business day after the business day of deposit with the carrier, if sent by Express Mail, Federal Express or other nationally-recognized express delivery service (receipt requested), in each case to the appropriate addresses and telecopier numbers as follows: If to the Company: Unique Fabricating NA, Inc., 800 Standard Parkway, Auburn Hills, MI 48326, Attention: Chief Financial Officer. If to Consultant: Kim Korth, Facsimile: ______________.





(c)Changes; No Waiver. The terms and provisions of this Agreement may not be modified or amended, or any of the provisions hereof waived, temporarily or permanently, without the prior written consent of each of the parties hereto. The Company’s waiver or failure to enforce the terms of this Agreement or any similar agreement in one instance shall not constitute a waiver of its rights hereunder with respect to other violations of this or any other agreement.
(d)Governing Law; Jurisdiction. This Agreement and (unless otherwise provided) all amendments hereof and waivers and consents hereunder shall be governed by the internal law of the State of Michigan, without regard to the conflicts of law principles thereof. Each party hereby submits itself, for the sole purpose of this Agreement and any controversy arising hereunder, to the exclusive jurisdiction of the state and Federal courts located in the State of Michigan, and waives any objection (on the grounds of lack of jurisdiction, forum non conveniens or otherwise) to the exercise of such jurisdiction over it by any such court in the State of Michigan. Each party hereby agrees that service of process may be served on it by certified mail, return receipt requested, or overnight courier, sent to address of such entity listed in Section 12(b) above (or such other address as any such party notifies the others thereof by written notice).
(e)Survival. The obligations and responsibilities of Consultant under the Sections 4, 5 and 6 of this Agreement shall remain in full force and effect and survive expiration or termination of this Agreement.
(f)Fees and Expenses. The parties hereby agree that each party shall each bear his, her or its own legal and other expenses with respect to these transactions.


IN WITNESS WHEREOF, the parties have executed this Consulting Agreement on the date written below.


UNIQUE FABRICATING NA, INC.


By:____________________    
Name: Richard Baum
Title: Chairman

CONSULTANT:
6th Avenue Group



By:_________________________
Name: Kim Korth
Title: President    
 



 











SCHEDULE A
DESCRIPTION OF SERVICES





CEO Transition Services including onsite (once per week) and telephonic meetings as required., weekly board updates and CEO search assistance.






Unique Fabricating, Inc.
2014 Omnibus Performance Award Plan
NQO AWARD AGREEMENT
Unique Fabricating, Inc., a Delaware corporation (the “Corporation”), pursuant to the terms of its 2014 Omnibus Performance Award Plan (the “Plan”) and the Non-Qualified Stock Option Award attached to this NQO Award Agreement, hereby grants to the individual named below the option to purchase the number of shares of the Corporation’s Common Stock, also as is set forth below. The terms of this NQO Award Agreement are subject to all of the provisions of the Plan and the attached Non-Qualified Stock Option Award, with such provisions being incorporated herein by reference.
1.    Date of Grant:        June 11, 2019
2.    Name of Participant:    Kim Korth
3.    Number of Shares:    30,000 of Common Stock
4.    Exercise Price:    $2.93 per Share of Common Stock.
5.    Vesting of Options:    100% Vested Upon Grant
6.    Expiration Date:    June 11, 2029
The Participant acknowledges receipt of, and understands and agrees to be bound by all of the terms of this NQO Award Agreement, the attached Non-Qualified Stock Option Award and the Plan, and that the terms thereof supersede any and all other written or oral agreements between the Participant and the Corporation regarding the subject matter contained herein.
Unique Fabricating, Inc.:


By:
Title:Date:
Participant:



Name:Date:



















NON-QUALIFIED STOCK OPTION AWARD
THIS AGREEMENT made as of the grant date set forth in Section 1 of the NQO Award Agreement to which this Agreement is attached (the “Date of Grant”) between Unique Fabricating, Inc., a Delaware corporation (hereinafter referred to as the “Corporation”), and the individual identified in Section 2 of the NQO Award Agreement to which this Agreement is attached (hereinafter referred to as the “Participant”).

W I T N E S S E T H:
WHEREAS, the Corporation desires, in connection with the engagement of [Name of Entity], as a consultant (the “Consultant”), to grant to the Participant, an officer and principal equity holder of Consultant and in accordance with its 2014 Omnibus Performance Award Plan (the “Plan”), to provide the Participant with an opportunity to acquire Common Stock of the Corporation on favorable terms and thereby increase her proprietary interest in the continued progress and success of the business of the Corporation;
NOW, THEREFORE, in consideration of the premises, the mutual covenants herein set forth and other good and valuable consideration, the Corporation and the Participant hereby agree as follows:
1.Confirmation of Grant of Option. Pursuant to a determination by the Committee, the Corporation, subject to the terms of the Plan and this Agreement, hereby grants to the Participant as a matter of separate inducement and agreement, and in addition to and not in lieu of salary or other compensation for services by Participant or Consultant, the right to purchase (hereinafter referred to as the “Option”) an aggregate number of shares of Common Stock as is set forth in Section 3 of the attached NQO Award Agreement, subject to adjustment as provided in the Plan (such shares, as adjusted, hereinafter being referred to as the “Shares”). The Option is not intended to qualify as an incentive stock option under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”).

2.Purchase Price. The purchase price of shares of Common Stock covered by the Option will be the per share amount set forth in Section 4 of the attached NQO Award Agreement, at all times being not less than 100% of the Fair Market Value of one share of Common Stock on the Date of Grant, subject to adjustment as provided in the Plan.

3.Exercise of Option. The Option shall be exercisable on the terms and conditions hereinafter set forth:
(a)The Option shall become exercisable cumulatively as to the number of Shares originally subject thereto (after giving effect to any adjustment pursuant to the Plan), and on the date, as set forth in Section 5 of the attached NQO Award Agreement.

(b)The Option may be exercised pursuant to the provisions of this Section 3, by notice and payment to the Corporation as provided in Sections 9 and 13 hereof.

4.Term of Option. The term of the Option shall be the period of years from the Date of Grant as is set forth in Section 1 of the attached NQO Award Agreement and shall expire on the date set forth in Section 6 of the NQO Award Agreement, subject to earlier termination or cancellation as provided in this Agreement.






5.Non transferability of Option. The Option shall not be assigned, transferred or otherwise disposed of, or pledged or hypothecated in any way, and shall not be subject to execution, attachment or other process, except as may be provided in the Plan. Any assignment, transfer, pledge, hypothecation or other disposition of the Option attempted contrary to the provisions of the Plan, or any levy of execution, attachment or other process attempted upon the Option, will be null and void and without effect. Any attempt to make any such assignment, transfer, pledge, hypothecation or other disposition of the Option will cause the Option to terminate immediately upon the happening of any such event; provided, however, that any such termination of the Option under the foregoing provisions of this Section 5 will not prejudice any rights or remedies which the Corporation or any Affiliate may have under this Agreement or otherwise.

6.Exercise Upon Termination of Service. (a) If, the Consultant for any reason (other than Disability or death of Participant or the satisfactory conclusion of the provision of services by Consultant in accordance with Consultant’s engagement by the Corporation or its Affiliates (“Satisfactory Conclusion”)) incurs a Termination of Consulting Relationship, the Option may, subject to the provisions of Section 5 hereof, be exercised by the Participant to the same extent the Participant would have been entitled under Section 3 hereof to exercise the Option immediately prior to such Termination of Service, at any time within one year after such Termination of Service, at the end of which period the Option, to the extent not then exercised, shall terminate and the Participant shall forfeit all rights hereunder, even if the Consultant subsequently returns to the Service of the Corporation or any Affiliate. For avoidance of doubt, if the Termination of Service is as a result of a Satisfactory Conclusion, the Term shall continue until the date as provided in Section 4. In no event, however, may the Option be exercised after the expiration of the term provided in Section 4 hereof.

(a)The Option shall not be affected by any change of duties or position of the Consultant or Participant so long as Participant continues to be in Service of the Consultant or of any Affiliate thereof. If the Participant is granted a temporary leave of absence of 90 days or less, such leave of absence shall be deemed a continuation of her Service by Consultant or of any Affiliate thereof for the purposes of this Agreement, but only if and so long as the Company consents thereto.

7.Exercise Upon Death or Disability. (a) If the Consultant incurs a Termination of Consulting Relationship due to Participant’s death, and on or after the first date upon which she would have been entitled to exercise the Option under the provisions of Section 3 hereof, the Option may, subject to the provisions of Section 5 hereof, be exercised (to the same extent the Participant would have been entitled under Section 3 hereof to exercise the Option immediately prior to her death), by the estate of the Participant (or by the person or persons who acquire the right to exercise the Option by written designation of the Participant) at any time within one year after the death of the Participant, at the end of which period the Option, to the extent not then exercised, shall terminate and the estate or other beneficiaries shall forfeit all rights hereunder. In no event, however, may the Option be exercised after the expiration of the term provided in Section 4 hereof.

(a)In the event that the Service of the Consultant with the Corporation or an Affiliate is terminated by reason of the Disability of the Participant and on or after the first date upon which she would have been entitled to exercise the Option under the provisions of Section 3 hereof, the Option may, subject to the provisions of Section 5 hereof, be exercised (to the same extent the Participant would have been entitled under Section 3 hereof to exercise the Option immediately prior to her termination due to Disability) by or on behalf of the Participant within the period ending one year after the date of such Termination of Service, at the end of which period the Option, to the extent not then exercised, shall terminate and the Participant shall forfeit all rights hereunder even if the Participant or Consultant subsequently returns





to the Service of the Corporation or any Affiliate. In no event, however, may the Option be exercised after the expiration of the term provided in Section 4 hereof.

8.Registration. At the time of issuance, the shares of Common Stock subject hereto and issuable upon the exercise hereof may not be registered under the Securities Act of 1933, as amended, and, if required upon the request of counsel to the Corporation, the Participant will give a representation as to her investment intent with respect to such shares prior to their issuance. The Corporation may register or qualify the shares covered by the Option for sale pursuant to the Securities Act of 1933, as amended, at any time prior to or after the exercise in whole or in part of the Option.

9.Method of Exercise of Option. (a) Subject to the terms and conditions of this Agreement, the Option shall be exercisable by notice in the manner set forth in Exhibit “A” hereto (the “Notice”) and provision for payment to the Corporation in accordance with the procedure prescribed herein. Each such Notice shall:
(i)state the election to exercise the Option and the number of Shares with respect to which it is being exercised;

(ii)contain a representation and agreement as to investment intent, if required by counsel to the Corporation with respect to such Shares, in a form satisfactory to counsel to the Corporation;

(iii)be signed by the Participant or the person or persons entitled to exercise the Option and, if the Option is being exercised by any person or persons other than the Participant, be accompanied by proof, satisfactory to counsel to the Corporation, of the right of such other person or persons to exercise the Option;

(iv)include payment of the full purchase price for the shares of Common Stock to be purchased pursuant to such exercise of the Option; and

(v)be received by the Corporation on or before the date of the expiration of this Option. In the event the date of expiration of this Option falls on a day which is not a regular business day at the Corporation’s executive office in Auburn Hills, Michigan then such written Notice must be received at such office on or before the last regular business day prior to such date of expiration.

(b)     Payment of the purchase price of any shares of Common Stock, in respect of which the Option shall be exercised, shall be made by the Participant or such person or persons at the place specified by the Corporation on the date the Notice is received by the Corporation (i) by delivering to the Corporation a certified or bank cashier’s check payable to the order of the Corporation, (ii) by delivering to the Corporation properly endorsed certificates of shares of Common Stock (or certificates accompanied by an appropriate stock power) with signature guaranties by a bank or trust company, (iii) by having withheld from the total number of shares of Common Stock to be acquired upon the exercise of this Option a specified number of such shares of Common Stock, or (iv) by any combination of the foregoing. For purposes of the immediately preceding sentence, an exercise effected by the tender of Common Stock (or deemed to be effected by the tender of Common Stock) may only be consummated with Common Stock held by the Participant for a period of six (6) months or acquired by the Participant other than under the Plan (or a similar plan maintained by the Corporation).

(c)     The Option shall be deemed to have been exercised with respect to any particular shares of Common Stock if, and only if, the preceding provisions of this Section 9 and the provisions of





Section 10 hereof shall have been complied with, in which event the Option shall be deemed to have been exercised on the date the Notice was received by the Corporation. Anything in this Agreement to the contrary notwithstanding, any Notice given pursuant to the provisions of this Section 9 shall be void and of no effect if all of the preceding provisions of this Section 9 and the provisions of Section 10 shall not have been complied with..

(d)The certificate or certificates for shares of Common Stock as to which the Option shall be exercised will be registered in the name of the Participant (or in the name of the Participant’s estate or other beneficiary if the Option is exercised after the Participant’s death), or if the Option is exercised by the Participant and if the Participant so requests in the notice exercising the Option, will be registered in the name of the Participant and another person jointly, with right of survivorship and will be delivered as soon as practical after the date the Notice is received by the Corporation (accompanied by full payment of the exercise price), but only upon compliance with all of the provisions of this Agreement.

(e)If the Participant fails to accept delivery of and pay for all or any part of the number of Shares specified in such Notice, her right to exercise the Option with respect to such undelivered Shares may be terminated in the sole discretion of the Committee. The Option may be exercised only with respect to full Shares.

(f)The Corporation shall not be required to issue or deliver any certificate or certificates for shares of its Common Stock purchased upon the exercise of any part of the Option prior to the payment to the Corporation, upon its demand, of any amount requested by the Corporation for the purpose of satisfying its minimum statutory liability, if any, to withhold federal, state or local income or earnings tax or any other applicable tax or assessment (plus interest or penalties thereon, if any, caused by a delay in making such payment) incurred by reason of the exercise of this Option or the transfer of shares thereupon. Such payment shall be made by the Participant in cash or, with the written consent of the Corporation, by tendering to the Corporation shares of Common Stock equal in value to the amount of the required withholding. In the alternative, the Corporation may, at its option, satisfy such withholding requirements by withholding from the shares of Common Stock to be delivered to the Participant pursuant to an exercise of the Option a number of shares of Common Stock equal in value to the amount of the required withholding.

10.Approval of Counsel. The exercise of the Option and the issuance and delivery of shares of Common Stock pursuant thereto shall be subject to approval by the Corporation’s counsel of all legal matters in connection therewith, including, but not limited to, compliance with the requirements of the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder, and the requirements of any stock exchange or automated trading medium upon which the Common Stock may then be listed or traded.

11.Reservation of Shares. The Corporation shall at all times during the term of the Option reserve and keep available such number of shares of Common Stock as will be sufficient to satisfy the requirements of this Agreement.

12.Limitation of Action. The Participant and the Corporation each acknowledges that every right of action accruing to her or it, as the case may be, and arising out of or in connection with this Agreement against the Corporation or an Affiliate, on the one hand, or against the Participant, on the other hand, shall, irrespective of the place where an action may be brought, cease and be barred by the expiration of three years from the date of the act or omission in respect of which such right of action arises.






13.Notices. Each notice relating to this Agreement shall be in writing and delivered in person, by recognized overnight courier or by certified mail to the proper address. All notices to the Corporation or the Committee shall be addressed to them at 800 Standard Parkway, Auburn Hills, Michigan 48326, Attn: Chief Financial Officer. All notices to the Participant shall be addressed to the Participant or such other person or persons at the Participant’s address set forth in the Corporation’s records. Anyone to whom a notice may be given under this Agreement may designate a new address by notice to that effect.
14.Benefits of Agreement. This Agreement shall inure to the benefit of the Corporation, the Participant and their respective heirs, executors, administrators, personal representatives, successors and permitted assignees.

15.Severability. In the event that any one or more provisions of this Agreement shall be deemed to be illegal or unenforceable, such illegality or unenforceability shall not affect the validity and enforceability of the remaining legal and enforceable provisions hereof, which shall be construed as if such illegal or unenforceable provision or provisions had not been inserted.

16.Governing Law. This Agreement will be construed and governed in accordance with the laws of the State of Delaware without regard to its principles of conflicts of law. In the event that either party is compelled to bring a claim related to this Agreement, to interpret or enforce the provisions of the Agreement, to recover damages as a result of a breach of the Agreement, or from any other cause (a “Claim”), such Claim must be processed in the manner set forth below:

(i)THE SOLE AND EXCLUSIVE METHOD TO RESOLVE ANY CLAIM IS ARBITRATION, EACH PARTY WAIVES THE RIGHT TO A JURY TRIAL OR COURT TRIAL. Neither party shall initiate or prosecute any lawsuit in any way related to any Claim covered by this Agreement.

(ii)The arbitration shall be binding and conducted before a single arbitrator in accordance with the then-current JAMS Arbitration Rules and Procedures for Employment Disputes or the appropriate governing body, as modified by the terms and conditions of this paragraph. Venue for any arbitration pursuant to this Agreement will lie in Auburn Hills, Michigan. The arbitrator will be selected by mutual agreement of the parties or, if the parties cannot agree, then by striking from a list of arbitrators supplied by JAMS or the appropriate governing body. The Corporation shall pay the arbitrator’s fees and arbitration costs (recognizing that each side bears the cost of its own deposition(s), witness, expert and attorneys’ fees and other expenses as and to the same extent as if the matter were being heard in a court of law). Upon the conclusion of the arbitration hearing, the arbitrator shall issue a written opinion revealing, however briefly, the essential findings and conclusions upon which the arbitrator’s award is based. The award of the arbitrator shall be final and binding. Judgment upon any award may be entered in any court having jurisdiction thereof.

17.Service. Nothing contained in this Agreement shall be construed as (a) a contract of employment between the Participant and the Corporation or any Affiliate or a contract of engagement between the Consultant and the Corporation or any Affiliate, (b) a right of the Participant or Consultant to be continued in the Service of the Corporation or of any Affiliate, or (c) a limitation of the right of the Corporation or of any Affiliate to discharge the Participant or Consultant at any time, with or without cause (subject to any applicable employment or consulting agreement).

18.Definitions. Unless otherwise defined herein, all capitalized terms used in this Agreement shall have the same definitions as set forth in the Plan.






19.Incorporation of Terms of Plan. This Agreement shall be interpreted under, and subject to, all of the terms and provisions of the Plan, which are incorporated herein by reference.

20.No Strict Construction. The language used in this Agreement shall be deemed to be the language chosen by the parties hereto to express their mutual intent, and no rule of strict construction shall apply against any party.
BY WAY OF THEIR EXECUTION OF THE NQO AWARD AGREEMENT TO WHICH THIS AGREEMENT IS ATTACHED, the Corporation and the Participant (and each and every one of their heirs, successors and assigns) agree to be bound by each and every one of the terms set forth in this Agreement.































EXHIBIT A
NON-QUALIFIED OPTION EXERCISE FORM
[DATE]
Unique Fabricating, Inc.
800 Standard Parkway
Auburn Hills, MI 48326
Attention: Chief Financial Officer

Dear Sirs:
Pursuant to the provisions of the Non-Qualified Stock Option Award and related NQO Award Agreement dated May __, 2019 (collectively, the “Agreement”), whereby you have granted to me a Non-Qualified Stock Option (the “Option”) to purchase up to [20,000   ] shares of the Common Stock of [   ] (the “Corporation”) subject to the terms of the Agreement, I hereby notify you that I elect to exercise my option to purchase [   ] of the shares of Common Stock covered by such Option at the [$___] per share price specified therein. In full payment of the price for the shares being purchased hereby, I am delivering to you herewith (i) certified or bank cashier’s check payable to the order of the Corporation in the amount of $____________, or (ii) a certificate or certificates for [   ] shares of Common Stock of the Corporation, and which have a fair market value as of the date hereof of $___________, [and a certified or bank cashier’s check, payable to the order of the Corporation, in the amount of $________________]. Any such stock certificate or certificates are endorsed, or accompanied by an appropriate stock power, to the order of the Corporation, with my signature guaranteed by a bank or trust company or by a member firm of the New York Stock Exchange.
Very truly yours,



______________________________
[Address]
(For notices, reports, dividend checks and other communications to stockholders.





Exhibit 31.1
CERTIFICATION OF INTERIM CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350.
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Thomas Tekiele, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Unique Fabricating, Inc..;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 7, 2019
By:
/s/ Thomas Tekiele
 
 
Name: Thomas Tekiele
 
 
Title:  Interim Chief Executive Officer





Exhibit 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350.
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Thomas Tekiele, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Unique Fabricating, Inc..;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 7, 2019
By:
/s/ Thomas Tekiele
 
 
Name: Thomas Tekiele
 
 
Title:  Chief Financial Officer (Principal Financial and Accounting Officer)





Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350.
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
Under 18 U.S.C. section 1350, adopted by section 906 of the Sarbanes-Oxley Act of 2002, in connection with the attached periodic report, the undersigned each certify that (i) the periodic report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (ii) the information contained in the periodic report fairly presents, in all material respects, the financial condition and results of operations of the issuer.
 
Date: August 7, 2019
By:
/s/ Thomas Tekiele
 
 
Name: Thomas Tekiele
 
 
Title:  Interim Chief Executive Officer and Chief Financial Officer (Principal Financial and Accounting Officer)
 
 
 
The foregoing certification is being furnished as an exhibit to the Form 10-Q pursuant to Item 601(b)(32) of Regulation S-K and Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) and, accordingly, is not being filed as part of the Form 10-Q for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and is not incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.